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Abstract 
This thesis details the development of a gold-catalysed, ketone-stabilised ylide synthesis and the 
intermolecular reaction of this ylide.  The reaction of this ylide with butenone proceeds via a novel, 
three-component coupling.  This represents the first intermolecular reaction of a gold-derived ylide. 
 
Figure 1: Intermolecular reaction of a gold-derived ylide 
The development of a novel, gold-catalysed, amide-stabilised ylide synthesis was also successful.  The 
ylides underwent 2,3-sigmatropic rearrangements and Stevens 1,2-shifts.  The Stevens 
rearrangement has previously not been reported for gold-derived ylides.  These ylide 
transformations gave a range of novel, polysubstituted thiomorpholinones, which are difficult to 
access via classical approaches.  The amide-stabilised ylides were found to be unsuitable for 
intermolecular reaction. 
 
Figure 2: Intermolecular reaction of gold-derived thiomorpholinone ylides 
 
Thioynol ethers were also investigated as triple-bonded substrates for gold-catalysed reactions.   
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Figure 3: Thioynol ethers as triple bonds for gold catalysis 
While the thioynol ethers were found to be significantly less reactive than the equivalent alkyne or 
ynamide, it was possible employ them for the synthesis of oxazoles in comparable yield to ynol 
ethers.  
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Chapter 1: Introduction 
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Oxidative synthesis of gold carbenoids from triple bonds via precious metal 
catalysis  
This chapter aims to review the development of the field of catalytic α-keto and α-imido gold 
carbenoid synthesis and to introduce the recent developments in ylide synthesis via these gold 
carbenoids.  These carbenoids are obtained by a gold-catalysed redox cascade, where X and Y are 
heteroatoms, such as sulfoxides or N-oxides (Scheme 1). 
 
Scheme 1:  General gold-catalysed redox cascade 
The general process for these reactions occurs via the intra- or intermolecular nucleophilic addition 
of a dipolar nucleophile to a gold-activated triple bond 1.  The cationic portion of the dipole is 
eliminated from the resulting zwitterionic gold complex 2, resulting in an α-keto or α-imido gold 
carbenoid complex (3 & 4), which may be harnessed to access further reactivity. 
Gold catalysis is typified by mild reaction conditions and exceedingly selective catalyst reactivity 
which, combined with the reactivity of a carbene, gives a powerful synthetic tool.1, 2  Gold carbenoid 
complexes have been known since 1973,3, 4 however their application was limited to stoichiometric 
processes and it was not until the advent of catalytic carbenoid syntheses, that they were employed 
in reactions with real synthetic utility.  Over the last eight years, gold carbenoids have been accessed 
in a number of ways, the classic approach of metal-catalysed decomposition of a diazo compound 
being the most straightforward.  For example, in 2005, Nolan, Pérez and co-workers demonstrated 
that NHC-ligated gold complexes can catalyse these reactions, reporting a range of simple 
cyclopropanations with their newly developed IPrAuCl catalyst (Scheme 2).5    
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Scheme 2: Gold-catalysed cyclopropanation with ethyl diazoacetate 
The use of diazo derivatives is not attractive however, given their toxicity and instability.6-8  More 
elegantly, carbenoids may be accessed via the rearrangement of an alkynyl ester or during enyne 
cyclisation reactions.  These rearrangements are well explored and have been applied to a variety of 
different metal carbenoids.9-16  For example in 2005 Toste and co-workers demonstrated that the 
gold-catalysed rearrangement of propargyl pivalate 8, could access the desired carbenoid moiety 11. 
The carbenoid was subsequently trapped with good stereocontrol, difficult to achieve with a gold 
catalyst (Scheme 3).17   
 
Scheme 3: Toste’s pivaloyl rearrangement 
This carbenoid was subsequently trapped by a range of alkenes and use of a suitable chiral ligand 
gave control over the stereochemistry of the resulting cyclopropane 12.  These early approaches 
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allowed access to the desired carbenoid functionality; however they have a significant drawback, 
requiring the pre-installation of a migrating group, cyclising group or sacrificial diazo moiety.  
Bonding in gold carbenoids 
Despite the widespread application of gold catalysis, the exact nature of the Au-C bonding in gold 
carbenoid complexes remains unclear.  Whether these complexes exist as gold-stabilised 
carbocations or gold carbenes has been a matter of considerable debate.18-21  
 
Scheme 4:  Cation vs. Carbene 
NMR spectroscopic observation of gold complexes by Fürstner’s group suggested that the complexes 
typically have a bond order approximately equal to or less than one, although the complexes studied 
were limited to phosphine-ligated gold catalysts.18, 22  DFT and NBO studies by Toste’s and Hashmi’s 
groups agree with this value, but also indicate the Au-C bond may possess both σ and π-bonding 
character, allowing it to function as a gold carbene (Scheme 5).23, 24 The degree of π-bonding is 
dependent upon the substrate and ligand, suggesting that carbenoid character is a tuneable 
property.25  These gold complexes cannot be described as purely “carbene”- or “cation”-like and in 
their review of π-acid catalysis, Fürstner and Davies recommend that the bonding of these complexes 
be considered as a continuum, with the carbene and cation at the two extremes (Scheme 4).20 
 
Scheme 5: Toste's DCD model for Au(I) carbenoid bonding 
Toste’s and Hashmi's models describe the ligand and alkylidene σ-interactions with the gold as a 3 
centre, 4-electron hyperbond, as the Au(I) only possesses one free valence orbital.  Strong σ-donor 
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ligands therefore weaken the overall σ-bond, leading to an increase in the Au-C bond length.  The 
gold centre can also π-bond to the alkylidene, however, this is in competition with backbonding to 
the ligand.  Strongly π-acidic ligands, reduce the π component of the Au-C bond leading to an 
increase in Au-C bond length and a decrease in carbenoid character.  To maximise carbenoid 
character in the Au-C complex, therefore, a ligand would be strongly σ-donating to weaken the σ 
component of the Au-C bond and display minimal π-acidity to maximise the π component, although 
maximising π-acidity of the alkylidene substrate is also key.23, 24 
Intramolecular oxidation systems 
Early azide-based carbenoid synthesis 
In 2005, Toste’s group published the synthesis of a variety of pyrroles from the cyclisation of alkynyl 
azides.  These pyrroles were obtained via nucleophilic attack of the azide onto the gold-activated 
alkyne 13.  Subsequent loss of nitrogen generated gold carbenoid 15.  Elimination of a proton, proto-
demetallation and then prototropy gave the final pyrrole 18 (Scheme 6).26 
 
Scheme 6: Toste’s pyrrole synthesis 
Toste reasoned that the intermediate gold carbenoid could tolerate other modes of carbenoid 
reactivity and was able to successfully expand the reactivity to include to silyl ether migrating groups 
and ring expansions (Scheme 7). 
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Scheme 7: Expanded carbenoid reactivity 
Hiroya et al subsequently demonstrated that this transformation could also be performed with 
platinum (IV) chloride to obtain trisubstituted pyrroles.27 
Sulfur-based oxidants 
In 2007, Shapiro and Toste reported the synthesis of α-keto carbenoids using a gold-catalysed redox 
cascade (Scheme 8).  It was postulated that the resulting carbenoids were rapidly trapped in an 
electrophilic aromatic substitution.  This protocol allowed an alkyne moiety to function as a masked 
α-keto gold carbenoid.28 
 
Scheme 8: Toste’s carbenoid synthesis 
Toste expanded upon this approach, showing that the oxidant is not limited to sulfoxides; 
sulfonimines also proved viable oxidants, leading to sulfonenamides (Scheme 9).   
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Scheme 9: Sulfonamide synthesis 
Shortly after Toste, L. Zhang’s group published a paper with similar findings, however they also 
demonstrated that electrophilic aromatic substitution could be disfavoured by tuning the sulfoxide 
substituent (Scheme 10).   
 
Scheme 10: Tuning carbenoid reactivity 
By exploiting the competing reactivity of o-chlorophenyl and cyclopentyl alcohol substituents, Zhang 
was able to competitively access alternative carbenoid reactivity, in this case ring expansion.29  
Toste’s and Zhang’s combined work demonstrated that redox cascades of these kinds had the 
potential to access diverse carbenoid functionality from a variety of oxidants.  Crucially, the pendant 
sulfoxide, responsible for oxidant delivery during Zhang’s carbenoid formation, was placed 
significantly further from the reacting alkyne than in Toste’s propargyl migrations (Scheme 3 vs. 
Scheme 8).  This increased the synthetic flexibility considerably, allowing the resulting sulfide to be 
easily cleaved or used for further transformations.   
Maulide’s group suggested that the proposed carbenoid 27 in Zhang’s and Toste’s intramolecular 
transformations does not form (Path A) and that the resulting bicycle could be explained by a [3,3]-
sigmatropic rearrangement of the vinyl gold intermediate 26 to give the final bicycle 29 (Path B).30  
Very recent studies by L. Zhang’s group have confirmed this hypothesis (Scheme 11).31 
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Scheme 11: Alternative [3,3]-sigmatropic rearrangement 
Zhang’s DFT study and comparison with intermolecularly oxidised systems indicate that the [3,3] 
sigmatropic rearrangement of 26 (Path B) is favoured compared to the relatively high energy barrier 
for carbenoid 27 formation (Path A). 
While Toste’s and Zhang’s sulfoxide protocols ultimately were determined to proceed via a 
rearrangement, rather than a gold “carbene” complex, these reactions, and Toste’s azide protocol, 
introduced the concept that an alkyne could function as a masked α-keto or α-imido gold carbenoid 
and inspired what has become a rapidly advancing field within gold catalysis. 
Nitrogen-based oxidants 
Shin’s group reported the first nitrogen-based oxidant system in 2008 and went on to explore their 
reactivity in great depth.  In place of the sulfoxide, Shin’s system used a nitrone (36) which 
performed the redox cascade necessary to generate a carbenoid (38).  The resulting imine was not 
redundant after performing the initial oxygen delivery and Shin demonstrated that it could be 
employed further in the cascade reaction, both as a nucleophile and an electrophile (Scheme 12).   
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Scheme 12: Shin’s intramolecular nitrone-based [3+2] cycloaddition 
In Shin’s first example the generated imine re-trapped the carbenoid, generating a 1,3 dipole (40) 
which underwent Huisgen-type 3+2 cycloaddition with the tethered alkene.  This approach allows 
complex polycyclic structures to be readily assembled, typically as single diastereomers.  Shin also 
demonstrated that the dipole could be trapped with an intermolecular dipolarophile, eliminating the 
need for a tethered alkene (Scheme 13).32 
 
Scheme 13: Shin’s intermolecular nitrone-based [2+3] cycloaddition 
Liu’s group further developed this concept, reporting an intermolecular 3+2 cycloaddition between a 
1,3 dipole (48) derived from an o-nitrophenylacetylene (44), and an electron-rich alkene.  High 
diastereoselectivity was observed again, Liu obtaining only single diastereomers (Scheme 14).33 
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Scheme 14: Liu’s intermolecular nitroalkyne-based [2+3] cycloaddition 
The reaction tolerated a range of dipolarophiles and substituents, providing the product typically in 
yields of 60 to 80%.  Crucially, cyclopropanation of the intermediate carbenoid 46 was not observed; 
however Liu was able to trap this intermediate by varying the ligand and introducing a large excess of 
styrene (Scheme 15). 
 
Scheme 15: Liu’s carbene intermolecular trap 
Shin’s group further expanded the reactivity of the nitrone-derived carbenoid system, to one that 
disfavoured trapping of the carbenoid 56 by the imine; instead undergoing a 1,2-alkyl shift.  The 
resulting gold enolate 58 then attacked the imine to give a variety of spirocycles, in most cases as a 
diastereomer.  This further demonstrated the utility of nitrones as oxidant moieties, the intermediate 
imine now functioning as an electrophile (Scheme 16).34 
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Scheme 16: Shin’s spirocycle synthesis 
Shin rationalised the high diastereoselectivity by suggesting that coordination of the gold catalyst to 
the imine and enolate (59) controls the resulting geometry.  Low catalyst loading was also tolerated. 
The work of Shin’s and Liu’s groups demonstrated the level of control that can be exercised over 
these cascades, which possess multiple nucleophilic and electrophilic sites, potentially resulting in 
competing reaction pathways (Scheme 17).  
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Scheme 17: Regiochemistry in Shin’s ketoxime-based cyclisation 
Shin subsequently illustrated the complexity involved in optimising such transformations.  By 
replacing the nitrone with an oxime, Shin was able to use oxidants with fixed geometry which, 
combined with careful tuning of the substrate, allowed a variety of isomeric products to be obtained 
selectively.35  In this case, controlling the regioselectivity of nucleophilic attack onto the alkyne was 
key, given the ketoxime’s dual nucleophilic positions and possibility of cyclisation onto either of the 
alkyne carbons.   
Table 1: Effect of ketoxime geometry and substitution upon product distribution 
Ketoxime geometry R R’ 
Yield (%) 
63 68 72 
E CH3 CH3 82 - - 
Z CH3 CH3 - 66 - 
Z CH3 Ph - 30 41 
Z n-Pr CH3 - 94* - 
* 10 mol% catalyst      
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The E ketoxime 61 gave only isoquinoline N-oxide 63, without carbenoid formation, due to the 
proximity of the ketoxime oxygen to the alkyne.  O attack upon the alkyne was obtained with Z 
ketoxime 64, however, controlling the regioselectivity of attack on the alkyne proved difficult (Table 
1).  Tuning the substrate and increasing catalyst loading allowed Shin to obtain 68 in almost 
quantitative yield.  7-endo attack was more favourable with alkyl substituents, owing to favourable 
carbenoid stabilisation by the adjacent aromatic ring.  Unfortunately, substitution of the alkyne with 
a second phenyl ring gave mixtures of 68 and 72, as the carbenoid is stabilised in both positions.  
Shin’s protocol highlights the precise conditions required for complex gold cascades to achieve a 
given outcome, which can limit the scope for substrate elaboration.   
Li’s group subsequently showed that further control over imine-forming redox cascades could be 
exerted, employing a t-butyl-substituted nitrone (73) to sterically disfavour nucleophilic attack by the 
imine intermediate (Scheme 18).36   
 
Scheme 18: Li’s regioselectivity switch 
Instead, Li’s system underwent a hydride shift to generate a gold enolate and nitrilium (77), to give a 
substituted iminoisobenzofuran (78).  Shi’s group also expanded the scope of control over competing 
N and O attack by elegantly tuning the catalyst systems (Scheme 19).37 
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Scheme 19: Favouring O or N attack by catalyst selection  
Shin was able to select the nucleophilic region of the hydroxylamine and control the regiochemistry 
of nucleophilic attack onto the alkyne.   JohnPhos ((2-biphenyl)di-tert-butylphosphine) was observed 
to lead to a vinyl gold species (80) rather than a carbenoid, however the complex subsequently 
underwent a 1,3 sulfonyl migration, resulting in nitrone formation (82). However, the NHC-ligated 
IPrAuCl was shown to favour carbenoid formation (86) via O attack and subsequent redox cascade, as 
is typical of this catalyst, leading to a 3-pyrrolidinone (88). 
L. Zhang’s group reported a similar N-oxide system (Scheme 20), using an N-oxide generated in situ 
(90) to perform a redox cascade analogous to his and Toste’s previous sulfur systems (Scheme 8 and 
Scheme 9).38 
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Scheme 20: Zhang’s in situ N-oxide formation and electrophilic aromatic substitution 
Expansion of this protocol to non-aromatic substrates was also successful, proceeding via a formal 
1,5-hydride shift to form iminium 98, gold enolate 99 and ultimately piperidinone 100 (Scheme 21).39 
Zhang’s initial publication suggested the reaction proceeded via the formation of gold carbenoid 97 
(Path A), followed by a 1,6 shift to give 98. However, Zhang’s subsequent DFT study indicated that 
ring-opening of the vinyl gold species 96 and hydride shift are a concerted process. Ammonium 96 
leads directly to iminium 98 via a 1,5 shift, without formation of the free carbenoid 97 (Path B).40   
 
Scheme 21: In situ N-oxide formation followed by hydride shift 
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Zhang demonstrated the applicability of these gold-catalysed cascades to the synthesis of complex 
structures, synthesising (+/-)-cermizine C (Scheme 22).  
 
Scheme 22: Zhang’s (+/-)-cermizine C synthesis 
The dimethylpiperidine precursor 102 was assembled via sequential Boc protection, oxidation, 
nucleophilic ring opening with methyl magnesium bromide, deprotection, re-cyclisation and 
reduction.  The key gold catalysed cyclisation was accomplished using a one-pot procedure.  The 
necessary alkyne was installed using butynyl tosylate, the N-oxide formed with m-CPBA and cyclised 
using Zhangs’s gold catalysed process to give bi-cycle 103. Lewis acid-catalysed thioacetal formation 
and reduction using Raney nickel gave the target (+/-)-cermizine C. 
Recently, Gagosz’s and L. Zhang’s groups utilised Toste’s and Hiroya’s early azide-based carbenoid 
syntheses (Scheme 6), with the specific aim of exploiting the α-imino carbenoids.  These azides may 
be considered to be umpolung equivalents of the previously discussed O- and S- oxides, as the tether 
is attached at the nucleophilic, anionic position of the oxidant, rather than at the cationic leaving 
group.  This arrangement is unique for intramolecular oxidants, as the leaving group is therefore not 
incorporated into the final structure and this allows the construction of interesting polycyclic 
products.   
Wetzel and Gagosz employed a phenyl azide (105), which allowed access to a gold-indole carbenoid 
(106).  The presence of a carbenoid allowed the indole to display umpolung reactivity, subject to 
nucleophilic attack at the normally nucleophilic 3-position (Scheme 23).41 
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Scheme 23: Gagosz’s indole synthesis  
The carbenoid 106 was successfully trapped with a range of alcohol nucleophiles, allyl alcohol 
subsequently undergoing a Cope rearrangement to give 108.  
Zhang’s first example also generated a gold-indole complex, which was subsequently trapped by the 
anisole solvent via an intermolecular electrophilic aromatic substitution.  This trapping can occur at 
the vinyl gold intermediate 110, as a concerted process with loss of nitrogen (Path A), or after 
carbenoid 111 formation (Path B).  42 
 
Scheme 24: Zhang’s azide-based carbenoid synthesis and intermolecular trap 
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Zhang observed an inverse correlation of the observed isomers with temperature, elevated 
temperature improving the yield of the less sterically-demanding para-methoxy isomer 115.  Zhang 
rationalised this by suggesting that elevated temperature facilitates the loss of N2, leading to 
increased carbenoid 111 formation (Path B).  The gold-carbon carbenoid bond is shorter than that in 
the vinyl gold complex 110 (Path A), leading to increased steric demands on the orientation of the 
anisole during its attack by interference with the bulky JohnPhos ligand.23 
Zhang’s group further expanded this protocol, synthesising 2,3-dihydro-1H-pyrrolizines (120), by 
addition of an electron-deficient alkene adjacent to the alkyne (116).43 By careful tuning of the 
reaction conditions, Zhang was able to obtain 120 in almost quantitative yield and avoid Huisgen 
type 1,3 dipolar addition of the azide over the alkyne, which was observed as a side-product during 
optimisation (121). 
 
 
Scheme 25:  Intramolecular rearrangement of the imino carbenoid 
Xioa and Zhang further explored solvent traps for the α-imino carbenoid, reporting the synthesis of 
bicyclic imidazoles (126) from nitriles.  Using benzonitrile, the nitrilium cation (124) generated by 
nucleophilic attack onto the carbenoid (123) was subsequently attacked by the imine.44 
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Scheme 26: Nitrile carbenoid trap 
In this case Zhang was unable to eliminate the Huisgen side product (127), although it could be 
readily removed chromatographically due to its higher polarity. 
Intermolecular oxidation systems  
A wide range of intramolecular carbenoid syntheses have been reported, however the necessity for a 
tethered oxidant limits the overall synthetic utility of these reactions.  While the intramolecular 
protocol had been applied to obtain valuable polycycles, removal of the tethered oxidant would 
allow much greater flexibility in the structure of carbenoid intermediates.  It would also allow simple 
triple bonds to act directly as α-keto carbenoid equivalents without requiring any further elaboration 
of the substrate molecule.  
Intramolecular carbenoid syntheses possess advantageous regiochemical and reaction rate controls.  
Regiocontrol of the oxidant delivery, and therefore carbenoid formation, may be determined by the 
geometry of cyclisation.  Moreover, the rate of intramolecular carbenoid formation is typically more 
rapid than intermolecular trapping of the gold-activated alkyne, minimising intermolecular side 
reactions.  Equivalent intermolecular processes lack these innate controls, with regiochemical control 
of carbenoid formation and ensuring correct reaction order being much more complex. 
Early attempts 
Asensio’s group reported an attempted carbenoid formation via an intermolecular oxidant.  
Analogous to Zhang’s and Toste’s sulfoxide-based intramolecular electrophilic aromatic substitution 
(Scheme 8 and Scheme 10), Asensio’s system utilised an intermolecular sulfoxide trap (Scheme 27).45 
The regioselectivity of substitution was exclusively ortho to the sulfide, irrespective of any directing 
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groups appended to the ring, leading Asensio to suggest that a [3,3] sigmatropic rearrangement 
pathway is responsible, instead of stepwise carbenoid (130) formation and substitution.   
 
Scheme 27: Alternative reaction pathways in Asensio’s redox cascade 
A DFT study of the reaction pathway appeared to confirm the sigmatropic rearrangement, owing to 
the vinyl gold intermediate’s (129) orientation during the catalytic cycle giving a particularly low 
activation barrier for sigmatropic rearrangement, compared to carbenoid formation.46   
While investigating carbenoid ring expansions, Liu’s group observed similar reactivity to Asensio, 
noting regioselective substitution of the oxidant (135) instead of the expected carbenoid reactivity, in 
this case via a 1,2-hydride shift to give 136 (Scheme 28).47 
Scheme 28: Liu’s oxidant trap and crossover experiments 
Liu attempted to observe crossover of the liberated sulfide, by mixing diphenyl sulfoxide and methyl 
phenyl sulfide, which would suggest carbenoid formation via a stepwise process.  However no 
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crossover product (139) was observed, lending further weight to Asensio’s assertion that the reaction 
proceeds via a concerted [3,3] sigmatropic rearrangement.  Also important to note is the robust 
nature of Liu’s protocol, despite superstoichiometric presence of sulfide at the beginning of the 
reaction, catalyst performance is not attenuated.  Zhang’s and Toste’s equivalent intramolecular 
reactions were subsequently found to follow the same rearrangement pathway as proposed by 
Asensio and Liu (Scheme 8 and Scheme 9).31 
Early pyridine N-oxide reactions 
The first successful oxidative intermolecular carbenoid synthesis was reported by L. Zhang’s group in 
2010.  Avoiding the use of sulfoxides, Zhang screened a variety of pyridine N-oxides as intermolecular 
oxidants, 3,5-dichloropyridine N-oxide proving optimal (Scheme 29). 
 
Scheme 29: Zhang’s intermolecular carbenoid synthesis 
Like Asensio’s sigmatropic rearrangement, Zhang’s reaction may proceed via emission of the leaving 
group and carbenoid formation (143) (path A), or immediate trapping of the vinyl gold complex (142) 
by the adjacent alcohol group as an SN2’ process (Path B).  It is important to note that in this instance 
the vinyl gold species 142 can also be formally considered a carbenoid, as it is electrophilic α to the 
gold atom and gives the same overall “carbene” reactivity.  Whether gold carbenoid reactions of this 
kind proceed via a π-bonded carbenoid or vinyl gold species, and the implications this has on their 
reactivity, became a matter of considerable debate in subsequent publications.   
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Zhang’s protocol successfully demonstrated that alkynes could be used as direct α-keto carbenoid 
equivalents without having to incorporate the oxidant into the substrate architecture.  Observing 
significantly reduced yields compared to previously reported intramolecular systems (vide supra), 
Zhang suggested that liberated pyridine was attenuating catalyst activity.  Accordingly, addition of 
methanesulfonic acid, to prevent the pyridine by-product from poisoning the gold catalyst, gave a 
marked increase in yield.48  Exploring the scope of this protocol, Zhang was able to obtain oxetan-3-
ones (148 & 151) from easily-constructed propargylic alcohols (Scheme 30).49 
 
Scheme 30: Zhang’s oxetan-3-one synthesis 
Regiocontrol for terminal, secondary propargylic alcohols was good; however, tertiary alcohols 
required an ester-substituted alkyne to retain the regioselectivity of carbenoid formation.  
Racemisation of enantioenriched alcohols was not observed, allowing the formation of 
enantioenriched oxetanones.  Again Zhang added an acid, in this case triflimidic acid, preventing the 
use of substrates with acid-labile groups. 
In 2012, Hashmi showed that if the ester substituent is replaced with an aryl group, the opposite 
regioselectivity may be obtained from internal alkynes with tertiary alcohols (Scheme 31).50 
23 
 
 
Scheme 31: Hashmi’s regioselectivity switch 
Ring expansion occurred, rather than cyclisation, however this selectivity was only possible with 
tertiary alcohols and alkynes not bearing strongly electron-withdrawing groups. 
In 2011, soon after Zhang, Davies et al. also reported the synthesis of gold carbenoids, using pyridine 
N-oxide.  Rather than terminal alkynes, Davies employed a range of ynamides.  The adjacent nitrogen 
atom renders the β carbon of the ynamide nucleophilic, which, upon complexation with the catalyst, 
forms a gold ketene-iminium (157) (Scheme 32).51   
 
Scheme 32: Ynamide resonance forms 
Davies used this electronic bias as a highly effective regiocontrol, ensuring site-specific formation of 
both the ketone and carbenoid (159).  
 
Scheme 33: Enimide vs. ketoimide formation 
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A 1,2-hydride shift followed carbenoid formation (160); however, this was in competition with a 
second pyridine N-oxide trapping the gold carbenoid to give an α-keto sulfonimide (161) (Scheme 
33). Further optimisation of the reaction conditions suppressed formation of the competing 
oxidation product, by using air-stable Au(III) catalysts at elevated temperature or air-sensitive Au(III) 
catalysts at room temperature (Table 2). 
The catalytic system proved extremely selective, even in substrates containing a second alkyne, only 
the ynamide was oxidised.  No acid additive was necessary; with the catalyst proving sufficiently 
robust to withstand the pyridine by-product. 
Table 2: Davies’ optimised conditions 
 
Catalyst Conditions Yield (%) E:Z ratio 
Au-I CH2ClCH2Cl, 70 °C 71 2.3:1 
AuBr3 THF, r.t. 70 3.7:1 
Shortly after Davies’ publication, Zhang’s group reported a similar 1,2-hydride shift using alkynes 
instead of ynamides.  The lack of a controlling electronic effect meant that Zhang observed 
regioisomeric products (164 & 165) arising from carbenoid formation at both alkyne positions 
(Scheme 34).52 
 
Scheme 34: Regioisomers from Zhang’s 1,2-shift 
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Despite the issues with regioselectivity, Zhang did not observe any diketone formation, which Zhang 
ascribed to the lower nucleophilicity of the bulky 8-isopropylquinoline N-oxide, compared to that of 
pyridine N-oxide. 
Electrophilic aromatic substitutions 
Zhang’s group developed increasingly complex oxidants and catalysts, reporting the synthesis of 
chroman-3-ones from propargyl ethers.  This reaction is conceptually an intermolecular equivalent of 
Zhang’s sulfur and nitrogen electrophilic aromatic substitutions, however, competition between the 
tethered aryl group and the pyridine N-oxide led to high yields of the doubly-oxidised product 
observed by Davies (Scheme 35 and Scheme 33).53 
 
Scheme 35: Zhang’s chromanone synthesis 
Zhang was forced to use an elaborate tetrasubstituted N-oxide and an extremely bulky phosphine 
ligand to sterically disfavour over-oxidation of the alkyne.  These chromanones (168) are accessed in 
two steps, compared to the four required for the equivalent diazo route. 
Other groups subsequently obtained a range of bicyclic compounds via this route.  J. Zhang’s group 
showed that the opposite regioselectivity for carbenoid formation may be obtained for these 
substitution reactions by utilising an electron-deficient alkyne (169), obtaining a range of substituted 
oxindoles (171) in this way (Scheme 36).54   
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Scheme 36: J. Zhang’s oxindole synthesis 
Using a phosphite-gold complex, J. Zhang observed complete selectivity for electrophilic aromatic 
substitution, even in the presence of allyl substituents, which are susceptible to cyclopropanation.  
Gagosz’s group has also shown that the equivalent process for propargyl arenes is viable, employing 
a novel biarylphosphonite catalyst in conjugation with 2,6-dibromopyridine N-oxide ( 
Scheme 37).55 
 
Scheme 37: Gagosz’s electrophilic aromatic substitution 
Ensuring that the gold complex displays sufficient carbenoid character to accomplish a given 
transformation can be challenging.  Gagosz was forced to develop an elaborate catalyst as Zhang’s 
Me4tBuXPhos gave extremely poor yields when applied to Gagosz’s substrates, despite the minor 
variation in structure, highlighting the frequently capricious nature of these catalytic systems 
(Scheme 35 vs. Scheme 37). 
Not all substrates are suitable for electrophilic aromatic substitution in this manner.  Liu’s group 
observed that substrates with alkyl substituents can undergo a 1,5-hydride shift instead of carbenoid 
formation (Scheme 38).56 
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Scheme 38: Liu’s 1,5-hydride shift 
Liu suggested that this hydride shift occurs much faster than carbenoid formation, preventing 
electrophilic aromatic substitution.  To test this hypothesis Liu synthesised the equivalent diazo 
compounds which, when reacted with a suitable gold catalyst, formed the corresponding carbenoid 
without passing through a vinyl gold intermediate.  With carbenoid formation electrophilic aromatic 
substitution of the pendant arene was observed, supporting Liu’s proposal that the hydride shift 
does not proceed via a carbenoid. 
Enyne reactions 
Cyclopropanation is also possible for substrates bearing accessible alkenes.  In 2011 Liu’s group 
reported the cyclopropanation of 1,5-enynes to give tricyclic indanone derivatives (181) (Scheme 
39).57 
 
 
Scheme 39: Liu’s enyne cyclopropanation 
Because a gold carbenoid may also form through the reaction of gold-activated enynes, Liu suggested 
that the reaction may proceed via an α-keto gold carbenoid (Scheme 39) or enyne 
cyclopropanation/carbenoid formation, with subsequent quenching of the carbenoid by the 
intermolecular oxidant (Scheme 40). 
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Scheme 40: Alternative cyclopropanation pathway 
Liu proposed that α-keto gold carbenoid 180 formation was more likely, given that monosubstituted 
enynes did not give the potentially competing naphthalene (184) from elimination of the cationic 
intermediate 183. 
J. Zhang’s group subsequently expanded Liu’s work to include electron-deficient alkynes (187), giving 
the opposite regioselectivity (Scheme 41).58 
 
Scheme 41: Cyclopropanation of electron-deficient alkynes 
Liu’s group observed that 1,4-enynes do not undergo cyclopropanation, due to the ring strain which 
would develop, instead undergoing a Wagner-Meerwein rearrangement after carbenoid (189) 
formation and initial cyclisation (190) (Scheme 42).59 Initially the redox cascade provides an α-keto 
gold carbenoid (189), however it cannot undergo cyclopropanation, instead cyclising to provide a 
secondary cation (190) which is quenched by a 1,2-migration and simultaneous elimination of the 
gold catalyst.   
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Scheme 42: Liu’s Wagner-Meerwein rearrangement 
Using a combination of experimental and DFT studies, Liu determined that selectivity for the 
migrating group is not controlled by steric factors.  The Z substituent of the alkene, in this case a 
methy group, was always observed to be the migrating group. To explain the selectivity for the 
migrating group Liu suggested that the orbital arrangement depicted in structure 189 favours 
“disrotation” to form the core cyclopentane. The gold complex then activates the substituent anti to 
the catalyst for migration.  
Liu’s group also demonstrated that the use of an intermolecular oxidant can allow a formal [4+1] 
cycloaddition, with a suitable conjugated enyne (192), to access trisubstituted furans (196) (Scheme 
43).60 
 
Scheme 43: Liu’s electrocyclisation 
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Liu proposed that the reaction proceeds via an oxa-Nazarov cyclisation.  Liu found Buchwald 
phosphine-ligated gold complexes most efficient, reasoning that these complexes behave as a gold-
stabilised cation, in agreement with Toste’s model, rather than as a carbene.  Use of IPrAuCl gave 
mostly α-diketone, due to the NHC-ligated complex’s greater carbene character. 
Intermolecular carbenoid reactions 
L. Zhang’s group have demonstrated that the carbenoid may be intermolecularly trapped by a variety 
of nucleophiles, the first example being a carbenoid trap by a nitrile solvent, to give disubstituted 
oxazoles (201).61 
 
Scheme 44: Zhang’s oxazole synthesis 
Complete regioselectivity was observed, however the reaction was limited to terminal alkynes. 
Formation of α-diketones was not observed owing to the high concentration of nitrile compared to 
N-oxide.  The use of the nitrile as the solvent, or in large excess, renders the reaction impractical if 
the nitriles used are difficult to obtain.  
Zhang’s group was able to trap the carbenoid with other nucleophiles.  Amides proved possible, using 
Stradiotto’s MorDalPhos as ligand for the gold catalyst, to give disubstituted oxazoles (207).62  
MorDalPhos was designed as a bidentate ligand and Zhang proposed that in this case the carbenoid 
was stabilised by chelation from the nitrogen, forming a tricoordinate carbenoid complex (204) 
increasing the longevity of the carbenoid intermediate (Scheme 45).62, 63 
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Scheme 45: Zhang’s oxazole synthesis via a tricoordinate carbenoid 
Carbenoid formation (204), followed nucleophilic attack by the amide, proto-demetallation and 
condensation gave the desired oxazole (207).  Zhang rationalised the regiochemistry of the product 
oxazole by invoking O-attack of the amide, rather than the N-attack one might expect.  Due to the 
poor nucleophilicity of the amide oxygen, compared to that of the N-oxide, Zhang was forced to 
introduce the oxidant gradually via syringe pump to prevent glyoxal formation. 
Continued investigation of these tricoordinate carbenoid complexes led Zhang to report the coupling 
of α-keto carbenoids with carboxylic acids (Scheme 46).64 
 
 
Scheme 46: Carboxylic acid coupling with Zhang’s optimised ligand 
Zhang designed and screened a range of catalysts derived from MorDalPhos to maximise the 
stabilisation from the ligand.  Optimisation of the ligand structure allowed coupling with carboxylic 
acids in near quantitative yield, although oxidant delivery still required the use of a syringe pump.  
Using this catalyst, Zhang was able to exert quite considerable control over the carbenoid, as 
commercial ligands including PPh3, IPr and BrettPhos gave less than 7% yield for this transformation.  
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Sulfoxide oxidants 
In late 2010, Liu’s group reported a successful intermolecular carbenoid synthesis using sulfoxides as 
oxidants.  Liu employed diphenylsulfoxide to access carbenoid reactivity with cyclopropylethyne 
derivatives (211), which readily underwent ring expansion to give valuable α-keto cyclobutenes (215 
& 216).  This protocol was applicable to both alkynes and ynamides and the regioselectivity of 
oxidation was preserved regardless of whether electron-donating or -withdrawing substituents were 
present on the alkyne (Scheme 47).47 
 
Scheme 47: Liu’s gold-catalysed ring expansion 
The reaction pathway is believed to proceed via a concerted ring expansion and sulfide elimination 
(Path A), rather than stepwise “carbene” formation 213, followed by ring expansion. 
Following Liu’s publication, C,-Y. Li’s group reported the general synthesis of α-diketones (221) from 
a range of aryl-substituted alkyne and ynamide derivatives.  Expanding upon the double oxidation 
observed by Davies, Li used refluxing conditions combined with diphenyl sulfoxide to ensure 
complete conversion (Scheme 48).65 Li suggested that the reaction proceeded via SN2’ addition to the 
vinyl gold intermediate 218 (Path B), despite not observing the 3,3-sigmatropic rearrangement, 
reported by both Liu and Asensio, that would compete with this pathway.45, 47   
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Scheme 48: Chuan-Ying Li’s double oxidation 
As Li did not report the products of alkyl-substituted substrates, a gold “carbene” (219) pathway 
cannot be ruled out (Path A). 
Hashmi’s group also investigated this type of double oxidation, albeit with 6-methoxyquinoline N-
oxide (223), reasoning that terminal alkynes would allow access to reactive glyoxal moieties (224) 
(Scheme 49).66   
 
Scheme 49: Hashmi’s glyoxal synthesis 
Hashmi was unable to isolate the glyoxal (224), instead trapping it in situ with o-phenyldiamine (225) 
to form quinoxalines (226). 
Other N-oxides 
Carbenoid formation by intermolecular oxidants is not limited to pyridine N-oxide or sulfoxide-based 
oxidants; in 2011, Liu’s group reported the generation of gold carbenoids from nitrones and 
nitrosobenzenes (Scheme 50).   
34 
 
 
Scheme 50:  Liu’s intermolecular nitrone oxidation 
These oxidants, like their intramolecular equivalents, are able to effect carbenoid formation and the 
reduced leaving group immediately traps the carbenoid.67  Liu’s first system generated a gold 
carbenoid (228) from the ynamide/nitrone pair and the liberated imine (229) immediately trapped 
the nascent carbenoid.  Hydrolysis of the gold iminium enolate (231) gave the final structure (232).  
Liu failed to observe crossover of the reduced oxidant in any of the experiments, leading to the 
suggestion that the reaction proceeds via a carbenoid, which is held in close proximity to the reduced 
nitrone by the solvent shell, immediately reacting to quench the carbenoid.  Liu was also able to use 
nitrosobenzenes to obtain similar reactivity (Scheme 51).  
 
Scheme 51: Liu’s intermolecular nitrosobenzene oxidation 
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Re-optimisation of the reaction conditions allowed oxo-imination (238) in almost quantitative yield.  
Liu conducted a number of reactions to probe the mechanisms of these transformations, observing a 
1,2-hydride shift with alkyl-substituted ynamides and electrophilic aromatic substitution of the 
phenyl substituent of the oxidant, both indicative of carbenoid formation.   
Pyridinium ylides 
Examples of intermolecular α-imino carbenoids are rare, compared to their intramolecular 
equivalents.  However, while exploring hydride shifts, L. Zhang’s group replaced the N-oxide 
component with an aminopyridinium ylide (240), allowing the formation of an α-imino carbenoid 
(241) (Scheme 52).68 
As with Zhang’s previous examples, it was necessary to optimise the oxidant in order to ensure that it 
was sufficiently reactive, while suppressing side reactions.  With these pyridinium ylides the 
formation of an α-diimine side product was not observed.   
 
Scheme 52: Hydride shift from Zhang’s α-imino carbenoid 
More complex pyridinium ylides have been combined with gold catalysis.  In 2011, Davies’ group 
reported the use of aminopyridinium ylides, reasoning that the ylide could be used to generate the 
required carbenoid (247) which could then immediately trap the ylide oxygen, to give a formal 3+2 
cycloaddition.  Davies obtained trisubstituted oxazoles (249) as single regioisomers (Scheme 53).69 
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Scheme 53: Davies’ oxazole synthesis 
While the reaction was designed envisaging a carbenoid pathway (Path A), Davies suggested that a 
4π electrocyclisation, from the vinyl gold pyridinium complex 244, was more feasible (path B).  This 
was supported by the observation that alkyl-substituted ynamides did not undergo 1,2-hydride shift, 
suggesting that cyclisation to form the C-O bond is a rapid process, occurring concomitantly with N-N 
bond cleavage.  Were a carbenoid pathway dominating, this hydride shift would be expected to 
compete with cyclisation. 
Synthesis of ylides by gold catalysis 
Sulfonium ylides are valuable synthetic intermediates, allowing access to a diverse range of reactions 
that are capable of migrations, ring expansions and contractions, and wide range of cyclisation 
processes.70, 71  The classical approaches to ylide syntheses can broadly be divided into two groups: 
synthesis of ylides via diazo derivatives or via sulfonium salts.  While these reactions have seen 
considerable development since their conception, they still possess significant drawbacks.72-74  The 
use of diazo moieties is frequently challenging, their instability and toxicity make them difficult to 
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handle and their installation adds synthetic complexity.6-8, 75, 60  Complex sulfonium salts can be 
difficult to prepare, especially with sterically demanding substituents, frequently requiring strong 
alkylating agents and super-stoichiometric silver salts.76  Transformation of a sulfonium salt to the 
desired ylide may also be problematic, requiring either a strong base or fluoride source. Also, the 
ylide anion may equilibrate with a more acidic hydrogen before it is quenched, which can lead to 
complex mixtures of undesirable side-products.77-79  Alternative routes to sulfonium ylides are 
therefore extremely attractive and their synthesis by gold catalysis has recently become an emerging 
field.  
Sulfonium ylides 
L. Zhang’s group’s 2007 paper, one of the earlier examples of gold-catalysed oxidative carbenoid 
synthesis, proposed that the gold carbenoid (250) was stabilised by interaction with the pendant 
sulfide, generating a gold-stabilised sulfonium ylide (251).29 
 
Scheme 54: Ylide stabilisation of gold carbenoids 
Liu’s group concurred, suggesting that heteroatomic stabilisation of the carbenoid in this manner 
renders it less electrophilic and is responsible for the difficulty in intermolecularly trapping these 
carbenoids experienced by many groups.80  Gold-ylide complexes had been reported; however as 
these have not been used for typical ylide reactions, it was not known whether the stabilisation 
provided by the gold would impede their reactivity, or whether coordination to the ylide would 
poison the gold catalyst.81-83 
In 2008, Davies’s group reported the first synthesis of a sulfonium ylide by gold catalysis.  Davies 
employed a propargylic rearrangement to obtain the necessary carbenoid (253), which was 
38 
 
subsequently trapped intermolecularly by an allyl sulfide, providing the ylide moiety 254 (Scheme 
55).84 
Scheme 55: Davies’ sulfonium ylide synthesis 
The resulting sulfonium ylide then rearranged to give Z alkenyl sulfides, either via a sequential 2,3-
sigmatropic rearrangement, then 3,3-Cope rearrangement; or via an oxygen-assisted 1,4-shift and 
elimination.  Competing cyclopropanation was not observed and the simple gold(I) chloride catalyst 
proved sufficiently robust to withstand catalyst poisoning.  For certain examples, the rearrangement 
could be curtailed after quenching the ylide, by varying the non-migrating sulfur substituent (Scheme 
56).85 
 
Scheme 56: Halting migration 
Davies’s group further expanded this methodology, using the recently developed sulfoxide redox 
cascades of Toste and Zhang (Scheme 8 and Scheme 9).  Appending an allyl group onto the sulfide 
allowed immediate 2,3-sigmatropic rearrangement upon trapping the carbenoid 231, leading to a 
range of heterocycles (233) previously only accessible via diazo chemistry (Scheme 57).75 
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Scheme 57: Davies’ sulfoxide-based ylide synthesis 
Gold and platinum catalysts were both able to achieve ylide formation, platinum proving more 
effective for terminal alkynes and gold for internal alkynes.  While exploring bicyclic equivalents, 
Davies observed decreased regioselectivity for attack of the sulfoxide onto the alkyne (Scheme 58). 
 
Scheme 58: Regioselectivity in carbenoid formation 
Nitrogen ylides 
Accessing nitrogen-based ylides is also an attractive target for methodological development.  Shin’s 
group has published a [3+2] cycloaddition, proceeding via an azomethine ylide (Scheme 13).  Shin 
attempted to obtain a free ylide (268) using a modification of his optimised protocol (Scheme 59).32 
 
Scheme 59: Shin’s attempts to isolate an azomethine ylide 
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No consumption of the starting material was observed, despite applying identical reaction conditions 
to the [3+2] cycloaddition.  Modification of the reaction conditions only gave indole 270; in no case 
was a free or gold-ligated ylide isolated.  
Ammonium intermediates have also been suggested for other catalytic systems.  L. Zhang’s group 
reported the synthesis of azetidin-3-ones, which were proposed to form via an ammonium ylide.  
Zhang’s system used chiral sulfinamide derivatives (271) to obtain azetidin-3-ones (275) in high 
optical purity (Scheme 60).86 
Scheme 60: Zhang’s ammonium ylide intermediate 
In Zhang’s example the ylide decays by proton transfer, simultaneously effecting proto-demetallation 
of the catalyst.  Zhang did not report migrating groups other than a proton, despite allyl and benzyl 
migrating groups being widely explored for ammonium ylides derived by classical means.87 
Oxonium ylides 
Oxonium ylides have recently been obtained via gold catalysis.  Oxonium ylide cascade reactions can 
be difficult to control, owing to the instability of the oxonium ylide.88  In late 2012, C.-Y. Li’s group 
published the first gold-catalysed oxonium ylide synthesis.  Using pyridine N-oxide as an 
intermolecular oxidant, Li generated a carbenoid (277) which was intercepted by a tethered ether 
appended to the alkyne (278).  These ylides underwent typical decay processes: β-elimination (280 & 
284) and ring contraction (285) (Scheme 61 and Scheme 62).89 
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Scheme 61:  Li’s oxonium ylide synthesis and β-elimination 
Selectivity was poor, with Li frequently observing mixtures of products due to competing decay 
processes, particularly with electron-donating substituents, which are able to stabilise carbocation 
formation.  While Li’s reaction lacked synthetic utility, it ably demonstrated that this highly reactive 
class of ylides could be obtained via diazo-free gold catalysis. 
 
Scheme 62: Ylide decay by ring contraction 
Tang’s group subsequently combined Li’s approach with a more controllable 2,3-sigmatropic 
rearrangement, to access highly-substituted dihydrofuranones (Scheme 63).90 
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Scheme 63: Tang’s oxonium ylide synthesis 
The reaction pathway was ambiguous, with Tang proposing a number of possible mechanisms.  A 
direct 2,3-sigmatropic rearrangement of the oxonium ylide 288 may directly give the final product 
(path A).  In some examples Tang observed the formation of benzofuran 290, suggesting that a 
formal 1,4-shift occurs from the ylide 288 (path B), or its enolate tautomer 289 (path C), followed by 
a Cope rearrangement.  Tang screened a variety of Lewis and Brønsted acids, which are typically 
added to gold reactions of this type to inhibit catalyst poisoning by the pyridine by-product, finding 
Yb(OTf)3 the most efficacious.
91  Rare earth salts are not commonly used for this process and it has 
been suggested that the increase in yield from ytterbium(III) triflate is also due to participation in 
other processes in the catalytic cycle.92 
Conclusion  
The synthesis of α-keto and α-imino carbenoids via gold catalysis has seen rapid development over 
the past six years.  From intramolecular sulfoxide redox cascades a wide range of catalytic systems 
have been developed, utilising N and S-oxides, ylides, azides and sulfonimines with a broad selection 
of gold catalysts.  These processes allow access to complex, often polycyclic, heterocycles from 
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comparatively simple starting materials, without the significant drawbacks of classical diazo 
chemistry.  
These redox cascades are not without problems; they are frequently complex, due to their 
propensity for multiple reaction pathways, resulting from regiochemical issues with initial attack 
onto alkynes and the presence of multiple electrophilic and nucleophilic sites during the catalytic 
cycle.  The nature of the key gold complexes involved is still ambiguous, which can hinder reaction 
design.  A given reaction may proceed via a gold “carbene” complex, a gold-stabilised cation, a vinyl 
gold complex or a sigmatropic rearrangement, while still displaying overall carbene-like reactivity.   
Project Aims 
Gold catalysis has been demonstrated to be a viable means of obtaining sulfonium ylides. Thus far 
these ylides have only been used for intramolecular reactions. This research project aims to explore 
the following: 
 To investigate whether the reactivity of gold-derived sulfonium ylides can be expanded.  
Specifically, whether these ylides can react with electrophiles in an intermolecular fashion 
and to investigate the ylide structures that may be obtained via gold catalysis. 
 To apply the most recently developed techniques of gold catalysis to the synthesis of these 
ylides, such as the use of pyridine N-oxides, Zhang’s chelating Buchwald phosphines, 
ynamide substrates and cooperative silver catalysis. 
 To explore the structural motifs that may be obtained via gold-derived ylides. Specifically, to 
target motifs which are difficult to access via established methods and may be of 
pharmaceutical value. 
 To gain further insights into the catalytic cycle when using gold complexes to generate 
sulfonium ylides. 
  
44 
 
 
Chapter 2: Ketone-stabilised ylides 
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Introduction 
When this project commenced in 2009, there was little literature regarding the synthesis of ylides by 
gold catalysis.  These examples were exclusively intramolecular ylide reactions and the first aim of 
this research project was to expand this reactivity to include intermolecular ylide reactions.  Davies et 
al had reported the synthesis of sulfonium ylides (293 & 296) from gold-catalysed carbonyl 
rearrangements and from a sulfoxide redox cascade (Scheme 64).75, 84   
 
Scheme 64: Davies’ gold-catalysed sulfonium ylide reactions 
These systems quenched the ylide by sigmatropic rearrangement, therefore the first objective was to 
synthesise an ylide which could not undergo intramolecular rearrangement but could instead be 
intercepted with a suitable electrophile. 
Davies’ sulfoxide protocol was used as the basis for this work, as the sulfoxide carbenoid synthesis is 
more flexible in terms of the substrate structures that it will tolerate. When combined with an 
intermolecular electrophile this would give a two-component coupling, rather than the three 
components necessary for an intermolecular version of Davies’ acetate migration.  The use of 
minimal components would reduce overall reaction complexity, limiting potential side reactions and 
simplifying reaction development.  An intermolecular protocol based on Davies’ acetate 
rearrangement would also be of lower impact, as Toste has already reported a direct intermolecular 
cyclopropanation from the intermediate carbenoid, rendering sulfonium ylide formation unnecessary 
to access this reactivity.17 
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Examples of intermolecular reactions by cyclic ylides, where the ylidic anion and cation are within the 
same ring, were also rare, but not unheard of.93-96  Moreover, classical intermolecular ylide reactions, 
such as epoxidation or cyclopropanation, had not been reported for cyclic ylides.  While these cyclic 
ylides are challenging substrates for intermolecular reactions, and the envisaged epoxidation is not 
reported, the manifold benefits of developing a non-classical ylide synthesis/intermolecular trap 
cascade make this a worthwhile target, none the less. 
Tanaka’s group has reported the intermolecular trapping of cyclic ylides (299 & 302) with 
cyclopropenones and benzoyl chloride (Scheme 65).93 
 
Scheme 65: Tanaka’s intermolecular cyclic ylide reactions 
Tanaka’s electrophiles are incompatible with the gold-catalysed cascade.  Cyclopropenes have been 
shown to react with gold catalysts and an acid chloride would bond to the sulfoxide substrate.  The 
use of electrophiles which are unreactive until ylide formation has occurred was therefore 
imperative.  The initial reaction screening was conducted with benzaldehyde as an electrophilic trap 
which, if successful, would generate keto-epoxide 311 (Scheme 66).  Benzaldehyde was selected as 
the epoxidation of carbonyl compounds is well understood and synthetically useful.97  A carbonyl 
compound could also take advantage of gold’s capability of functioning as a Lewis acid, potentially 
increasing the reactivity of the electrophile.98   
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Scheme 66: Envisaged reaction pathway 
Initial substrate design was straightforward and based on a combination of Davies’ and L. Zhang’s 
sulfoxide conditions (Scheme 66).  Zhang’s group has shown that appending these substrates with o-
chlorophenyl substituents can avoid electrophilic aromatic substitution; therefore the allyl 
substituent of Davies’ ylide precursor was replaced with an o-chlorophenyl moiety.29  The designed 
ylide needed to be sufficiently stable to avoid decay before being intercepted, but nucleophilic 
enough to react with a range of electrophiles.  Whether the ylide reacts as the gold-stabilised ylide, 
gold enolate or free ylide was uncertain and therefore the degree of stabilisation imparted by 
coordination to the gold was unknown.  Whether the equivalent copper and rhodium ylides react via 
a metal-bound or free ylide is still a matter of considerable debate.99  A terminal alkyne was chosen 
in order to minimise steric demands at the anionic position of the ylide.   
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Five-membered cyclic ylides  
The necessary o-chlorophenyl sulfoxide was synthesised in three steps from butynol (Scheme 67).   
 
Scheme 67: Synthesis of the o-chlorophenylsulfoxide 
Mesylation, followed by substitution with o-chlorothiophenol and oxidation with m-CPBA gave the 
butynyl sulfoxide.  The substrate was subjected to L. Zhang’s conditions for ylide formation with a 
small range of catalysts and in the presence of an excess of benzaldehyde (Table 3). 
 
Table 3: Yields of substitution product 
 
Catalyst Time (h) Yield of 315 a 
AuCl 17 74 
Au-I 17 89 
PtCl2 17 -
 b 
(PPh3AuNTf2)2.toluene 
c 22 65 
a 
Yield determined by NMR spectroscopy calibrated against a known mass 
of 1,2,4,5-tetramethylbenzene.  
b 
No reaction. 
c 
2.5 mol% of catalyst. 
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The reaction proved facile at room temperature, however epoxide formation was not observed; 
instead substitution of the aryl substituent occurred with Au(I) and Au(III).31  PtCl2 was not active for 
this transformation.  Evidently, the o-chloro substituent was not deactivating the aromatic system 
sufficiently to prevent substitution competing with ylide formation.  Rather than continue screening, 
steps were taken to prevent this competing reactivity  The aryl substituent was replaced with an alkyl 
substituent, which is unable to undergo the observed substitution, either by 3,3-sigmatropic 
rearrangement or by electrophilic aromatic substitution.  A methyl group was envisaged as the ideal 
replacement for the o-chlorophenyl substituent, owing to its minimal steric bulk.  Synthesis of the 
required methyl sulfoxide 317 by the previous reaction sequence (Scheme 67) would necessitate the 
formation of methybutynylsulfide, the volatility of which would render it difficult to handle. Instead, 
substitution of propargyl bromide by a dimsyl ion was attempted, as it would bypass the volatile 
sulfide and also shorten the synthetic sequence (Scheme 68).100   
 
Scheme 68: Attempted synthesis of methylbutynylsulfoxide via a dimsyl ion 
This approach was unsuccessful; while the desired substrate was obtained, the yield was extremely 
poor owing to the relative pKas of the dimsyl ion (35.1 in DMSO) and the alkyne proton 
(approximately 26.7 in DMSO, based on hexyne).101, 102  Deprotonation of the alkyne led to significant 
polymerisation of the starting material and was not a practical substrate synthesis.  
Instead, an analogous synthesis to that of 304 was employed, replacing the o-chlorothiophenol with 
hexanethiol.  The hexyl substituent offered a minimal increase in steric bulk over the desired methyl 
group and the resulting sulfide was sufficiently non-volatile to be isolated, with careful handling 
(Scheme 69). 
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Scheme 69: Synthesis of the hexyl sulfoxide 
The n-hexyl sulfoxide 319 was synthesised in the same manner as 304, however sodium hydride was 
used to deprotonate the sulfide, prior to substitution, owing to its reduced acidity compared 
to thiophenol (approximately 17.0 and 10.3 respectively, in DMSO).103  This alkyne was also subjected 
to L. Zhang’s conditions, again with benzaldehyde as the electrophile (Table 4). 
 
Table 4: Yield of enone and α-chloro ketone 
 
Catalyst Time (h) Temperature (°C) 
Yield of 320 
 (%) a 
Yield of 321 
 (%) a 
Au-I 24 r.t. - b - b 
Au-I 18 80 21 Trace 
PtCl2 18 80 23 Trace 
AuCl 20 80 Trace Trace 
(PPh3AuNTf2)2.toluene 
c 18 80 - b - b 
a 
Yield determined by NMR spectroscopy calibrated against a known quantity of 1,2,4,5-
tetramethylbenzene.  
b 
No reaction. 
c 
2.5 mol% of catalyst. 
 
L. Zhang’s conditions proved ineffective, even with the temperature elevated in excess of that 
reported by Davies in an attempt to force an intermolecular reaction.  Epoxidation of the ylide was 
51 
 
again not observed, despite preventing the competing electrophilic aromatic substitution, instead 
enone 320 was obtained, accompanied by the formation of traces of α-chloro ketone 321.  
 
 
Scheme 70: Proposed mechanism for the formation of catalysis products 320 and 321 
The enone arises from elimination of the ylide 324: a decay process commonly observed for ylides.89, 
104-106  Davies’ group had also observed the formation of chlorides during their gold-catalysed, 
sulfoxide-based ylide protocol.75  These may arise from abstraction of a chlorine atom from the 
dichloroethane solvent by the gold carbenoid (322), combined with proto-demetallation.107  
Alternatively, decomposition of the catalyst may liberate the necessary chloride.  While not 
successful as an intermolecular trap, these results confirmed that carbenoid and ylide formation 
were occurring with the modified substrates and that this ylide was sufficiently long-lived to undergo 
equilibration and elimination. 
Zhang’s group has very recently observed similar reactivity with ylides obtained via an intermolecular 
oxidation (Scheme 71) and subsequently optimised the chloride abstraction process (Scheme 72).31, 
107 
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Scheme 71: Decay products from Zhang’s intermolecular ylide synthesis 
 
Scheme 72: Zhang’s optimised α-chloro ketone synthesis  
Zhang did not observe substitution of the aryl sulfide to give 329, as the 3,3-sigmatropic 
rearrangement that is believed to be responsible for this product is not possible with an 
intermolecular oxidant.  Electrophilic aromatic substitution of the aryl ring, by the intermediate 
carbenoid, is also prevented.  Zhang suggested that substitution is not competitive with ylide 
formation, however, the (p-CF3Ph)3P ligand is extremely -acidic, which imparts a significantly 
cationic character to the carbenoid, which may also prevent this pathway.23, 108 
Six-membered cyclic ylides  
In order to avoid the undesired formation of an enone by elimination of the ylide, which was 
observed for five-membered cyclic ylides, the substrate was modified to prevent the formation of a 
conjugated alkene, by elongation of the alkyl spacer between the sulfoxide and alkyne.  The 
necessary substrate was synthesised in the same manner as 319, this time beginning with pentynol 
(Scheme 73).   
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Scheme 73: Synthesis of the pentynol-based substrate 
This substrate was then subjected to the ylide-forming conditions with benzaldehyde (Scheme 74). 
 
Scheme 74: Attempted epoxidation with pentynyl sulfoxide 
Addition to the ylide was again not observed, however the elimination decay reaction observed for 
the previous five-membered ylides was suppressed.  The starting sulfoxide 335 was returned, as 
observed by Shin for his ammonium ylide system (Scheme 59).32  Given the previous success of these 
reaction conditions, this suggested that although the ylide was forming but was not sufficiently 
nucleophilic to react with these electrophiles.  The presence of the metal catalyst also appeared to 
stabilise the free ylide, as decay by ring contraction was also not observed.109 
Attention was turned to electron-deficient alkenes, as Aggarwal’s group have shown that these are 
able to react with acyclic, stabilised ylides (338) similar to those obtained in this study (Scheme 
75).110   
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Scheme 75: Cyclopropanation of a ketone-stabilised ylide 
The pentynyl sulfoxide 335 was subjected to gold catalysis with butenone, using Davies’ conditions as 
the starting point, as Zhang’s had proved ineffective for the butynyl sulfoxide substrate (Table 5). 
Intermolecular trapping of the ylide was observed, however the expected cyclopropane did not form.  
Instead, α-hydroxy ketone 340 was obtained, corresponding to incorporation of water in addition to 
the butenone.  This was accompanied by chloride 341, as observed for previous reactions.  
The addition of 4 Å molecular sieves did not prevent the formation of 340, suggesting that at least a 
portion of the water involved in the reaction is introduced during work up.  The slight decrease in 
yield may not result from reduced water present in the reaction mixture, as Davies’s group observed 
the addition of molecular sieves was detrimental to the 2,3-sigmatropic rearrangement of ylides 
derived in this manner.75   
Varying the solvent proved unproductive; toluene was screened with the aim of destabilising the 
intermediate betaine to promote cyclisation to 342, however only a low yield of 340 was achieved.  
Polar solvents that could promote betaine formation, acetonitrile and nitromethane, were also 
examined, but these proved incompatible with the gold-catalysed cascade, giving only complex 
mixtures of degradation products.  Introducing water to the reaction mixture in an attempt to allow 
complete conversion to 340 was unsuccessful, although the cascade reaction proved sufficiently 
robust to withstand its presence, despite the reaction normally being conducted under strictly 
anhydrous conditions.  By screening alternative catalysts the yield of 340 could be improved, 
although still in single figures, with the IPrAuCl/AgOTs catalyst pair proving most effective. 
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Table 5: Survey of reaction conditions 
 
Catalyst Additive Solvent 
Temp. 
(°C) 
Time 
(h) 
Yield of 340 
(%)a 
Yield of 341 
(%) a 
PtCl2 - CH2ClCH2Cl 70 20 6
b 2 b 
PtCl2 4 Å sieves CH2ClCH2Cl 70 17 4 Trace 
PtCl2 4 Å sieves toluene 70 17 4 Trace 
PtCl2 4 Å sieves CH3CN 70 17 - 
c - c 
PtCl2 4 Å sieves MeNO2 70 17 - 
c - c 
PtCl2 H2O (1 eq.) CH2ClCH2Cl 70 17 7 Trace 
Au-I - CH2ClCH2Cl 70 18 Trace 5 
Ph3PAuCl/AgSbF6 - CH2ClCH2Cl 70 18 - 
d - d 
AuCl3 - CH2ClCH2Cl 70 18 - 5 
Au-I - CH2ClCH2Cl 80 22 6 - 
IPrAuCl/AgOTs - CH2ClCH2Cl 80 22 9 - 
a 
Yield determined by NMR spectroscopy calibrated against a known quantity of 1,2,4,5-tetramethylbenzene. 
 b 
Isolated yield.  
c 
Complex mixture. 
 d
 No reaction. 
 
Mayr’s group had recently published a reactivity scale of ylides and electrophiles which suggested a 
number of electrophiles should, ignoring steric factors, successfully react with ketone-stabilised 
ylides similar to those being studied (Scheme 76).111   
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Scheme 76: Electrophiles screened 
A range of these electrophiles was screened; however successful trapping of the ylide could not be 
extended to other electrophiles, these electrophiles proving unreactive, giving only small traces of 
chlorinated 341 with both platinum and gold catalysts. 
Proposed mechanism and rationale 
The intermolecular reactivity of the gold-derived six-membered ylide is atypical and, to the author's 
knowledge, no other three-component ylide couplings of this type have been reported.  The 
observed product may be explained by two plausible reaction mechanisms: ring opening of the 
desired cyclopropane or equilibration of the ylide (Scheme 77).   
 
Scheme 77: Proposed mechanism for observed reactivity 
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The reaction proceeds via nucleophilic attack of ylide 344 (depicted as the ylide resonance form and 
unligated to the catalyst for simplicity) onto the butenone to form betaine 345.  This has been 
demonstrated to be a reversible process by Crudden and Aggarwal’s groups.97, 110, 112-114  This addition 
appears to be the controlling factor for the reaction's tolerance of the screened electrophiles.  
Unsubstituted butenone undergoes this addition; however the β-substituted enones do not.  This is 
in contrast with acyclic ketone-stabilised ylides which have been demonstrated to react with 
substituted and unsubstituted enones and alkenes.115, 116  This may be due to the increased steric 
demands of the cyclic ylides, as the rigid cyclic structure reduces the conformational freedom of the 
ylide and betaine, which has been shown to be of significant importance during ylide cyclisations.110  
Betaine 345 may then cyclise as per acyclic ylide reactivity, with loss of the sulfide, to give the desired 
cyclopropane (Path A).  The observed hydroxy ketone 340 would then arise from ring opening of the 
cyclopropane 346, which is known for keto-cyclopropanes in the presence of Lewis acids.117, 118  This 
ring opening could conceivably be in competition with ring opening by the tethered sulfide to reform 
betaine 345.  This pathway is unlikely to be responsible for the observed products as no trace of 
cyclopropane 346 was detected, including via mass spectrometry of the crude reaction mixtures.  
More tellingly, regioisomer 347 was also not obtained.   This product would arise from ring-opening 
at the alternative cyclopropane and an approximately 1:1 mixture of regioisomers would be expected 
from this pathway.  
Alternatively, cyclopropanation may be prevented by proton transfer at betaine 345, regenerating 
the ylide and forming 348 (Path B).  Proton transfer during the reaction of ylides with enones had 
been studied by Aggarwal et al and is particularly prevalent with ketone-stabilised ylides such as 
these.  This is due to the high acidity of the conjugate base and the disparity in acidity between the 
enolate and ylide (approximately 26.5 and 8.4 respectively, based on acetone and Bu2S
+CH2C(O)Ph in 
DMSO).119-121  For acyclic ylides, this equilibrium leads to a reduced e.e. in the final cyclopropane.  
This proton transfer has also been observed by Tanaka’s group during the reaction of cyclic ylides, 
albeit derived by classical means (Scheme 78).93   
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Scheme 78: Proton transfer in Tanaka’s cyclic ylides 
Initial trapping of the ylide by a dipolarophile then leads to proton transfer to reform the ylide (352, 
355 & 358), rather than ring closure.  In Tanaka’s case these ylides were heavily stabilised and no 
subsequent reactivity was observed, although this did allow them to be successfully isolated. 
For the gold-derived cyclic ylide 344, ring closure to form cyclopropane 346 does not occur, similarly 
to Tanaka’s system.  Instead, quenching of the reformed ylide 348 by water, either during the 
reaction or upon workup, leads to sulfonium 349.  This quenching process has not been previously 
reported for ylides, however an equivalent process has been postulated by Crudden’s group to 
explain a loss of enantioselectivity in epoxidation reactions.113, 114  Subsequent nucleophilic attack 
upon sulfonium ions by water is also a known process and would give the observed keto-alcohol 340 
and exclude the formation of regioisomer 347.122, 123 
Summary  
A gold-catalysed ylide synthesis has been developed, the ylide product of which is able to undergo 
subsequent intermolecular reaction.  This is the first example of ylides derived by gold catalysis 
reacting in this manner.  The reactivity of the ylide is also novel; proton transfer to regenerate the 
ylide, combined with the incorporation of water has not been reported for cyclic or acyclic ylides.  
59 
 
While the objective of trapping the ylide was successfully completed, it was not possible to optimise 
this procedure to give a viable synthetic reaction. 
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Chapter 3: Amide-stabilised ylides 
  
61 
 
Introduction 
The previous chapter detailed the development of a gold-catalysed ylide synthesis, which generated 
an ylide able to undergo an intermolecular reaction.  While it was demonstrated that such a reaction 
was possible, the reactivity of the ketone-stabilised, cyclic ylide was atypical, failing to undergo the 
desired cyclopropanation.  Instead, a three-component coupling incorporating water was observed.  
The failure of this ylide to undergo cyclopropanation was likely due to the cyclic nature of the ylide 
and the ketone group which stabilises the ylide anion, lowering its nucleophilicity to the extent that 
the ylide was unreactive towards β-substituted enones.  The ketone stabilisation also resulted in a 
highly ylidic proton leading to reformation of the ylide, impeding further reactivity. 
In order to overcome these limitations, the ylide was modified to increase its nucleophilicity and 
decrease the acidity of the ylidic proton.  To accomplish this, the alkyne (359) used in the synthesis of 
the previous substrates was replaced with an ynamide (361), in order to obtain an amide-stabilised 
(362) rather than ketone-stabilised ylide (360) (Scheme 79). 
 
Scheme 79: Alkyne- vs. ynamide-derived ylide products 
Amide-stabilised ylides have been demonstrated to be more nucleophilic than their ketone-stabilised 
equivalents and the lower acidity of the ylidic proton reduces the likelihood of proton transfer 
occurring, following betaine formation.110, 111, 120  Crucially, examples of amide-stabilised, cyclic ylides 
undergoing classical, intermolecular ylide reactions have been reported.  Sarabia’s group has 
demonstrated that cyclic, amide-stabilised ylides derived from Gleason-type chiral auxiliaries can 
undergo epoxidation reactions with aromatic and aliphatic aldehydes.  Epoxidations of this kind are 
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not known for ketone-stabilised, cyclic ylides, therefore Sarabia’s results were highly encouraging 
(Scheme 80).124 
 
Scheme 80: Sarabia’s epoxidation 
Sarabia’s protocol used a preformed sulfonium salt (363) which was subsequently deprotonated in 
sodium hydroxide and t-butanol.  Attack via the convex face of the ylide furnished epoxide 364 in 
near quantitative yield. 
Modifying the targeted ylide also addresses the wider objective of examining the gold-catalysed ylide 
cascade and exploring its applicability to a wider range of structural motifs.  The thiomorpholinone 
products obtained by employing ynamide triple bonds are also valuable.  This moiety is found in the 
natural product bafilomycin F (365), the brain antagonist analogue montirelin (366) and has been 
patented in potential drugs (Scheme 81).125-127 
 
Scheme 81: Bafilomycin F (365) and montirelin (366) 
Sulfonate-protected thiomorpholinones are particularly useful, having been patented for the 
treatment of thyroid conditions and multiple sclerosis, but are difficult to access.128, 129  There are 
currently no reported syntheses of sulfonate-protected thiomorpholinones.  Application of reported 
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conditions for Boc and alkyl protections gave low yields of the sulfonate-protected thiomorpholinone 
368 (Scheme 82).130 
 
Scheme 82: Tosylation of a simple thiomorpholinone 
A successful gold-catalysed approach to protected thiomorpholinones would therefore expand the 
applicability of gold-catalysed ylide synthesis and allow access to valuable compounds that are not 
easily available via conventional means. 
Sulfoxide oxidants 
Intramolecular oxidants 
The initial approach to the application of ynamide substrates was to employ the substrate design and 
reaction conditions which had been successfully applied to the previous alkynyl sulfoxides, with an 
ynamide moiety replacing the alkyne (Scheme 83).   
 
Scheme 83: Envisaged intramolecular ynamide-based ylide synthesis 
A tosyl group was selected to protect the ynamide as similar structures bearing tethered oxygen 
atoms had been reported by Hsung’s and Y. Zhang’s groups.131, 132  By using cysteamine hydrochloride 
as the starting material, smaller sulfide substituents were accessible as the sulfide itself was 
preinstalled, thus making volatile sulfides was unnecessary.  This allowed access to the methyl 
sulfides that had proven difficult to obtain with alkynyl sulfoxide substrates (Scheme 68).  A phenyl-
substituted ynamide was initially targeted because terminal ynamides have been demonstrated to be 
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unstable; therefore it was decided to investigate the behaviour of substituted ynamides under gold 
catalysis before returning to terminal ynamides with a better understanding of their reactivity.133, 134  
The desired ynamide was synthesised in a straightforward manner over three steps (Scheme 84). 
 
Scheme 84: Synthesis of S-methyl ynamide 
Cysteamine hydrochloride (373) was methylated using a modification of Tochtrop’s conditions and 
after workup the resulting reaction mixture was immediately tosylated.135  Sulfonamide 374 was then 
converted to the required ynamide 375 using Hsung’s copper-catalysed ynamide formation with 
bromophenyl acetylene.131  Installation of the sulfoxide was performed using Chand’s molybdenum-
catalysed procedure (Scheme 85).136 
 
Scheme 85: Molybdenum-catalysed oxidation 
Oxidation to the sulfoxide 376 proved capricious, giving varying yields of the desired sulfoxide 
product.  While alternative oxidation conditions may have improved yields of 376, the sulfoxide was 
also unstable making it extremely impractical to use.  The sulfoxide was not obtained in sufficient 
purity to test the ylide formation and the decay products were not successfully isolated.  It was 
decided to focus on an intermolecular oxidation strategy, the first examples of which had just been 
published.49, 51, 91 
Intermolecular oxidants 
Given that the intramolecular sulfoxide oxidant was not feasible, an intermolecular oxidant delivery 
was envisaged as a suitable replacement.  Asensio’s and Liu’s groups had shown that intermolecular 
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sulfoxides may be used to form vinyl gold species from gold-activated alkynes, which are able to act 
as carbenoids.  C.-Y. Li’s group demonstrated that the competing sigmatropic rearrangement, 
observed by Asensio and Liu, could be avoided.45, 47, 65  The reaction conditions were expected to vary 
significantly from the previous intramolecular alkynyl-sulfoxide protocol (Table 5) and controlling the 
order of reactivity would require careful optimisation to avoid the double oxidation observed 
previously by Davies and others.51  With that in mind it was decided to explore the 2,3-sigmatropic 
rearrangement of these thiomorpholinone ylides first, to obtain viable gold-catalysed cascade 
reaction conditions before reapplying them to intermolecular ylide reactions.  In this way attempting 
to optimise two unknown processes simultaneously would be avoided.  If successful this would also 
provide access to valuable, functionalised N-sulfonyl thiomorpholinone motifs from a readily-
obtained starting substrate.  Approaching thiomorpholinones in this manner would allow these 
complex and otherwise inaccessible structures to be obtained (Scheme 86).   
 
Scheme 86: Envisaged intermolecular reaction pathway 
Using this intermolecular approach, vinyl gold intermediate 378 would be expected to arise from 
addition of the gold and sulfoxide to the ynamide 377.  This could then directly cyclise to give the 
desired ylide 380, the vinyl gold species 378 in this case acting as a carbenoid (Path A).  Alternatively, 
elimination of the sulfide leaving group would generate a carbene-like, -bonded gold carbenoid 379 
which could also cyclise (Path B).  The thiomorpholinone 381 would then form by 2,3-sigmatropic 
rearrangement of the intermediate ylide 380.  In this manner the readily-available, linear substrate 
would cyclise, generating a quaternary centre and providing a disubstituted, protected 
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thiomorpholinone in a single synthetic operation.  The necessary S-allyl ynamide was synthesised in 
the same manner as 375 (Scheme 87). 
 
Scheme 87: Synthesis of S-allyl ynamide 
With a substrate capable of undergoing sigmatropic rearrangement in hand, 383 was subjected to 
gold catalysis with diphenyl sulfoxide as the external oxidant, as employed by Asensio, C.-Y. Li and 
Liu.  Given the significant departure in substrate structure from the alkynyl sulfoxides, re-
optimisation was expected to be necessary, therefore initial screening was conducted at room 
temperature in dichloromethane (Table 6).  
Table 6: Screen of reaction conditions with diphenyl sulfoxide 
 
Entry Catalyst Yield of 384 & 385 (%) a 
(Ratio)b  
Yield 386 
(%)a 
Recovered 383 (%) a 
1 Au-I 8 (1:0) c  0 c 35 c 
2 PPh3AuNTf2 37 (4:1) 18 0 
3 IPrAuCl/AgOTs 45 (3:1) 0 0 
4 IPrAuCl/AgOTs d 39 (4.5:1) 0 0 
a 
Yields and ratios determined by NMR spectroscopy against a known quantity of 1,2,4,5-tetramethylbenzene.  
b 
It was not possible to determine which isomer was the major product.  
 c 
Significant degradation observed, 
d 
Reaction performed without Ph2SO. 
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The reaction to form the desired thiomorpholinone 387 was not observed; the oxidant did not attack 
the ynamide under the reaction conditions and instead the products of a gold-catalysed 
carbothiolation process were obtained.  This was confirmed by conducting the reaction in the 
absence of an oxidant (Entry 4).  A mixture of carbothiolation products were observed for the IPrAuCl 
and Ph3PAuCl reactions, however pyridinecarboxylatogold(III) chloride (Entry 1) only gave a poor 
return of the starting material and very little discernible product.  384 and 385 proved inseparable 
and it was not possible to determine which stereoisomer was the major product.  Mixtures of 
isomers in gold-catalysed carbothiolations and carboalkoxylations are common.137-139 Use of 
Ph3PAuCl also gave the fascinating, six-membered 386.  Carbothiolation has not previously been 
reported for ynamides; however the carbothiolation of alkynes under gold catalysis has been 
extensively explored.  384 and 385 may arise via a number of pathways (Scheme 88).140 
 
Scheme 88: Possible pathways to 384 and 385 
Initial cyclisation may occur by anti-addition of the sulfide to the gold-ligated ynamide to give 388 or 
by syn addition to give 389.141, 142  These vinyl gold complexes may then undergo a 1,3 allyl migration 
or 3,3 sigmatropic rearrangement to give 384 and 385, respectively.  3,3 Rearrangement may occur 
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in a single step with concomitant loss of the gold catalyst (e.g. 388 to 384) or as a two-step process 
with subsequent elimination of the catalyst (e.g. 388 to 391 to 384).  Alternatively, vinyl complexes 
388 and 389 may undergo a 1,2-shift or 2,3-sigmatropic rearrangement to give gold carbenoid 390.  
This carbenoid may then undergo a further 1,2-shift, followed by elimination to give a mixture of 384 
and 385, depending upon the conformation during elimination.  Carbenoid formation in this manner 
has been postulated by Nakamura for the rearrangement of benzyl selenonium cations.143  Each of 
the rearrangement steps may occur via two mechanisms, as sigmatropic rearrangement pathways 
compete with stepwise allyl cation formation and migration (Scheme 89). 
 
Scheme 89: Stepwise vs concerted mechanisms for allyl migration 
The use of a symmetrical allyl group leads to the same product regardless of the dominating pathway 
and it is not possible to determine whether allylic inversion, which would indicate a 2,3 
rearrangement, is occurring with this migrating group. 
The formation of six-membered 386 is especially noteworthy as, upon initial inspection, it appears to 
form via a 6-endo-dig cyclisation, which is unknown for the gold-catalysed cyclisation of ynamides.  
The only other example of an ynamide reacting in a 6-endo-dig fashion under metal catalysis was 
reported by Urabe’s group or a copper-catalysed carboamination.  Urabe’s group were attempting to 
form the ynamide 398, but instead obtained cyclisation product 396 under the ynamide formation 
conditions (Scheme 90).144   
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Scheme 90: Urabe’s copper-catalysed 6-endo-dig cyclisation 
Ynamides are normally susceptible to nucleophilic addition at the α position, owing to the 
keteniminium complex 395 that results from ligation to the catalyst.145, 146  Urabe rationalised the 
regioselectivity by suggesting that ligation of the copper catalyst to the ynamide is accompanied by 
ligation to the adjacent tosyl group, forcing the copper to complex at the α position 394, blocking it 
from nucleophilic attack and rendering the β position electrophilic.   
 
Scheme 91: Possible pathways to 386 
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Although nucleophilic addition to the β position has not previously been reported for ynamides 
under gold catalysis, it could explain the observed product 386 (Scheme 91).  6-endo-dig cyclisation 
of the gold-activated alkyne would give 399, which could subsequently undergo a 1,3 shift or 3,3 
sigmatropic rearrangement to give the observed product 386.  Alternatively, a route via 5-exo-dig 
cyclisation is possible, which does not invoke umpolung ynamide reactivity.  After 5-exo-dig 
cyclisation, via a syn or anti addition, the resulting vinyl gold intermediate may undergo a 1,2-allyl 
migration or 2,3-sigmatropic rearrangement to generate carbenoid 390.  Ring expansion via a 1,2-
shift of the sulfide, followed by elimination, would give the observed product  386.  This route is 
more plausible, as ring expansion via carbenoids is a known process and it does not require a 6-endo-
dig cyclisation. 29, 34 
Pyridine N-oxide oxidants  
The use of sulfoxides as oxidants for the synthesis of thiomorpholinone ylides had proven 
unsuccessful.  Substrates incorporating the sulfoxide were unstable and difficult to obtain reliably.  A 
separate, intermolecular sulfoxide was not sufficiently nucleophilic to oxidise the ynamide substrate 
and instead competing unoxidised, carbothiolation led to a variety of isomeric products.  L. Zhang’s 
and Davies’ groups had recently developed methods of obtaining α-keto carbenoids using pyridine N-
oxides as intermolecular oxidants, therefore it was decided to investigate these oxidants in the place 
of sulfoxides.51, 91     
Initial catalyst optimisation 
Initial assessment of pyridine N-oxides was conducted under the same conditions as the previous 
diphenyl sulfoxide catalytic screen, in order to provide a direct comparison between the two.  
Gratifyingly, thiomorpholinone formation was observed using pyridine N-oxide, although this was 
accompanied by an α-diketone, caused by incorporation of a second equivalent of oxidant as 
observed by Davies and others (Table 7).2, 65  
Simple gold salts were observed to give similar reactivity (Entries 1 to 4), with consistent yields of 387 
and 402 in a 7:4 ratio, regardless of the catalyst oxidation state.  Phosphine-ligated gold  catalysts 
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were not suitable (Entries 5 & 6), giving the reverse selectivity and favouring the formation of 
diketone.  The NHC-ligated IPrAuCl proved most effective, providing the highest yield of 387 and the 
best 387:402 ratio of the catalysts screened.   
Platinum(II) chloride proved inactive for this transformation, providing only a low yield of 402.  The 
failure of platinum to catalyse this transformation illustrates the marked difference in reaction 
conditions between the original alkynyl sulfoxide rearrangements reported by Davies’ group, for 
which platinum was optimal, and the current ynamide/pyridine N-oxide pair.75   
Table 7: Synthesis of thiomorpholinones using pyridine N-oxides 
 
Entry Catalyst Yield 387 (%) a Yield 402 (%) a Recovered 383 (%) a 
1 Au-I 44 28 14 
2 AuCl3 45 29 14 
3 AuCl 40 25 22 
4 (CH3)2SAuCl 42 24 13 
5 PPh3AuCl/AgOTs 17 39 31 
6 PPh3AuNTf2 17 37 24 
7 IPrAuCl/AgOTs 56 18 13 
8 PtCl2 0 10 80 
a 
Yields determined by NMR spectroscopy against a known quantity of 1,2,4,5-tetramethylbenzene.  
The use of pyridine N-oxide had an unexpected benefit: no unoxidised carbothiolation products were 
observed in any of the above reactions, even for reactions where complete consumption of the 
oxidant had occurred leaving unreacted starting material.  A computational study by L. Zhang’s and 
Houk’s groups suggests that pyridine N-oxide readily ligates to gold, which may cause activation of 
the ynamide by the gold catalyst to occur concomitantly with syn delivery of the oxidant.40  This 
would prevent activation of the ynamide in the absence of oxidant, which would otherwise lead to 
carbothiolation.  The reaction’s by-product, pyridine, has been shown to attenuate the catalytic 
activity of gold.  The increasing concentration of pyridine during the reaction may act as a governing 
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effect; as the oxidant is consumed, the catalytic activity of the gold catalyst is also reduced, 
preventing undesirable unoxidised carbothiolation from occurring once the N-oxide is depleted. 
Oxidant optimisation 
A wide range of N-oxides have been reported as potential oxidants for intermolecular carbenoid 
formation.49, 52, 53 
Table 8: Oxidant screen 
 
 Entry Oxidant Yield 387 (%) a Yield 402 (%) a Recovered 383 (%) a 
 
1 
 
56 18 13 
 
2 
 
5 9 0 
 
3 
 
0 18 0 
 
4 
 
19 16 0 
 
5 
 
17 34 0 
 
6 
 
5 7 76 
 
7 
 
22 34 30 
a 
Yields determined by NMR spectroscopy against a known quantity of 1,2,4,5-tetramethylbenzene.  
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It was hoped that careful tuning of the oxidant’s steric and electronic factors could reduce diketone 
formation without impacting upon the yield of thiomorpholinone (Table 8).  Elaboration of the 
oxidant structure did not, however, provide any benefit over unsubstituted pyridine N-oxide.  In all 
cases except for 3-acetylpyridine N-oxide (Entry 4), the yield of thiomorpholinone 387 was 
significantly reduced and exceeded by the yield of diketone 402.   
Mesitylene N-oxide was curiously unreactive, giving significant return of unreacted starting material 
but no unoxidised carbothiolation products.  It is possible that the N-oxide sequesters the available 
gold catalyst but the additional steric bulk of the N-oxide prevents reaction with the ynamide.  
Alternatively, the bulk of the oxidant may otherwise retard the catalytic cycle, capturing the gold 
catalyst within the impeded catalytic cycle and preventing it from initiating carbothiolation. 
Solvent optimisation 
With a suitable oxidant established, attention was focused on improving the overall yield of the 
reaction by tuning the remaining reaction conditions.  A range of aprotic solvents were screened; 
temperature and concentration were also varied (Table 9). Addition of molecular sieves was not 
beneficial, a result also observed by Davies’ group for ylides derived from alkynyl sulfoxides (Entry 
2).75   
Of the solvents examined, acetonitrile proved the most efficient (Entry 6). This is possibly due to its 
ability to stabilise the active gold cation, which is generated by precipitation of silver(I) chloride by 
the reaction of the IPrAuCl and silver(I) tosylate precatalysts.147  Reducing the reaction concentration 
by a factor of two had a negligible improvement in overall yield and reduction in doubly oxidised by-
product (Entry 7).  Reducing the concentration further was not beneficial (Entry 8), nor was elevating 
the reaction temperature (Entry 9).   
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Table 9: Screen of further variables 
 
Entry Solvent 
Temperature 
(°C) 
Concentration 
(M) 
Yield 387 
(%) a 
Yield 402 
(%) a 
Recovered 383 
(%) a 
1 CH2Cl2 r.t. 0.1 56 18 13 
2 CH2Cl2 
b r.t. 0.1  44 18 15 
3 CHCl3 r.t. 0.1 37 26 14 
4 toluene r.t. 0.1 0 0 51 
5 THF r.t. 0.1 - c - c - c 
6 CH3CN r.t. 0.1 73 23 12 
7 CH3CN r.t. 0.05 74 
d 17 d 7 d 
8 CH3CN r.t. 0.025 59 18 14 
9 CH3CN 40 0.1 65 13 5 
a 
Yields determined by NMR spectroscopy against a known quantity of 1,2,4,5-tetramethylbenzene.  
b 
Reaction 
conducted in the presence of 4 Å mol. sieves.  
c 
Degradation.  
d 
Average of two experiments. 
Co-catalyst 
The neutral NHC and phosphine-ligated gold (I) catalysts were screened in the presence of a silver co-
catalyst.  The role of the co-catalyst is to provide the gold catalyst with a vacant coordination site by 
removal of chloride, precipitated as silver(I) chloride, as the gold-chlorine bond is close to covalent in 
nature and the chloride is otherwise not sufficiently labile to allow efficient catalysis to occur.148  
Depending upon the reaction conditions, some gold-catalysed protocols have been shown to be 
extremely sensitive to the nature of the silver co-catalyst and the way it is employed.  In 2012 Shi’s 
group reported that the presence of silver catalysts in the reaction mixture can change the nature of 
the gold catalyst, as observed by 31P NMR spectroscopy.  Shi showed that IPrAuCl/AgSbF6, IPrAuSbF6 
and IPrAuSbF6/AgSbF6 precatalyst mixtures can all behave differently and that for some reactions the 
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presence of excess silver or precipitated silver(I) chloride is necessary, and in other reactions it must 
be avoided.149  This is aptly demonstrated by Skrydstrup’s gold-catalysed furan synthesis, in which 
the presence of silver was detrimental to the reaction (Scheme 92). 
 
Scheme 92: Skrydstrup's gold-catalysed furan synthesis 
Skrydstrup observed the addition of a sulfonium ylide (404) to a gold-activated alkyne (403) in the 
presence of Gagosz’s pre-complexed gold(I) triflimidate, to give a disubstituted furan (405).150  
Catalysts prepared from a mixture of gold and silver salts however proved extremely detrimental and 
the addition of excess silver(I) triflimidate proved to be even poorer.76  The source of this silver effect 
may be attributed to bimetallic gold-silver interactions during the catalytic cycle or co-operative gold 
and silver catalysis resulting in a more efficient catalytic cycle than for gold alone.  Mixtures of gold 
and silver catalysts have been isolated as gold-silver-gold tri-metallic complexes.151  Gold-gold 
organometallic resting states have been isolated and characterised and complexes which are 
believed to be gold-silver organometallic species have been observed via NMR spectroscopy.142, 152, 153  
Other metal additives have been observed to modify the reactivity of the gold catalysis, gold and 
ytterbium displaying similar discrepancies in 31P NMR to gold-silver solutions.38   
The nature of the counterion can also be key; its basicity can influence the longevity of the active 
catalyst and in extreme cases it may play a part in the catalytic cycle, influencing the final product 
distribution.148, 154-156  Based upon these reports, a screen of silver co-catalysts was conducted in 
order to optimise the transformation and determine whether the reaction was dependent upon the 
presence of silver. Modifying the silver precatalyst counterion gave very little variation in yield, 
although tosylate was marginally superior.  Silver(I) tosylate was selected as the chosen co-catalyst 
owing to its air stability and lower cost compared to the triflimidate and hexafluoroantimonate salts.  
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Silver was omitted from the reaction mixture entirely by preparing an equimolar solution of IPrAuCl 
and AgOTs in dry acetonitrile and removing the silver(I) chloride precipitate by filtration through 
Celite, as per Shi’s protocol (Entry 4).149  Removal of the silver significantly reduced the yield of 
desired thiomorpholinone, with only a small portion of starting material recovered, however double 
oxidation product 402 was also suppressed.   
 
Table 10: Screen of co-catalysts 
 
Entry Catalyst Co-catalyst Yield 387 (%) a Yield 402 (%) a Recovered 383 (%) a 
1 IPrAuCl AgOTs 74 b 17 b 7 b 
2 IPrAuCl AgSbF6 70 26 10 
3 IPrAuCl AgNTf2 74 20 6 
4 IPrAuOTS - 29 - d 6 
5 - AgOTs 0 0 >95 
6 IPrAuCl c AgOTs c 66 14 12 
7 HOTf.H2O - - 
e - e - e 
a 
Yields determined by NMR spectroscopy against a known quantity of 1,2,4,5-tetramethylbenzene. 
 b 
Average 
of two experiments. 
c 
2.5 mol% catalyst. 
d 
Complex mixture.  
e 
Degradation.   
  
The reactivity of IPrAuCl is in contrast to that of the phosphine-ligated gold catalysts investigated 
during the initial catalyst screen (Entries 5 & 6).  While the NHC-gold complex reaction conditions 
display a pronounced dependency upon the presence of silver, phosphine-gold-catalysed reactions 
do not, giving extremely similar results regardless of the presence of silver (Table 7).   
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Conducting the reaction in the presence of silver(I) tosylate alone did not result in activation of the 
ynamide, suggesting that the effect upon the NHC-gold-catalysed reaction is the result of bimetallic 
or cooperative catalysis, rather than solely the silver.  The catalyst and co-catalyst loading was 
reduced to 2.5 mol%, however this was accompanied by a moderate reduction in thiomorpholinone 
387 yield (Entry 6).   
Brønsted acids have been demonstrated to catalyse reactions involving ynamides, as have 
electrophilic halides, therefore tosic acid was tested as a possible catalyst, unfortunately only a 
complex mixture of products was observed, none of which was the desired thiomorpholinone 387.157   
Substrate elaboration 
With optimised conditions for thiomorpholinone formation obtained, employing 5 mol % of IPrAuCl 
and AgOTs in acetonitrile, attention turned to exploring the substrate scope for this transformation.  
This accomplished two goals: obtaining a range of valuable thiomorpholinones and simultaneously 
surveying the ylides accessible through this gold-catalysed cascade. 
Sulfonamide variation 
Initial screening focused on the variation of the sulfonamide protecting group.  A range of N-
sulfonamide-protected ynamides were synthesised, although a triflyl-protected ynamide was not 
successfully obtained, the reaction mixture underwent severe degradation (Scheme 93). 
 
Scheme 93: Synthesis of various sulfonamide-protected ynamides 
The ynamides were duly subjected to the optimised thiomorpholinone-forming conditions until each 
reaction reached completion (Scheme 94). 
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Scheme 94: Synthesis of various sulfonamide N-protected thiomorpholinones 
The isolated yield of N-tosyl thiomorpholinone 387 was pleasingly higher than observed during the 
NMR spectroscopy optimisation study, owing to the larger reaction scale.  Modifying the electron 
withdrawing effect of the sulfonamide resulted in decreased yields for the N-mesyl and N-nosyl 
thiomorpholinones 411 and 412.  
Migrating group variation 
Exploration of a range of migrating groups followed (Scheme 95).  The migratory aptitude of 
substituted allyl moieties was investigated to assess the reactivity of the amide-stabilised ylide.   
 
Scheme 95: Synthesis of a variety of sulfides 
The regiochemistry of the products would also provide insight into the mechanism of the migration. 
S-Prenyl and S-cinnamyl ynamides 419 and 420 were readily obtained with the standard ynamide 
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synthetic sequence.  The S-crotyl sulfonamide 413 was obtained as an inseparable mixture of 
regioisomers, caused by allylic inversion (SN2’) during sulfide formation and therefore was not 
suitable for assessing migrating group aptitude.  An S-ethyl ynamide 421 was also synthesised, using 
a modified sequence via tosylation of 2-bromoethanamine 416 and nucleophilic substitution with 
ethanethiol. 
 
Scheme 96: Migratory aptitude of a variety of ylide substituents 
The substituted S-allyl ynamides were transformed to the corresponding thiomorpholinones with 
only a small reduction in yield compared to 387 (79%) (Scheme 96).  Complete allylic inversion was 
obtained, suggesting that the rearrangement is proceeding exclusively via a 2,3-sigmatropic 
rearrangement pathway and that 1,3 allyl migration is not occurring.  The amide-stabilised ylides 
proved to be more reactive than the ketone-stabilised ylides reported by Davies’ group, which were 
also unsubstituted at the α position (Scheme 97).75  The heavily substituted thiomorpholinone 422 is 
of note, as the synthesis of this thiomorpholinone by existing synthetic routes would be extremely 
challenging but is easily obtained via gold catalysis. 
 
Scheme 97: Davies rearrangement of substituted allyl groups 
The yields of thiomorpholinone were extremely promising, as it confirmed that the 
thiomorpholinone ylides were more reactive than their ketone-stabilised counterparts.  This justified 
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the investigation into thiomorpholinone ylides as their increased reactivity makes them more 
suitable for intermolecular reactions. 
 
Scheme 98: Elimination of an S-ethyl ylide 
Use of S-ethyl ynamide 421 was also successful, the ethyl moiety eliminating under the basic reaction 
conditions to quench the ylide 429 and allow access to α-monosubstituted thiomorpholinones such 
as 424 (Scheme 98). 
Ynamide variation 
Variation of the ynamide substituent was also examined.  The desired ynamides could be easily 
obtained from dibromo alkenes using Evano’s ynamide formation procedure, formed by Wittig 
olefination of the corresponding aldehyde (Scheme 99).158, 159 
 
Scheme 99:  Synthesis of a variety of substituted ynamides via Evano’s protocol 
A range of ynamides bearing electron-withdrawing and -donating aromatic groups were successfully 
synthesised from dibromo olefins, obtained from readily available aldehydes.  Alkyl-, terminal- and 
silane-protected thiomorpholinones were also synthesised, using Hsung’s conditions (Scheme 
100).160 
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Scheme 100:  Synthesis of a variety of substituted ynamides via Hsung’s protocol 
When subjected to the established conditions all of the synthesised ynamides successfully 
underwent thiomorpholinone formation (Scheme 101). 
 
Scheme 101: Synthesis of various 2-substituted thiomorpholinones 
Aromatic substituents were tolerated well, with electron-withdrawing and -donating substituents 
accepted by the gold-catalysed cascade.  The silane-substituted ynamide 436 was desilylated under 
the reaction conditions, only giving monosubstituted thiomorpholinone 443.  Desilylation of 
protected triple bonds under gold catalysis is a known side reaction in a number of processes.161  
Terminal ynamide 437 proved extremely unstable, rapidly decaying under high vacuum while drying.  
It was subjected to the reaction conditions immediately after drying, however the low yield of 443 is 
likely due to continued degradation under the reaction conditions.  Terminal tosyl ynamides have 
been reported to be unstable by other groups, so the low yield is not surprising.162  The exact nature 
of the degradation products was investigated by allowing a portion of the ynamide substrate to 
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decay, however a complex mixture of products was obtained, rather than a single rearrangement 
product. 
 
Scheme 102: Competing 1,2-hydride shift and ylide formation 
Alkyl-substituted ynamide 435 gave only a low yield of the desired thiomorpholinone 445, the major 
product being enamide 446 (Scheme 102).  The formation of enamide 446 gives an insight into the 
catalytic cycle, as it arises from a formal 1,2-hydride shift, implying strong carbene character is 
present in the intermediate gold-carbenoid complex.47, 51 
Proposed reaction mechanism 
Based on the observed reactivity during optimisation of the catalytic cycle and substrate elaboration, 
the mechanistic scenario below is proposed (Scheme 103). Activation of the ynamide by the gold 
catalyst may occur in one of two ways; via a concerted syn addition of the catalyst and oxidant to 
give D or a stepwise activation of the ynamide followed by anti-addition of the oxidant to the gold-
activated ynamide, giving E.  Isolated and characterised intermediates resulting from both syn and 
anti gold-catalysed additions to triple bonds have been reported, although not for pyridine N-
oxides.40, 141, 142, 163   
Zhang’s group has suggested that the intermolecular addition of pyridine N-oxides to triple bonds is 
more likely to occur in a syn than anti fashion.  Zhang’s computational study indicated that strong 
interaction between the N-oxide and gold catalyst is responsible for this syn addition and suggested 
there is no viable transition state for anti-addition.  Syn addition could explain why unoxidised 
carbothiolation was not observed to compete with oxidised thiomorpholinone formation.   
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Scheme 103: Proposed reaction mechanism for gold-catalysed thiomorpholinone formation 
Strong gold-N-oxide bonding would cause the gold catalyst to be immediately sequestered by the N-
oxide, preventing the gold catalyst from activating the ynamide without simultaneously delivering 
the oxidant, as depicted by B.  The lack of unoxidised carbothiolation (Table 6) could also be 
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explained if the rate of 1,3 migration is significantly slower than the rate of irreversible pyridine loss 
from D or E, leading to overall thiomorpholinone ylide formation, assuming the initial carbothiolation 
step is reversible (Scheme 104). 
 
Scheme 104: Competing carbothiolation and oxidation 
After the initial activation and oxidation of the ynamide, D and E may lose pyridine to generate 
carbenoid F.  Alternatively, immediate cyclisation of D and E may lead directly to thiomorpholinone 
ylides G – J.  Of these two possibilities, carbenoid F formation is more likely, owing to the observation 
of enamide P for alkyl-substituted ynamides.  While D and E may be considered carbenoids due to 
the electrophilic carbon α to the gold, other reactions that have strong evidence suggesting that they 
proceed via an equivalent vinyl gold ether do not undergo a 1,2-hydride shift and therefore 
“carbene” F is necessary to explain the formation of P.45, 47   
Doubly oxidised product N may arise from the addition of a second molecule of oxidant to D, E and 
F.51  Whether the gold-bound ylide exists in the Au-C ylide or Au-O enolate form is unknown, 
however stabilised ylides do display enolate character, with some ketone-stabilised ylides possessing 
sufficient enolate character to display E/Z isomerism.164  Similarly, it is not known whether the metal-
catalysed 2,3-sigmatropic rearrangement of ylides occurs via a metal-bound or free ylide; although 
Wang has shown that for copper-catalysed ylide formation, and subsequent 2,3 rearrangement, the 
ylide exists as an equilibrium of the free and metal-bound ylides.165   
Rearrangement of the ylide to give the final thiomorpholinone L may conceivably occur by a direct 
2,3-sigmatropic rearrangement or a stepwise 1,3 migration via an allyl cation and gold complex K.140  
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Given that complete allylic inversion was observed for all the substituted allyl moieties examined, a 
1,3 migration is extremely unlikely. 
Application 
Intermolecular reactions 
Having successfully optimised suitable conditions to access and quench thiomorpholinone ylides with 
a sigmatropic rearrangement, the next objective was the extension of these conditions to 
intermolecular reactions.  These amide-stabilised ylides had proven to be more reactive than their 
ketone-stabilised equivalents for intramolecular reactions.  The application of an amide-stabilised 
ylide was therefore considered to be a potential means of solving the problems observed when 
attempting to develop an intermolecular ylide reaction, with ketone-stabilised ylides, as detailed in 
Chapter 2.  During development of the ynamide-based 2,3-sigmatropic rearrangement it became 
apparent that pyridine N-oxides were capable of ylide formation by intermolecular oxidation.  An 
ynamide that could undergo reaction with pyridine N-oxide, based upon the previously examined 
alkynyl sulfoxide system, was therefore synthesised.  A substituted ynamide was unfortunately 
necessary as terminal ynamides had proven highly unstable and low-yielding for thiomorpholinone 
formation (Scheme 105). 
 
Scheme 105: Synthesis of a S-hexyl ynamide 
The ylide was subjected to gold catalysis using Davies’ original conditions for ylide formation, with 
pyridine N-oxide as the oxidant and butenone as the electrophile (Scheme 106).75 
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Scheme 106: Application of Davies’ ylide-forming conditions to intermolecular oxidants 
Davies’ reaction conditions did not give the desired cyclopropane or the previously observed keto-
alcohol.  Once fully optimised reaction conditions for 2,3-sigmatropic rearrangement of 
thiomorpholinone ylides had been obtained these were reapplied to a modified ynamide, bearing an 
S-methyl moiety in place of the S-hexyl, to reduce steric bulk at the sulfonamide (Scheme 107). 
 
Scheme 107: Attempted intermolecular trapping of a thiomorpholinone ylide 
Subjecting ynamide 375 to the optimised thiomorpholinone ylide-forming conditions in the presence 
of butenone was unsuccessful.  The desired cyclopropanation product 452 was not observed nor was 
replication of the three-component coupling obtained using ketone-stabilised ylides 453.  Small 
traces of doubly oxidised product were observed, which indicated that activation of the ynamide was 
proceeding, however this was in such low yield that it could not be isolated.  Given the failure of the 
reaction conditions optimised for sigmatropic rearrangement it was decided to re-optimise with the 
aim of developing more conducive conditions for intermolecular ylide reaction (Table 11).  A number 
of catalysts that had previously proven successful for the intermolecular reaction of ketone-stabilised 
ylides were screened.  Dichloromethane replaced acetonitrile as the reaction solvent as Aggarwal’s 
group have shown that amide-stabilised ylides can be forced to react with butenone in this 
solvent.110  These catalysts were not successful and formation of 452 or 453 was not observed.  
Moreover, significant decomposition of the ynamide starting material occurred, in contrast to the 
alkynyl sulfoxide system.   
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Table 11: Attempted intermolecular trapping of a thiomorpholinone ylide 
 
Entry Catalyst Yield 452 (%) a Yield 453 (%) a Recovered 375 (%) a 
1 IPrAuCl /AgOTs 0 0 12 
2 Au-I 0 0 18 
3 PtCl2 0 0 c.a. 85 
4 PPh3AuNTf2 0 0 24 
a 
Yields determined by NMR spectroscopy against a known quantity of 1,2,4,5-tetramethylbenzene.  
Attention turned to variation of the electrophilic trap for the ynamide.  Given the narrow window of 
reactivity observed for ketone-stabilised ylides, rescreening of the nucleophile was conducted to 
ensure that the butenone electrophile was not responsible for the lack of reactivity or degradation 
(Scheme 108). 
 
Scheme 108: Screen of electrophiles for reaction with thiomorpholinone ylides 
Despite screening a range of electrophiles capable of formal [1+2] and [1+4] cycloadditions to ylides, 
the only observed products of these reactions were traces of doubly oxidised ynamide and significant 
degradation of the starting material.71  Omission of the electrophile did not prevent this degradation.   
The attempted intermolecular reaction of these thiomorpholinone ylides revealed two main 
problems:  the inability to replicate the reactivity of the ketone-stabilised ylides, let alone improve 
upon it and the massive degradation of the ynamide starting material under the reaction conditions.  
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The failure of the ylides to undergo intermolecular reaction potentially stems from the necessity for 
the substituted ynamide, as this results in a tertiary ylidic anion.  Given that secondary, cyclic ylides 
have been reported to undergo epoxidation, it might be expected that removal of this substituent 
would significantly improve the reactivity of the thiomorpholinone ylide.  However, during substrate 
elaboration of the ylide 2,3-sigmatropic shift reaction, it was found that the structural limitations 
imposed upon the thiomorpholinone ylides by the gold cascade precluded this.  The terminal 
ynamide necessary to obtain a secondary thiomorpholinone ylide is unstable and a very poor 
substrate for thiomorpholinone formation.  Given these limitations the author was forced to 
conclude that thiomorpholinone ylides are not suitable substrates for intermolecular reaction. 
Stevens rearrangement  
Thus far the migrating groups studied for the rearrangement of thiomorpholinone ylides have been 
limited to allyl groups undergoing 2,3-sigmatropic rearrangement.  Ylides are also known to undergo 
1,2-Stevens rearrangement and 2,3-Sommerlet-Hauser rearrangement of benzyl substituents.175, 176  
These rearrangements are commonly in competition and mixtures of products may arise from ylides 
undergoing both transformations.165   
 
Scheme 109: Synthesis of S-benzyl ynamide and S-oxide 
Stevens and Sommerlet-Hauser rearrangements have not previously been reported for ylides formed 
by gold catalysis and it was therefore decided to investigate the behaviour of the gold-derived 
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thiomorpholinone ylides with benzyl migrating groups.  A suitable S-benzyl ynamide was readily 
obtained using a modification of the synthetic sequence for allyl ynamides (Scheme 109). 
In order to provide a comparison to Davies’ ketone-stabilised ylide system, a small portion of the S-
benzyl substrate was converted to the corresponding sulfoxide 462.  As with previous attempts to 
make sulfoxide-bearing ynamides, it proved unstable and was used immediately after 
characterisation. 
Table 12: Screen of solvents for the Stevens rearrangement of thiomorpholinone ylides 
 
Entry Substrate Catalyst Solvent Temperature (°C) 
Yield of  
thiomorpholinone (%) a 
1 459 R = H IPrAuCl/AgOTs MeCN r.t. 50 
2 459 R = H IPrAuCl/AgOTs CH2Cl2 r.t. 65 (54 
b) 
3 459 R = H IPrAuCl/AgOTs CH3Cl r.t. 24 
4 459 R = H IPrAuCl/AgOTs MeOH r.t. 40 
5 462 R = H c IPrAuCl/AgOTs CH2Cl2 r.t. 0 
6 462 R = H c Au-I (CH2Cl)2 70 18 
7 460 R = MeO IPrAuCl/AgOTs CH2Cl2 r.t. 0 
d 
8 461 R = CF3 IPrAuCl/AgOTs CH2Cl2 r.t. 0 
d 
a 
Yields determined by NMR spectroscopy against a known quantity of 1,2,4,5-tetramethylbenzene. 
b 
Isolated 
yield. 
 c 
No pyridine N-oxide 
d 
Degradation. 
Gratifyingly, the first attempt at benzyl rearrangement using the previously developed conditions for 
2,3-sigmatropic rearrangement was successful, giving thiomorpholinone 463 (Entry 1).  Exclusive 
selectivity for biradical 1,2-Stevens rearrangement was observed and in no entry was the 2,3-
sigmatropic Sommerlet-Hauser rearrangement product detected.  
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 Optimisation of the reaction solvent, crucial for Stevens rearrangements as it controls migration of 
the radical benzyl intermediate, was conducted with solvents that had previously proved compatible 
with the gold-catalysed cascade (Entries 1 -4).165  Improvement to the yield of 463 was found by 
using dichloromethane.   
The sulfoxide ynamide 462 was not reactive under the NHC-gold-catalysed conditions (Entry 5), 
analogous tonearlier attempts to oxidise ynamides with diphenylsulfoxide (  
Table 6).  Davies’ optimised conditions for ketone-stabilised ylide formation were also applied, with 
successful thiomorpholinone formation occurring, albeit in significantly reduced yield compared to 
the optimised pyridine N-oxide-based conditions (Entry 6).75   
While simple benzyl migration was successfully achieved, elaboration of the migrating group to 
include electron-withdrawing and electron-donating aromatic substituents was unsuccessful (Entries 
7 & 8).  Stabilisation of the benzyl radical led to decomposition of the reaction mixture and only small 
quantities of the starting materials could be isolated.  This effect has been observed by others; small 
changes to the migrating group frequently have a large impact upon Stevens and Sommerlet-Hauser 
rearrangements.77-79, 177 
Chiral ynamides  
Sarabia’s group has reported that cyclic, chiral, amine-stabilised ylides such as 363 may be utilised for 
stereoselective epoxidation reactions.124  Construction of ynamides bearing chiral directing groups 
was envisaged as a means of exerting control over the stereochemistry of the stereogenic centre 
constructed during thiomorpholinone formation (Scheme 110). 
 
Scheme 110: Potential control of diastereoselectivity 
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As the thiomorpholinone ylides explored in this project are synthesised from the amino acid 
derivative cysteamine hydrochloride, the use of modified, enantiopure amino acids allowed 
construction of the chiral backbone of the substrate (Scheme 111).  
 
Scheme 111: Attempted synthesis of an L-valine-derived ynamide 
The first chiral ynamide which was targeted derived from L-valine, as the isopropyl group was hoped 
to be sufficiently bulky to provide the desired directing effect.  Tosylation of the amino acid nitrogen, 
followed by reduction gave N-tosyl amino alcohol 468.  A Mitsonobu reaction then installed the 
necessary sulfur atom, in the form of thioacetate, which was converted to the necessary allyl sulfide 
by methanolysis in the presence of allyl bromide.  Unfortunately, Mitsunobu reactions of the N-tosyl 
amino alcohol were impractical.  The thioacetate product co-eluted with the hydrazine dicarboxylate 
by-product of the Mitsunobu reaction and was extremely difficult to separate, accounting for the low 
yield of valine-derived thioester 469.   
Having obtained the necessary chiral sulfonamide, formation of the final ynamide substrate 470 was 
attempted. Ynamide formation using Hsung’s copper-catalysed conditions was not successful.  The 
failure of the ynamide formation was believed to be due to the size of the isopropyl group.  This 
promotes chelation of the sulfonamide substrate to the copper catalyst by a reactive rotamer effect, 
rendering the catalyst inactive.  This phenomenon has been observed by the Davies group for similar 
substrates which possess structures which favour chelation.  Replacement of the isopropyl directing 
group with smaller substituents was therefore attempted (Scheme 112).   
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Scheme 112: Synthesis of L-alanine- and L-phenylalanine-derived ynamides 
The amino alcohols of L-alanine and L-phenylalanine were examined as viable alternatives.  As the 
synthesis of a chiral thioacetate via a Mitsunobu reaction had proven impractical for the valine-
derived substrate, the thioester was installed using a modified strategy. Double tosylation of the 
amino alcohol, followed by substitution with potassium thioacetate, accessed the desired 
thioacetates (475 & 476).  After methanolysis, ynamide formation proceeded smoothly with the 
smaller directing groups, to give 477 and 478, albeit in low yield. 
 
Scheme 113: Unsuccessful thiomorpholinone formation with chiral ynamides 
The chiral ynamides were then subjected to the optimised ylide formation conditions, but 
unfortunately no thiomorpholine products were obtained (Scheme 113).  The phenylalanine-derived 
ynamide 478 succumbed to complete degradation under the reaction conditions.  Alanine-derived 
ynamide 477 was converted to the doubly oxidised product 481, consuming almost all of the 
available oxidant in the process.   
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Scheme 114: Proposed mechanistic rationale for the formation of 481 
This change in reactivity is believed to be due to steric impedance of the thiomorpholinone ylide 
formation (Scheme 114).  The addition of a substituent to the backbone of the substrate prevents 
vinyl gold complexes C and E, and carbene D from adopting the conformations C’, E’ and D’ necessary 
for cyclisation, by steric clash between the sulfonamide protecting group and the substituent.  
Instead, the addition of a second molecule of oxidant is uncontested resulting in the exclusive 
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formation of doubly oxidised 481.  While the tosyl sulfonamide may have been replaced with a 
smaller mesyl sulfonamide, to reduce the steric interaction between the sulfonamide and the 
directing group, mesyl-substituted ynamides are poorly tolerated by the gold-catalysed cascade and 
are therefore unsuitable.   
Summary  
The gold-catalysed synthesis of thiomorpholinone ylides has been developed.  These ylides are 
derived from novel ynamide substrates, bearing a nucleophile tethered to the ynamide nitrogen, a 
structural motif that has not previously been investigated for gold catalysis.  These 
thiomorpholinones have been demonstrated to be more reactive than the equivalent ketone-
stabilised cyclic ylides.   
Reaction conditions are very mild, with reaction occurring at room temperature and in the presence 
of a weak base.  All of the reagents are commercially available and the most expensive component, 
the gold catalyst, may be reduced to 2.5 mol% loading with only minor reduction in 
thiomorpholinone yield.  The thiomorpholinones obtained are valuable, owing to the difficulty in 
preparing sulfonamide-protected thiomorpholinones and are readily obtained as complex, 
polysubstituted motifs from a highly modular synthesis of easily-constructed ynamides.  Competition 
with carbothiolation was successfully controlled, another novel process as ynamides have not thus 
far been used for gold-catalysed carbothiolation reactions.   
The reactivity of these ylides has been explored and is suitable for 2,3-sigmatropic rearrangements 
and 1,2-Stevens rearrangements, however substitution adjacent to the ynamide nitrogen is not 
tolerated.  The structural constraints introduced by the ynamide moiety render these 
thiomorpholinone ylides unsuitable for intermolecular reactions, as the necessary ynamide 
substituent renders the ylidic anion too congested to undergo intermolecular reaction and the 
substrate degrades under the reaction conditions. 
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Chapter 4: Thioynol ethers 
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Introduction 
The study of thioynol ethers described here came about through the author’s attempted synthesis of 
glitazones using gold catalysis.  Glitazones are a class of drug compounds incorporating the 
thiazolidinedione motif (Figure 4).   
 
Figure 4: Glitazone and marketed glitazone-based drugs 
These compounds are potent peroxisome proliferator-activated receptor (PPAR) activators and have 
been developed for the treatment of type 2 diabetes.  In 2010, Actos was the 11th highest selling 
drug in the US, with sales in excess of $2.6 billion.178   
 
Scheme 115: Synthesis of thiazolidinedione 
While the thiazolidinedione (483) core is simple to construct, such as in the example by Meng et al. 
shown in Scheme 115,179 application of the gold-catalysed Stevens rearrangement developed in the 
previous chapter would allow for facile construction of more complex, protected and polysubstituted 
thiazolidinediones, which would be of interest as potential lead compounds (Scheme 116). 
97 
 
 
Scheme 116: Proposed gold-catalysed thiazolidinedione synthesis 
By employing an ynamide with a tethered thioester, oxidative gold-catalysed ylide formation would 
construct the desired thiazolidinedione core.  Migration of the ylide substituent would then quench 
the ylide and further substitute the thiazolidinedione, leading to a 3,5,5-trisubstituted 
thiazolidinedione.  It was expected that significant re-optimisation of the gold-catalysed ylide 
formation would be necessary owing to the electronic difference between conjugated ylide 485 and 
the previously examined thiomorpholinone ylides. A Stevens rearrangement was chosen for the 
migration to be studied initially, as this would provide thiazolidinedione products similar to the 
existing glitazone drugs. Synthesis of the necessary ynamide substrate (489) began with construction 
of thiocarbamate 488 from N-tosyl isocyanate (Scheme 117).   
 
Scheme 117: Attempted synthesis of thiazolidinedione precursor ynamide 
Installation of the ynamide moiety (490) via Gagosz’s copper-catalysed conditions was not successful; 
instead thioynol ether 489 was obtained.  This thioynol ether (489) likely results from decomposition 
of thiocarbamate (488) due to the presence of the phosphate base. The decomposition of 
thiocarbamates, by bases, to give isocyanates is well understood.180  While this made the synthesis of 
a suitable ynamide precursor impossible, as all ynamide formations are performed under basic 
conditions,145, 146 the resulting thioynol ether was intriguing.  Thioynol ethers had not been 
investigated under gold catalysis, with the exception of a single substrate (Scheme 118).181 
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Scheme 118: Sanz’s gold-catalysed benzene synthesis 
Sanz reported the gold-catalysed cyclisation of sulfide-substituted enyne 491 via a Wagner-Meerwein 
rearrangement.  Given that Sanz had demonstrated that thioynol ethers are suitable for gold 
catalysis and the electron-rich nature of the triple bond, it was envisaged that these thioynol ethers 
may undergo similar reactions to ynamides and therefore expand the substrate scope of such 
reactions.   
Synthesis of thioynol ethers 
Synthesis of suitable substrates for reaction optimisation was attempted with phenyl acetylene and 
diphenyl disulfide under literature conditions (Scheme 119).182, 183 
 
Scheme 119: Attempted synthesis of substrate with diphenyl disulfide 
While the desired thioynol ether 494 was formed, it proved inseparable from the diphenyl disulfide 
starting material, despite following literature conditions.  This difficulty stems from the similar and 
extremely low polarities of both compounds.  In one case, careful examination of the supporting 
information for a supposedly quantitative method of synthesising this class of compounds revealed 
the same mixture of disulfide and thioynol ether.184  A more polar sulfide source was therefore 
employed to aid separation from the reaction product (Scheme 120).185 
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Scheme 120: Synthesis from S-phenyl benzenesulfonothioate 
This approach allowed alkyl- and aryl-substituted triple bonds to be synthesised.  A variety of sulfur 
substituents were obtained with Zheng’s conditions (Scheme 121).186 
 
Scheme 121: Introduction of a variety of sulfide substituents 
 
Electrophilic aromatic substitution 
Electrophilic aromatic substitution was targeted as a potential application of these thioynol ethers.  
Electrophilic substitution would obtain bicyclic thiolactones such as 504 (Scheme 122).   
 
Scheme 122: Proposed gold-catalysed electrophilic aromatic substitution 
Regioselective activation of the thioynol ether by the gold catalyst would lead to gold thioketene 
499.  Nucleophilic attack of a suitable intermolecular oxidant would then generate vinyl gold 500 
which could undergo carbenoid formation and subsequent substitution, or a 2,3-sigmatropic 
rearrangement to give the final thiolactone 504.31  This gold-catalysed approach offered significant 
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improvements over reported means of obtaining bicyclic thiolactones such as 510.  An example 
synthesis by Haeggström’s group requires five steps to reach an unsubstituted isothiochroman-3-
one, via a reduction which gave what they describe as “variable yield” (Scheme 123).187 
 
Scheme 123: Synthesis of isothiochroman-3-one 
The equivalent gold-catalysed synthesis would require two steps to reach a substituted 
isothiochroman-3-one, a significant improvement in synthetic efficiency and therefore a worthwhile 
goal.  
 
Scheme 124: Attempted synthesis of isothiochroman-3-one derivatives 
While a promising target, electrophilic aromatic substitution could not be obtained with either 
substrate (Scheme 124).  A wide range of conditions and catalysts were screened, including NHC, 
phosphite and Buchwald phosphine complexes.  The thioynol ethers proved to be significantly less 
reactive than the equivalent ynamide or alkyne.  In comparison, the first substrate screened in this 
thesis (304) readily underwent electrophilic aromatic substitution, in high yield, with a variety of 
simple gold catalysts.  Despite the electron-rich triple bond, these thioynol ethers appear to 
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significantly attenuate the catalytic activity, possibly acting as a highly effective ligand for the gold 
catalyst. 
Oxazole synthesis 
After the failure of thioynol ethers to undergo electrophilic aromatic substitution, it was decided to 
focus on another gold-catalysed ynamide reaction.  Davies has reported a gold-catalysed oxazole 
formation from ynamides (513) and pyridinium ylides.  This transformation can also be performed 
using alkynyl indoles (516) and also ynol ethers (518), albeit in reduced yield, suggesting that it may 
also tolerate the thioynol ethers under investigation in the present work (Scheme 125).69, 188 
 
Scheme 125: Davies’ oxazole synthesis from ynamides and ynol ethers 
Davies’ reaction regioselectively forms oxazoles by a proposed Nazarov 4 electrocyclisation or gold 
carbenoid (for mechanism and discussion see Scheme 53).69  The necessary pyridinium ylide was 
synthesised from aminopyridinium iodide and initial screening was performed with Davies' optimised 
conditions for ynol ethers (Scheme 126). 
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Scheme 126: Synthesis of the pyridinium ylide 
A range of thioynol ethers were tested, to determine a suitable substrate for more in-depth 
investigation (Table 13). 
Table 13: Screen of thioynol ethers 
 
Ynamide R R’ Yield of oxazole (%) a 
494 Ph Ph <5 
495 n-Bu Ph Trace b 
489 Ph Bn Trace b 
496 n-Bu Bn Trace b 
497 Ph CH3 13 
498 n-Bu CH3 <5 
 a 
Yields determined by NMR spectroscopy against a known quantity of 1,2,4,5-tetramethylbenzene. 
 
b 
Detected by TLC 
Thioynol ethers 489, 494, 495 and 496 proved largely unreactive, with only traces of the oxazole's 
characteristic fluorescence detected by TLC.  Methyl-substituted thioynol ethers 497 and 498 were 
slightly more suitable, with successful oxazole formation achieved in 13% yield for the 
phenylacetylene-based substrate.  Thioynol ether 497 was therefore employed in further 
screening.  The successful formation of an oxazole confirmed the hypothesis that thioynol ethers 
could be used as ynamide equivalents and via an intermolecular process.  Further optimisation of the 
oxazole synthesis was conducted (Table 14). 
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Applying Davies’ conditions for gold-catalysed oxazole formation gave a significantly lower yield than 
Davies observed for ynol ethers (Scheme 125).69  Gold(III) chloride gave a slight improvement (Entry 
2), however phosphine- and phosphite-ligated gold catalysts were not effective, even with elaborate 
Buchwald phosphines. (Entries 3 to 6).  Elevating the reaction temperature proved beneficial to the 
yield of oxazole (Entry 7), however increasing it further by using xylene and mesitylene was 
detrimental to the yield.   
Table 14: Optimisation of oxazole synthesis 
 
Entry Catalyst 
(mol %) 
Co-catalyst 
(mol %) 
Temperature 
(°C) 
Time 
(h.) 
Yield of 522 
(%) a 
1 Au-I (5) - 90 18 13 
2 AuCl3 (5) - 90 18 15 
3 Ph3PAuCl (5) AgNTf2 (5) 90 18 10 
4 Complex 1 (5) - 90 18 9 
5 Complex 2 (5) - 90 18 12 
6 (F3CPh)3PAuCl (5) AgSbF6 (5) 90 18 <5 
7 AuCl3 (5) - 100 18 27 
8 IPrAuCl (10) AgNTf2 (10) 100 18 24 
9 AuCl3 (10) AgOTs (30) 100 48 37 
10 AuCl3 (10) - 100 48 40 
11 Au-I (10) - 100 48 44 
The NHC-ligated IPrAuCl was not as effective as gold (III) chloride, even at double the catalyst 
stoichiometry.  Increasing the reaction time to two days offered significant improvement.  This 
suggests that catalyst activity is being attenuated by the presence of the thioynol ether and requires 
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a long time period for conversion to occur, rather than the reaction halting due to catalyst 
degradation.  Addition of sufficient silver co-catalyst to create a bare gold (III) cation, to provide 
maximum coordination sites for reaction to occur was not productive (Entry 9).  Ultimately 
pyridinecarboxylatogold (III) chloride proved most effective (Entry 11). 
At the conclusion of laboratory work, the yield of oxazole had successfully been raised to 44%, 
however further optimisation is continuing within the Davies group.  This yield is extremely close to 
the yields observed by Davies and co-workers for ynol ethers, which are considerably more 
reactive.69   
Future work 
Thioynol ethers have been confirmed to be able to act as ynamide equivalents under gold catalysis.  
The optimisation of this process is by no means complete, there remains a large selection of gold 
catalysts, such as Zhang’s recent bidentate Buchwald phosphine derived complexes, and reaction 
conditions yet to be screened.64  After sufficient optimisation, these thioynol ethers will allow access 
to a range of interesting, sulfur-containing oxazoles, from easily obtained ethers. 
 
Scheme 127: Yoshimatsu’s pyrazole synthesis 
During the preparation of this thesis Yoshimatsu’s group published the synthesis of pyrazoles from 
thioynol ethers, further confirming that these motifs are indeed suitable for gold catalysis.189  
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Chapter 5: Conclusion 
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Conclusion and Future Work 
At the outset, this research project had the following aims: 
 To investigate whether the reactivity of gold-derived sulfonium ylides can be expanded.  
Specifically, whether these ylides can react with electrophiles in an intermolecular fashion 
and to investigate the ylide structures that may be obtained via this catalysis. 
 To apply the most recently developed techniques of gold catalysis to the synthesis of these 
ylides, such as the use of pyridine N-oxides, Zhang’s chelating Buchwald phosphines, 
ynamide substrates and cooperative silver catalysis. 
 To explore the structural motifs that may be obtained via gold-derived ylides. Specifically, to 
target motifs which are difficult to access via established methods and may be of 
pharmaceutical value. 
 To gain further insights into the catalytic cycle when using gold complexes to generate 
sulfonium ylides. 
Intermolecular reaction of the ylides has proven possible, sulfonium ylides undergoing a novel, three-
component coupling.  However, development of this proof of concept was not possible, 
intermolecular reaction of alkynylsulfonium-derived ylides proved too low yielding to be a viable 
synthetic reaction.  During the development of this coupling a range of interesting side reactions 
were observed, including novel carbothiolations.  Thiomorpholinone ylides were developed in an 
attempt to overcome the limitations of the alkynylsulfonium-derived ylides.  These allowed access to 
more reactive ylides and demonstrated that gold-derived ylides could undergo Stevens 
rearrangements.  Structural limitations unfortunately prevented these ylides from undergoing 
intermolecular reactions.  Many recently developed gold catalysis techniques were successfully 
applied to the synthesis of sulfonium ylides, although phosphine ligands were not suitable for these 
transformations.  Complex thiomorpholinone structures were obtained, although the ylide concept 
could not be applied to the synthesis of glitazones.  These thiomorpholinones are undergoing 
biological screening to evaluate their pharmaceutical value (vida infra).  Evidence for strong 
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carbenoid character during the catalytic cycle was observed and removal of the silver co-catalyst was 
detrimental to the reaction.  
In addition to the stated aims, the research project also investigated the use of thioynol ethers as 
ynamide equivalents and successfully demonstrated that these substrates could be used to access 
the oxazole moiety. Research into these thioynol ethers is continuing, to optimise the oxazole 
synthesis and explore their reactivity. 
Biological Screening 
Given the interest in sulfonamide-protected thiomorpholinones for drug applications, 128, 129 the 
range of thiomorpholinone products obtained during screening was submitted to Eli Lilly's Open 
Innovation Drug Discovery Program for evaluation as potential lead molecules for drug 
development.166  Lilly's program comprised a number of screening modules to assess compounds 
from academia for their suitability for Lilly's current therapeutic targets.  The compounds 
were initially subjected to in silico assessment to determine the thiomorpholinones’ suitability for 
drug applications.  The thiomorpholinones were then screened against Lilly's phenotypic, target-
based and tuberculosis assays. 
Phenotypic screening was conducted in vitro against a variety of cell lines to determine whether 
introduction of these compounds could achieve a desired effect on an entire cellular 
system.  Osteogenic activity was desired, specifically stimulation of GPL-1 secretion for diabetes 
treatment.167, 168 
Target-based screening was conducted against a range of receptors in biological assays.  These 
included activation of cells expressing the human GPR119 receptor,169 for control of glucose 
homeostasis; inhibition of histone methyl transferase EZH2 to suppress tumour growth and 
metastasis;170 inhibition of Calcitonin Gene-Related Peptide for migraine treatment;171 
and antagonism of the mGlu2 receptor for use as a neurological indicator.172  The 
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tuberculosis screening module was conducted against a modified, fluorescent strain 
of Mycobacterium tuberculosis (H37Rv), measuring inhibition of bacterial growth. 
None of the compounds screened during these assays were sufficiently active to warrant further 
investigation.  They have also been submitted to Lilly's phenotypic  drug discovery program to assess 
their ability to inhibit the production of proprotein convertase subtilisin kexin type 9 (PCSK9), which 
is currently underway using human hepatoma cell lines (HepG2).  Inhibition of PCSK9 synthesis is 
desired as cholesterol-lowering statins stimulate PCSK9 synthesis which lowers their efficacy.173, 174   
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Appendix 1: Experimental Data 
 
  
110 
 
General experimental considerations 
Where specified, dry reactions were carried out under argon in flame-dried glassware, using dried 
solvents; otherwise reactions were carried out under air in oven-dried glassware, using solvents as 
received, unless otherwise specified.  Dry solvents used were purified using a Pure Solv-MD Solvent 
Purification System (alumina columns) from Innovative Technology and were transferred under 
argon.  Pyridine N-oxide was dried as a solution in CH2Cl2 over Na2SO4, filtered and then concentrated 
in vacuo to give white crystals. Pyridine N-oxide was stored under argon in a Schlenk tube or nitrogen 
in a glove box and was weighed using Schlenk techniques or in the glove box.  A Radleys Carousel 12 
or Asynt DrySyn heating blocks on stirrer hotplates were employed with temperature control via 
external digital probe.  Carousel and Schlenk tubes were cleaned with aqua regia to ensure they were 
free from contaminating metals.  Extracted reaction mixtures were dried over anhydrous Na2SO4 or 
MgSO4.  Solutions used during reaction work up were saturated unless otherwise specified.  Flash 
column chromatography was performed with Merck Geduran® Si 60 silica gel (43-63 µm) following 
Still’s procedure.190  Thin layer chromatography (TLC) was performed with Merck silica gel 60 F254 
analytical plates (plastic or aluminium support) which were developed using standard visualising 
agents: UV fluorescence (254 and 366 nm), ethanolic vanillin /∆ and potassium permanganate /∆.  
Melting points were measured using a Stuart Scientific SMP1 instrument, are reported to the nearest 
degree and are uncorrected.  Infra-red spectroscopy was performed using a Perkin-Elmer Spectrum 
100 FTIR spectrometer, only selected absorbancies (νmax) are reported in cm
-1.  Peaks are described as 
br (broad), s (sharp) and w (weak).  Mass spectrometry and high-resolution mass spectrometry (EI) 
were performed using a VG ProSpec or VG-ZabSpec instrument at 70 eV. High-resolution EI spectra 
were measured using perfluorokerosene (PFK) as an internal calibrant. Mass spectrometry and HR-
MS (ES) were performed using a Micromass LCT instrument using a methanol mobile phase. HR-MS 
were obtained using a lock-mass to adjust the calibrated mass scale. MS data is reported as m/z 
(relative intensity).  Commercially available compounds were purchased from Aldrich, Fisher, Acros, 
Strem, Alfa Aesar, VWR and used without further purification, unless specified.  Pyridine N-oxides 
were kindly donated by Mickael Dos Santos and Holly Adcock.  NMR spectra were recorded on 
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Bruker AVIII300 (300 MHz), Bruker AVIII400 (400 MHz) in the solvents indicated; CDCl3 was 
purchased from Aldrich (no TMS) and Cambridge Isotope Laboratory (0.05% v/v TMS); Chemical 
shifts (δ) are given in ppm relative to TMS. In the absence of TMS, solvent signals were used as 
references and the chemical shifts converted to the TMS scale (residual CHCl3 in CDCl3: δH ≡ 7.26 
ppm, CDCl3:  δC ≡ 77.16 ppm).
191  Coupling constants (J) are reported in Hz. Multiplicity is denoted in 
1H NMR spectroscopy by: s (singlet), d (doublet), t (triplet), q (quartet), qn (quintet), h (hextet), m 
(multiplet) and br (broad). 1D 13C NMR spectra were recorded using the UDEFT or PENDANT pulse 
sequences from the Bruker standard pulse program library. UDEFT were combined with DEPT 135 to 
assign quaternary carbons. 2D NMR spectra were recorded using the COSY, HSQC, HMBC or NOESY 
pulse sequences from the Bruker standard pulse program library and key couplings are indicated 
with arrows. 
General procedures  
GP1: General procedure for gold-catalysed reactions with sulfoxide substrates 
The specified electrophile was added under argon to a flame-dried Schlenk flask or Radleys tube 
containing a stirred solution of sulfoxide substrate (1 eq.) in dry solvent.  The specified gold catalyst 
(0.05 eq.) was then added under argon.  If the reaction was conducted at elevated temperature the 
reaction vessel was then immediately heated to the specified temperature using a preheated block 
with external temperature probe.  After the specified time had elapsed the reaction mixture was 
cooled to room temperature, filtered through a plug of silica eluting with ethyl acetate, was 
concentrated in vacuo and purified by flash column chromatography to give the catalysis product.   
Sulfonamides were synthesised utilising the following general procedures: 
GP2: Prepared via a modified literature procedure.192  An aqueous solution of LiOH (2.1 eq.) was 
added to a stirred solution of cysteamine hydrochloride (1.0 eq.) and alkyl halide (1.0 eq.) in ethanol 
and heated to 35 °C.  Ethanol was removed in vacuo and the resulting oily solution was extracted 
with CH2Cl2 (3 x ca. 50 ml), dried over Na2SO4 and filtered.  The resulting solution was cooled to 0 °C 
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then sulfonyl chloride (1.01 eq.) and triethylamine (1.75 – 3.33 eq.) were added.  The solution was 
stirred vigorously overnight and a thick, pale yellow precipitate formed.  The reaction mixture was 
added to NH4Cl solution (ca. 100 ml), the organic fraction collected and washed with water (2 x ca. 
100 ml).  The organic phase was dried over Na2SO4, filtered, concentrated in vacuo and purified by 
flash column chromatography, to give the sulfonamide. 
Ynamides were synthesised utilising the following general procedures: 
GP3:  Prepared via a literature procedure.160  Synthesis of bromoalkyne: the necessary bromoalkyne 
was prepared by the addition of n-butyl lithium (1.05 eq.) to a solution of alkyne in dry THF at -78 °C. 
After 15 minutes Br2 (1.10 eq.) was added and the reaction mixture stirred for a further 15 minutes.  
The reaction was quenched with Na2S2O3 solution and extracted three times with CH2Cl2.  The organic 
fractions were combined, dried over Na2SO4, filtered and concentrated under reduced pressure to 
give the crude bromoalkyne as a brown oil.  The bromoalkynes were not stable and were used 
immediately, crude, as per Hsung’s procedure.  Synthesis of ynamide: a portion of freshly synthesised 
crude bromoalkyne (1.10 eq.) was added under argon to a stirred solution of sulfonamide (1.0 eq.), 
1,10-phenanthroline (0.18 – 0.20 eq), CuSO4.5H2O (0.10 – 0.12 eq.) and K2CO3 (2.0 eq.) in dry toluene.  
The reaction mixture was immediately heated to 65 °C using a preheated block.  After the specified 
time, the reaction mixture was cooled to room temperature, silica gel was added and then the 
mixture was concentrated in vacuo to give a dry, free-flowing powder that was purified by flash 
column chromatography to give the ynamide. 
GP4:  Prepared via a literature procedure.160  CuI (0.12 eq.) and Cs2CO3 (4.0 eq.) were added under 
argon to a stirred solution of sulfonamide (1.0 eq.), dibromoalkene (1.1 - 1.5 eq.) and 
dimethylethylenediamine (1.8 eq.) in dry dioxane or DMF.  The reaction mixture was immediately 
heated to 60 °C using a preheated block.    After the specified time the reaction mixture was cooled 
to room temperature.  For reactions in dioxane silica gel was added and then the mixture was 
concentrated in vacuo to give a dry, free-flowing powder, the resulting powder was purified by flash 
column chromatography to give the ynamide. 
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Optimised conditions for thiomorpholinone formation: 
GP5: Catalysis was performed using the following procedure, under Schlenk conditions.  Ynamide 
(1.0 eq.) was added under argon into a flame-dried Schlenk or Radleys tube.  Dry CH3CN (0.2 M based 
on ynamide) was added under argon, followed by dry pyridine N-oxide (1.1 eq.), AgOTs (0.05 eq.) and 
then IPrAuCl (0.05 eq.).  The reaction mixture was stirred for the specified time, filtered through a 
small plug of silica (ca. 500 mg) in a Pasteur pipette, eluting with ethyl acetate, concentrated in vacuo 
and purified by flash column chromatography to give the catalysis product. 
Formation of dibromo-olefins: 
GP6: PPh3 (4 eq.) was added to a 0 °C solution of CBr4 (2 eq.) in dry CH2Cl2 (0.1 M based on the 
aldehyde) with vigorous stirring.  After 10 minutes the aldehyde (1 eq.) was added and the reaction 
mixture was allowed to reach room temperature overnight.  Chromatography silica gel was added 
until the solution decolourised, the reaction mixture was concentrated in vacuo to give a dry, free-
flowing powder and then purified by flash column chromatography to give the dibromo-olefin. 
Synthesis of catalysts 
Dimethylsulfidegold(I) chloride Prepared according to literature procedure.193  (CH3)2S (150 µl, 2 
mmol, 2.9 eq.) was added to a solution of NaAuCl4 (250 mg, 690 µmol, 1.0 eq.) in dry 
CH3OH (10 ml) and the flask was covered in foil.  After four hours the white precipitate 
was collected by suction filtration, washed with CH3OH (ca. 2 ml) and dried in vacuo to give 
dimethylsulfidegold(I) chloride as bright white crystals (138 mg, 68%).  Decomposed at approximately 
90 °C (Lit.194 110 °C).  δH (300 MHz, CDCl3) 2.75 (6H, s, SCH3).  IR (Neat): νmax = 2994 (CH), 2921 (CH), 
1436, 1422, 1412, 1318, 1298, 1032, 994, 954.  1H NMR and IR data in agreement with literature 
values.195 
 Bis(2,6-diisopropylphenyl)diazabutadiene Prepared according to literature 
procedure.196  Glyoxal (40% solution in water, 3.18 ml, 28 mmol, 1 eq.) was 
added to a solution of 2,6-diisopropylaniline (6.99 ml, 56 mmol, 2 eq.) in 
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ethanol (10 ml).  A drop of formic acid was added and the reaction mixture was stirred for 2 days.  
The resulting yellow crystals were collected by suction filtration, washed with CH3OH and dried in 
vacuo to give bis(2,6-diisopropylphenyl)diazabutadiene (5.04 g, 48%).  Melting point 100-101 °C from 
methanol (Lit.197 102-103 °C).  δ H (300 MHz, CDCl3) 8.10 (2H, s, CHN), 7.23-7.13 (6H, m, ArH), 3.01-
2.84 (2H, m, CH3CHCH3), 1.21 (12H, d, J 6.9, CHCH3). IR (Neat): νmax = 3065 (CH), 2963 (CH), 2926 (CH), 
2865 (CH), 1626 (C=N), 1465, 1436, 1176, 924, 789, 760.  Data in agreement with literature values.196 
IPr.HCl Prepared according to literature procedure.196  Paraformaldehyde (402 mg, 13.4 mmol, 1 eq.) 
was added to a solution of bis(2,6-diisopropylphenyl)diazabutadiene (5.04 g, 
13.4 mmol, 1 eq.) in dry toluene (100 ml), the mixture was heated to 100 °C.  
After 30 minutes the reaction mixture was cooled to 40 °C and a 4 M solution 
of HCl in dioxane (3.35 ml, 13.4 mmol, 1 eq.) was added; then the reaction mixture was heated to 70 
°C for 5 hours.  The reaction mixture was cooled to room temperature, the pink precipitate collected 
by suction filtration and purified by recrystallisation from CH3OH and diethyl ether to give white 
crystals.  The crystals were dried in vacuo at 100 °C for three days to give IPr.HCl (293 mg, 51%).  
Decomposed at approximately 250 °C (Lit.198 250 °C).  δH (300 MHz, CDCl3) 10.06 (1H, s, NCHN), 8.17 
(2H, d, J 1.6, ArH, NCHCHN), 7.70-7.46 (4H, t, J 7.8, ArH), 7.35 (2H, d, J 7.8, ArH), 2.57-2.33 (4H, m, 
CH3CHCH3), 1.29 (12H, d, J 6.8, CHCH3), 1.25 (12H, d, J 6.9, CHCH3).  IR (Neat): νmax = 3293br (HCl), 
3116, (CH), 3069 (CH), 2967 (CH), 2933 (CH), 2871 (CH), 2752 (CH), 1534 (C=C), 1469, 1444, 1332, 
1206, 1062, 810.  Data in agreement with literature values.196 
1,3-bis(diisopropylphenyl)imidazol-2-ylidenegold(I) chloride Prepared according to literature 
procedure.199  Ag2O (118 mg, 510 µmol, 1.50 eq.) was added to a solution of 
bis(2,6-diisopropylphenyl)diazabutadiene (152 mg, 360 µmol, 1.05 eq.) in dry, 
degassed CH2Cl (20 ml), stirring in a flame-dried, foil-covered, 50 ml Schlenk 
flask.  After 3.5 hours the reaction mixture was transferred via cannula into a flame-dried Schlenk 
filter and filtered through a plug of celite, under argon, into a flame-dried, 50 ml Schlenk flask.  
Freshly prepared (CH3)2SAuCl (100 mg, 340 µmol, 1.00 eq.) was added and the reaction mixture 
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stirred for a further 2.5 hours.  Activated charcoal was added and the reaction mixture was 
transferred via cannula into a flame-dried Schlenk filter and filtered through a plug of celite, under 
argon, into a fresh, flame-dried, 50 ml Schlenk flask.  The Schlenk flask was half immersed in a flask of 
room temperature water and a pressure-controlled vacuum pump, equipped with a liquid nitrogen 
trap, was connected directly to the Schlenk flask.  The reaction mixture was concentrated in vacuo 
with great care to ca. 7 ml and then transferred by syringe to a pre-weighed, flame-dried, 10 ml 
Schlenk flask, where it was further concentrated in vacuo to saturation, ca. 3 ml, at which point small 
crystals began to appear at the meniscus.  n-Pentane (ca. 3 ml) was carefully layered on top of the 
CH2Cl2 and the resulting precipitated crystals were allowed to settle to the bottom of the flask.  The 
solvent was carefully pipetted off, under a flow of argon, to the level of the crystals. The crystals 
were washed by decantation with n-pentane (3 x 3 ml), each time leaving enough solvent to cover 
the crystals.  The Schlenk flask was reconnected to the vacuum pump and the solution was 
concentrated in vacuo to dryness, to give IPrAuCl as bright white crystals (62.0 mg, 59%). δH (300 
MHz, CDCl3) 7.54- 7.46 (2H, t, J 7.8, ArH), 7.29 (4H, d, J 7.8, ArH), 7.17 (2H, s, NCHCHN), 2.62-2.45 (4H, 
m, CH3CHCH3), 1.34 (12H, d, J 6.9, CHCH3), 1.22 (12H, d, J 6.9, CHCH3).   IR (Neat): νmax = 3164 (CH), 
3141 (CH), 2967, (CH), 2926 (CH), 2869 (CH), 1583 (C=C), 1550 (C=C), 1470, 1456, 808, 764, 743, 705.  
Data in agreement with literature values.5, 200 
Silver(I) triflimidate Prepared according to literature procedure.201  Ag2CO3 (58.8 mg, 213 µmol, 0.6 
eq.) was added under argon to HNTf2 (100.0 mg, 356 µmol, 1 eq.), followed by water (1.5 
ml).  The flask was covered in foil and the reaction mixture heated to 65 °C for 2 hours.  The 
reaction mixture was cooled to room temperature and filtered through a plug of silica.  The reaction 
mixture was concentrated in vacuo to give a dirty white solid, which was dissolved in dry diethyl 
ether (10 ml), stirred for 2 hours and then filtered through a plug of celite.  Concentration in vacuo 
gave AgNTf2 as bright white crystals (117 mg, 85%).  Decomposed at approximately 200 °C.  δF (282 
MHz, THF) -78.19 (s). IR (Neat): νmax = 1767 vw, 1592, 1332, 1301, 1318, 1193, 1100, 1026, 792, 772, 
735.  Data in agreement with literature values.201, 202 
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Triphenylphosphine gold(I) chloride 2,2'-Oxydiethanethiol (195 µl, 1.89 mmol, 3.75 eq.) was added 
in ca. 20 µl portions to a solution of NaAuCl4 (250 mg, 628 µmol, 1.25 eq.) in water (5 
ml).  The resulting precipitate was allowed to dissolve before the addition of the next portion of thiol.  
A solution of PPh3 (132 mg, 502 µl, 1.00 eq.) in ethanol (10 ml) was added dropwise (ca. 1 drop per 
minute) by dropping funnel.  After 23 hours the resulting precipitate was collected by vacuum 
filtration, washed with ethanol and dried in vacuo to give Ph3PAuCl as white crystals (149 mg, 60%). 
Melting point 240 °C from ethanol (Lit.203 239-241 °C).  δH (300 MHz, CDCl3) 7.61-7.42 (15H, m, ArH).  
δC (101 MHz, CDCl3) 134.4 (CH), 134.3 (CH), 132.2 (CH), 129.5 (CH), 129.3 (CH), 128.6 (C).  δP (121 
MHz, CDCl3) 33.17.  IR (Neat): νmax = 3073 (CH), 3060 (CH), 1479, 1433, 1102, 999, 747, 713, 689. Data 
in agreement with literature values.204 
Experimental data  
But-3-yn-1-yl methanesulfonate (313) Methanesulfonyl chloride (1.23 ml, 10.7 mmol, 1.5 eq.) was 
added to a stirred solution of but-3-yn-1-ol (540 µl, 7.14 mmol, 1.0 eq.) and 
triethylamine (1.49 ml, 10.7 mmol, 1.5 eq.) in dry diethyl ether (15 ml) under 
argon.  After 20 hours the reaction mixture was added to hexane (20 ml) and washed with brine (3 x 
20 ml), dried over Na2SO4, filtered and concentrated in vacuo to give mesylate 313 as a pale brown 
oil (1.04 g, 98%) which was used without further purification.  δH (300 MHz, CDCl3): 4.29 (2H, t, J 6.7, 
CH2O), 3.02 (3H, s, CH3), 2.62 (2H, td, J 6.7, 2.7, CCH2CH2), 2.04 (1H, t, J 2.7, CH); δC (101 MHz, CDCl3): 
78.6 (C), 70.8 (CH), 67.1 (CH2), 37.4 (CH2), 19.5 (CH3).  IR (Neat): νmax = 3287 (C≡H), 1350, 1170 (SO2).  
Data in accordance with literature values.205, 206 
But-3-yn-1-yl(2-chlorophenyl)sulfide (314) A solution of mesylate 313 (1.55 g, 10.4 mmol, 1.0 eq.), in 
dry dimethylformamide, (10 ml) was added to a stirred suspension of K2CO3 (3.60 
g, 26.1 mmol, 2.5 eq.) in dry DMF (50 ml), followed by 2-chlorothiophenol (1.30 
ml, 11.5 mmol, 1.1 eq.).  After 15 hours the reaction mixture was added to deionised water (30 ml) 
and the organic phase collected.  The aqueous phase was extracted with hexane (2 x 50 ml), the 
organic fractions were combined, washed with 1 M aqueous HCl (2 x 20 ml), Na2CO3 solution (2 x 20 
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ml) and then brine (2 x 20 ml).  The solution was dried over Na2SO4, filtered and concentrated in 
vacuo to give sulfide 314 as a yellow oil (1.67 g, 81 %).  δH (300 MHz, CDCl3): 7.40-7.31 (2H, m, ArH), 
7.25-7.11 (2H, m, ArH), 3.11 (2H, t, J 7.5, CH2S), 2.53 (2H, td, J 7.5, 2.7, CCH2CH2), 2.07 (1H, t, J 2.7, 
CH); δC (101 MHz, CDCl3): 134.6 (C), 134.3 (C), 129.9 (CH), 129.4 (CH), 127.1 (CH), 81.9 (C), 69.9 (CH), 
31.5 (CH2), 18.9 (CH2); IR (neat): νmax = 3297 (C≡H), 3071 (CH), 2931 (CH), 2116 (C≡C), 1576 (C=C), 
1451, 1431, 1252, 1224, 1115, 1035, 742; HR-MS (EI+): m/z calcd for C10H9ClS: 196.0110 found 
196.0113 [M+•]. 
1-(But-3-yn-1-yl)-1-(2-chlorophenyl)-sulfide (304) 70% m-CPBA (1.689 g, 6.90 mmol, 1.0 eq.) was 
cautiously added to a stirred solution of sulfide 314 (1.347 g, 6.90 mmol, 1.0 eq.) 
in CH2Cl2 (40 ml) at -78 °C.  The reaction was allowed to reach room temperature 
over a period of 2 hours.  The reaction mixture was quenched with NaHCO3 solution (40 ml) and 
extracted with CH2Cl2 (2 x 20 ml).  The organic fractions were combined, washed with brine (20 ml), 
dried over Na2SO4, filtered and concentrated in vacuo.  Purification by flash column chromatography, 
eluting with 3:1 ethyl acetate:n-hexane, gave sulfoxide 304 as colourless crystals (1.250 g, 86%), 
melting point 62-63 °C from CH2Cl2.  δH (300 MHz, CDCl3): 7.87 (1H, dd, J 7.5, 2.0, ArH), 7.54-7.38 (3H, 
m, ArH), 3.34-3.25 (1H, m, CHHS(O)), 3.01-2.92 (1H, m, CHHS(O)), 2.84-2.72 (1H, m, CCHHCH2), 2.51-
2.39 (1H, m, CCHHCH2), 1.99 (1H, t, J 2.7, CH); δ C (101 MHz, CDCl3) 140.9 (C), 132.3 (CH), 130.2 (C), 
130.0 (CH), 128.0 (CH), 126.5 (CH), 80.7 (C), 70.4 (C), 51.8 (CH2), 11.8 (CH2); IR (neat): νmax = 3281 
(C≡H), 3078 (CH), 2911 (CH), 1572 (C=C), 1446, 1433, 1321, 1271, 1244, 1223, 1098 (SO); MS (EI+): 
m/z (%): 212 (90) [M+•], 184 (100), 156 (95); HR-MS (EI+): m/z calcd for C10H9ClOS: 212.0063, found 
212.0068 [M+•]. 
9-chloro-2,3-dihydrobenzo[b]thiepin-4(5H)-one (315) Prepared using GP1 with 
pyridinecarboxylatogold(I) chloride (3.9 mg, 10.0 µmol, 0.0500 eq.), benzaldehyde 
(21.2 µl 210 µmol, 1.05 eq.) and sulfide 304 (425 mg, 200 µmol, 1.00 eq.) in dry 1,2-
dichloroethane (1 ml) for 17 hours.  The reaction gave dihydrobenzothiepinone 315 as 
a pale yellow oil (89% by NMR). The yield was calculated against a known quantity of 1,2,4,5-
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tetramethylbenzene.  δH (300 MHz, CDCl3) 7.36 (1H, d, J 2.7, ArH), 7.33 (1H, d, J 2.7, ArH), 7.20-7.10 
(1 H, m, ArH), 4.00 (2H, s, CCH2CO), 3.16-3.02 (2H, m, COCH2CH2), 2.88-2.76 (2H, m, SCH2CH2CO).  δC 
(101 MHz, CDCl3) 205.4 (CO), 140.4 (C), 137.9 (C), 134.4 (C), 129.1 (CH), 129.1 (CH), 128.8 (CH), 51.8 
(CH2), 44.5 (CH2), 31.3 (CH2); IR (neat): νmax = 3053 (CH), 2921 (CH), 1707 (C=O), 1576 (C=C), 1558 
(C=C), 1446, 1433, 1321, 1271, 1244, 1223, 1098; MS (EI+): m/z (%): 212 (100) [M+•], 184 (85), 156 
(58); HR-MS (EI+): m/z calcd for C10H9ClOS: 212.0063, found 212.0056 [M
+•]. 
 4-(methylsulfinyl)but-1-yne (317) A freshly prepared and titrated solution of  lithium diisopropyl 
amide in THF (1.55 ml, 4.03 mmol, 1.2 eq.) was added to a solution of dry DMSO (723 
µl, 6.72 mmol 2.0 eq.) in dry THF (20 ml) at -78 °C and stirred for 2 hours.  A 50% 
solution of propargyl bromide in toluene (375 µl, 3.36 mmol, 1.0 eq.) was added and after a further 
hour the reaction was quenched with NH4Cl solution (50 ml) and allowed to warm to room 
temperature.  The reaction mixture was extracted with ethyl acetate (3 x 50 ml), the organic fractions 
were combined, dried over Na2SO4, filtered and concentrated in vacuo.  Purification by flash column 
chromatography, eluting with ethyl acetate, gave sulfoxide 317 as a yellow oil (21 mg, 11%).  δH (300 
MHz, CDCl3) 3.15-2.83 (2H, m, CH2S), 2.71 (2H, td, J 7.0, 2.6, CHC2), 2.63 (3H, s, SCH3), 2.07 (1H, t, J 
2.6, CH).  δC (101 MHz, CDCl3) 80.9 (C), 70.7 (CH), 52.9 (CH2), 38.7 (CH3), 12.6 (CH2).  IR (neat): νmax = 
3228 (C≡CH), 1647, 1426, 1308, 1032, 650: m/z (%): 212 (100) [M+•], 184 (85), 156 (58); HR-MS (EI+): 
m/z calcd for C10H9ClOS: 212.0063, found 212.0056 [M
+•]. 
But-3-yn-1-yl(hexyl)sulfide (318)  Hexanethiol (2.10 ml, 14.9 mmol, 1.10 eq.) was added  to a 
suspension of 50% NaH (0.682 g, 14.2 mmol, 1.05 eq.) in dry THF (150 ml) 
under argon at 0 °C.  After 1 hour methanesulfonate (313) (2.00 g, 13.5 mmol, 1.00 eq.) was added 
by syringe and the reaction mixture was allowed to reach room temperature.  After 24 hours the 
reaction mixture was quenched with 10% NaOH solution (50 ml) and then extracted with CH2Cl2 (2 x 
50 ml), dried over Na2SO4, filtered and concentrated in vacuo.  Purification by flash column 
chromatography, eluting with n-hexane, then 9:1 n-hexane:CH2Cl2, gave sulfate 318 as a colourless 
oil (2.02 g, 88%).  δH (300 MHz, CDCl3): 2.67 (2H, t, J 7.6, SCH2), 2.54 (2H, t, J 7.6, SCH2), 2.46 (2H, td, J 
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7.6, 2.6, CCH2), 2.01 (1H, t, J 2.6, CH), 1.57 (2H, qn, J 7.5 Hz, SCH2CH2CH2), 1.41-1.25 (6H, m, 
CH2CH2CH2CH3), 0.87 (3H, t, J 6.8, CH3); δC (100 MHz, CDCl3): δ 82.7 (C), 69.2 (CH), 32.1 (CH2), 31.3 
(CH2), 30.8 (CH2), 29.5 (CH2), 28.4 (CH2), 22.4 (CH2), 19.85 (CH2), 13.9 (CH3); IR (neat): 3310 (C≡H), 
2956 (CH), 2926 (CH), 2856 (CH), 1466, 1434, 1378, 1305, 1223, 1084, 1058; MS (EI+): m/z (%): 116 
(100) [M+•], 64 (66), 53 (79); HR-MS (EI+): m/z calcd for C5H8OS: 116.0296, found 116.0296 [M
+•]. 
But-3-yn-1-yl(hexyl)sulfoxide (319)  70% m-CPBA (2.331  g, 10.4 mmol, 1 eq.) was added cautiously 
to a stirred solution of sulfide  318 (1.778 g, 10.4 mmol, 1 eq.) in CH2Cl2 
(200 ml) at -78 °C and allowed to reach room temperature over a period of 
17 hours.  The reaction mixture was quenched with NaHCO3 (50 ml) and extracted with CH2Cl2 (2 x 50 
ml).  The organic fractions were combined, washed with brine (3 x 50 ml), dried over Na2SO4, filtered 
and concentrated in vacuo.  Purification by flash column chromatography, eluting with 4:1 ethyl 
acetate:n-hexane, gave sulfoxide 319 as colourless crystals (1.477 g, 76%).  Melting point 21-22 °C, 
from CH2Cl2.  δH (300 MHz, CDCl3): 2.88-2.64 (6H, m, 3CH2), 2.07 (1H, t, J 2.6, CH), 1.83-1.72 (2H, m, 
CH2), 1.54-1.40 (2H, m, CH2), 1.38-1.29 (4H, m, 2CH2) 0.89 (3H, t, J 6.9, CH3); δC (100 MHz, CDCl3): 81.0 
(C), 70.4 (CH), 52.5 (CH2), 50.6 (CH2), 31.3 (CH2), 28.5 (CH2), 22.6 (CH2), 22.4 (CH2), 13.9 (CH2), 12.5 
(CH3); IR (neat): νmax = 3217 (CH), 2956 (CH), 2928 (CH), 2859 (CH), 1460, 1408, 1032 (SO), 725; HR-
MS (ES+): m/z calcd for C10H18OSNa: 209.0976 found: 209.0978 [M+Na
+]. 
1-(hexylthio)but-3-en-2-one (320)  Prepared using GP1 with PtCl2 (2.7 mg, 10.0 µmol, 0.0500 eq.), 
benzaldehyde (21.2 µl, 210 µmol, 1.05 eq.) and 319 (37.3 mg, 200 µmol, 
1.00 eq.) in dry 1,2-dichloroethane (1 ml) at 80 °C for 18 hours.  Purification by flash column 
chromatography, eluting with 95:5 ethyl acetate:n-hexane, gave butenone 320 as a colourless oil (8.2 
mg, 23%).  δH (400 MHz, CDCl3) 6.57 (1H, dd, J 17.5, 10.5, COCHCH2), 6.33 (1H, dd, J 17.5, 1.2, 
CHCHH), 5.84 (1H, dd, J 10.5, 1.2, CHCHH), 3.34 (2H, s, SCH2CO), 2.53-2.43 (2H, t, J 7.4, CH2), 1.56 (2H, 
qn, J 7.4, CH2), 1.41-1.18 (6H, m, CH2CH2CH2), 0.87 (3H, t, J 6.9, CH3).  δC (101 MHz, CDCl3) 194.5 (C), 
134.3 (CH), 129.3 (CH2), 39.3 (CH2), 32.2 (CH2), 31.5 (CH2), 29.0 (CH2), 28.5 (CH2), 22.7 (CH2), 14.1 (CH-
3).  IR (neat): 2956 (CH), 2928 (CH), 2857 (CH), 1693 (C=O), 1619 (C=C), 1459, 1401, 1201, 983; MS 
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(EI+): m/z (%): 186 (100) [M+•], 131 (54), 83 (49); HR-MS (EI+): m/z calcd for C10H18OS: 186.1078, 
found 186.1084 [M+•]. 
Pent-4-yn-1-yl methanesulfonate (333) Triethylamine (1.24 ml, 8.92 mmol, 1.5 eq.) was added to a 
stirred, 0 °C solution of but-3-yn-1-ol (0.55 ml, 5.94 mmol, 1.0 eq.) in dry diethyl 
ether (10 ml), followed by methanesulfonyl chloride (0.69 ml, 8.92 mmol, 1.5 eq.) 
and allowed to slowly reach room temperature.  After 22 hours the reaction mixture was added to n-
hexane (10 ml) and washed with brine (3 x 20 ml), dried over Na2SO4, filtered and concentrated in 
vacuo.  Purification by Kugelrohr distillation gave methanesulfonate 333 as a colourless oil (0.70 g, 
79%)  δH (300 MHz, CDCl3): 4.36 (1H, t, J 6.1, CH2O), 3.03 (3H, s, CH3), 2.36 (2H, td, J 7.0, 2.7, CCH2), 
2.01 (1H, t, J 2.7, CH), 1.96 (2H, qn, J 6.5, CH2); δC (100 MHz, CDCl3): 82.0 (C), 69.6 (CH), 68.2 (CH2), 
36.9 (CH2), 27.5 (CH2), 14.4 (CH3).  MS (EI+): m/z (%): 147 (7) [M
+•], 120 (94), 109 (100); HR-MS (EI+): 
m/z calcd for C5H7O3S: 147.0116, found 147.0112 [M+CH3
+•]. 
Hexyl(pent-4-yn-1-yl)sulfide (334)  Hexanethiol (0.56 ml, 4.00 mmol, 1.2 eq.) was added to a stirred 
suspension of 50% NaH (0.18 g, 3.80 mmol, 1.1 eq.) in dry 0 °C THF (30 
ml) under argon atmosphere.  After 1 hour a solution of methanesulfonate 333 (0.54 g, 3.60 mmol, 
1.0 eq.) in dry THF (20 ml) was slowly added by syringe and the reaction mixture was allowed to 
reach room temperature.  After 22 hours the reaction mixture was washed with 10% NaOH solution 
(2 x 10 ml).  CH2Cl2 (30 ml) was added and the mixture was washed with brine (3 x 20 ml), dried over 
Na2SO4, filtered and concentrated in vacuo.  Purification by flash column chromatography, eluting 
with neat n-hexane, then 9:1 n-hexane:CH2Cl2, then neat CH2Cl2, gave sulfide 334 as a colourless oil 
(0.47 g, 70%).  δH (300 MHz, CDCl3) 2.62 (2H, t, J 7.0, SCH2CH2CH2C), 2.51 (2H, t, J 7.3, (CH2)3CH2S), 
2.32 (2H, td, J 7.0, 2.7, CCH2), 1.96 (1H, t, J 2.7, CH), 1.80 (2H, qn, J 7.0, SCH2CH2CH2C), 1.66-1.51 (2H, 
qn, J 7.3, SCH2CH2(CH2)3CH3), 1.44-1.20 (6H, m, (CH2)3CH3), 0.88 (3H, t, J 6.8, CH3); δC (100 MHz, 
CDCl3): δ 83.6 (C), 68.8 (CH), 32.1 (CH2), 31.4 (CH2), 30.9 (CH2), 29.7 (CH2), 28.6 (CH2), 28.4 (CH2), 22.5 
(CH2), 17.5 (CH2), 14.0 (CH3); IR (neat): νmax = 3300 (C≡H), 3240 (C≡H), 2922 (CH), 1449, 1431, 1245, 
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1058, 1025, 756;  MS (EI+): m/z (%): 183 (10) [M+•], 169 (20), 100 (100); HR-MS (EI+): m/z calcd for 
C11H20S: 184.1286, found 184.1272 [M
+•]. 
Pent-3-yn-1-yl(hexyl)sulfoxide (335) 70% m-CPBA (0.136  g, 606 µmol, 1 eq.) was added cautiously to 
a -78 °C stirred solution of sulfide  334 (0.112 g, 606 µmol, 1 eq.) in 
CH2Cl2 (30 ml) and allowed to reach room temperature over a period of 16 hours.  The reaction 
mixture was quenched with NaHCO3 (50 ml) and extracted with CH2Cl2 (3 x 20 ml).  The organic 
fractions were combined, washed with brine (20 ml), dried over Na2SO4, filtered and concentrated in 
vacuo.  Purification by flash column chromatography, eluting with 3:1 ethyl acetate:n-hexane, gave 
sulfide 335 as a colourless oil (0.107 g, 88%).  δH (300 MHz, CDCl3): 2.85-2.57 (4H, m, 2CH2), 2.40-2.34 
(2H, m, CH2), 2.04-1.94 (2H, m, CH2), 2.00 (1H, t, J 2.0, CH), 1.74 (2H, m, CH2CH2CH2), 1.50-1.36 (2H, 
m, CH2), 1.32-1.26 (4H, m, 2CH2), 0.86 (3H, t, J 7.0, CH3); δC (100 MHz, CDCl3): 82.4 (C), 69.7 (CH), 52.6 
(CH2), 50.9 (CH2), 31.3 (CH2), 28.5 (CH2), 22.5 (CH2), 22.3 (CH2), 21.6 (CH2), 17.6 (CH2), 13.9 (CH3); IR 
(neat): νmax =  3310 (C≡H), 2959 (CH), 2926 (CH), 2856 (CH), 1455, 1433, 1379, 1281, 1256; MS (EI+): 
m/z (%): 200 (2) [M+•], 183 (100), 100 (25); HR-MS (EI+): m/z calcd for C11H20OS: 200.1235, found 
200.1238 [M+•]. 
 9-(hexylthio)-5-hydroxynonane-2,6-dione (340) and  1-chloro-5-(hexylthio)pentan-2-one (341)  
Prepared using GP1 with PtCl2 (6.0 mg, 20 µmol, 0.05 eq.), 
benzaldehyde (123.8 µl, 1.60 mmol, 4 eq.) and sulfoxide 335 
(80.2 mg, 400 µmol, 1 eq.) in dry 1,2-dichloroethane (1 ml) at 
70 °C for 17 hours.  Purification by flash column chromatography, eluting with 1:19 then 1:9 ethyl 
acetate:n-hexane gave dione 340 as a colourless oil (7.0 mg, 6%) and chloropentanone 341 as a 
colourless oil (1.7 mg, 2%).  9-(hexylthio)-5-hydroxynonane-2,6-dione (340) δH (400 MHz, CDCl3) 4.36 
(1H, dd, J 8.8, 5.0, CHOH), 2.84 (1H, dt, J 17.9, 7.0, CHHCOCHOH), 2.75 (1H, dt, J 17.9, 7.0, 
CHHCOCHOH), 2.65 (2H, t, J 6.8, CH2COCH3), 2.53 (2H, t, J 7.0, SCH2CH2CH2CO), 2.50-2.44 (2H, m, 
CH3(CH2)4CH2S), 2.34-2.22 (1H, m, CHHCHOH), 2.16 (3H, s, COCH3), 2.05 (1H, ddt, J 14.9, 8.8, 6.8, 
CHHCHOH), 1.95-1.84 (2H, m, SCH2CH2CH2CO), 1.62-1.49 (2H, m, CH3(CH2)3CH2CH2S), 1.44-1.21 (6H, 
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m, CH3(CH2)3), 0.88 (3H, t, J 6.9, CH3CH2), OH not observed.  δC (101 MHz, CDCl3) 207.1 (CO), 204.4 
(CO), 62.6 (CHOH), 39.4 (CH2), 37.9 (CH2), 32.0 (CH2), 31.6 (CH2), 31.4 (CH2), 30.2 (CH2), 29.7 (CH3), 
28.7 (CH2), 27.4 (CH2), 23.4 (CH2), 22.7 (CH2), 14.2 (CH3).  IR (neat): νmax = 3320br (OH), 2957 (CH), 
2926 (CH), 2858 (CH), 1715 (CO), 1408, 1370, 1225, 1166, 1029, 749.  HR-MS (ES-TOF+): m/z calcd for 
C15H28NO3SNa: 311.1657 found: 311.1654 [M+Na
+].   
1-chloro-5-(hexylthio)pentan-2-one (341) δH (400 MHz, CDCl3) 4.10 (2H, s, CH2Cl), 2.73 (2H, t, J 7.0, 
CH2CH2CO), 2.54 (2H, t, J 7.0, SCH2CH2CH2CO), 2.48 (2H, t, 7.5, SCH2(CH2)4CH3), 1.92 (2H, p, J 7.0, 
CH2CH2CO), 1.62-1.50 (2H, m, CH2), 1.43-1.22 (6H, m, 3CH2), 0.89 (3H, t, J 7.0, CH3).  δC (101 MHz, 
CDCl3) 202.3 (CO), 48.4 (CH2Cl), 38.4 (CH2), 32.0 (CH2), 31.6 (CH2), 31.4 (CH2), 29.7 (CH2), 28.7 (CH2), 
23.2 (CH2), 22.7 (CH2), 14.2 (CH3).  IR (neat): νmax =  2955 (CH), 2927 (CH), 2858 (CH), 1720 (CO), 1459, 
1423, 1381, 1292, 1262, 1163, 107; MS (EI+): m/z (%): 236 (45) [M+•], 201 (50), 144 (53), 115 (100); 
HR-MS (EI+): m/z calcd for C11H21
35ClOS: 236.1002, found 236.1000 [M+•]. 
Thiomorpholin-3-one (367) Prepared via literature procedure.207  Ethyl bromoacetate (2.23 ml, 20.0 
mmol, 1 eq.) was added to a stirred solution of cysteamine hydrochloride (2.27 g, 20.0 
mmol, 1 eq.) and K2CO3 (5.53 g, 40.0 mmol, 2 eq.) in ethanol (150 ml) and heated to reflux 
for 3 hours.  The reaction mixture was cooled to room temperature, added to water (100 ml) and 
extracted with CH2Cl2 (3 x 100 ml).  The organic fractions were combined, dried over Na2SO4, filtered 
and concentrated in vacuo.  Purification by flash column chromatography, eluting with ethyl acetate, 
gave thiomorpholinone 367 as white crystals (1.25 g, 52%), mp 84-85 °C from CH2Cl2 (Lit.
208 84-86 °C).  
δH (300 MHz, CDCl3) 6.75 (1H, brs, NH), 3.77–3.56 (2H, m, CH2CH2NH), 3.31 (2H, s, SCH2CO), 2.88 – 
2.71 (2 H, m, SCH2CH2).  νmax = 3392br (NH), 3186 (NH), 2987 (CH), 2942 (CH), 1662 (CO), 1491.  Dat in 
agreement with literature values.209 
N-tosylthiomorpholinone (368) Prepared via a modified literature procedure.207  Thiomorpholinone 
367 (0.500 g, 42.7 mmol, 1.0 eq.) was added to a stirred suspension of 50% NaH (0.205 g, 
42.7 mmol, 1.0 eq.) in dry THF (10 ml) under argon.  After 45 minutes tosyl chloride (0.894, 
46.9 mmol, 1.1 eq.) was added and the reaction mixture was stirred for 4 hours.  Water (20 ml) was 
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added and the mixture extracted with CH2Cl2 (3 x 50 ml).  The organic fractions were combined, dried 
over Na2SO4, filtered and concentrated in vacuo.  Purification by flash column chromatography, 
eluting with 1:5 ethyl acetate:n-hexane, gave thiomorpholinone 368 as white crystals (0.202 g, 17%) 
mp 68-71 °C.  δH (300 MHz, CDCl3) 7.88 (2H, d, J 8.4, ArH), 7.37–7.28 (2H, d, J 8.4, ArH), 4.24 (2H, t, J 
5.8, CH2CH2N), 3.24 (2H, s, SCH2CO), 3.07–2.92 (2H, t, J 5.8, SCH2CH2), 2.42 (3H, s, CH3).  δC (101 MHz, 
CDCl3) 166.7 (C), 145.2 (C), 135.7 (C), 129.6 (CH), 128.6 (CH), 45.7 (CH2), 31.3 (CH2), 27.0 (CH2), 21.7 
(CH3).  IR (Neat): νmax = 3011 (CH), 2931 (CH), 1706 (CO), 1596, 1351, 1321.  HR-MS (ES-TOF+): m/z 
calcd for C11H13NO3S2Na: 294.0235 found: 294.0232 [M+Na
+].  
S-methyl-N-tosylcysteamine (374) Prepared using GP2.  Methylation was performed using 
cysteamine hydrochloride (5.00 g, 44.0 mmol, 1.00 eq.), CH3I (2.75 ml, 44.0 mmol, 1.00 
eq.) in ethanol (150 ml) and LiOH (2.21, 92.4 mmol, 2.10 eq.) in water (50 ml) for 5 
hours.  N-protection was performed with tosyl chloride (8.47 g, 44.4 mmol, 1.01 eq.) and 
triethylamine (11 ml, 77.0 mmol, 1.75 eq.) for 19 hours.   Purification by flash column 
chromatography, eluting with 3:7 ethyl acetate:n-hexane, gave tosylcysteamine 374 as a colourless 
oil (8.97 g, 83% over 2 steps).  δH (300 MHz, CDCl3) 7.76 (2H, d, J 8.1, ArH), 7.32 (2H, d, J 8.1, ArH), 
4.92 (1H, t, J 6.3, NH), 3.13 (2H, q, J 6.3, CH2NH), 2.57 (2H, t, J 6.3, SCH2CH2), 2.43 (3H, s, ArCH3), 1.96 
(2H, s, CH3). δC (101 MHz, CDCl3) 143.7 (C), 137.0 (C), 129.9 (CH), 127.2 (CH), 41.1 (CH2), 33.9 (CH2), 
21.7 (CH3), 14.8 (CH3). IR (Neat): νmax = 3282br (NH), 2920 (CH), 1598 (C=C), 1426, 1324, 1157s.  MS 
(EI+): m/z 245.1 (5) [M+•], 14.0 (69), 155.0 (100), 91.1 (15).  HR-MS (EI+): m/z calcd for C10H15NO2S2: 
245.0546 found: 245.0544 [M+•].   
 S-methyl-N-phenylethynyl-N-tosylcysteamine (375) Prepared using GP3.  Alkynylation was 
performed with tosylcysteamine 374 (1.08 g, 4.39 mmol, 1.0 eq.), crude 
bromophenyl acetylene (0.58 ml, ca. 4.83 mmol, 1.1 eq.), 1,10-phenanthroline 
(158 mg, 878 µmol, 0.20 eq.), CuSO4.5H2O (110 mg, 439 µmol, 0.10 eq.) and K2CO3 (1.21 g, 8.78 
mmol, 2.0 eq.) in toluene (5 ml) for 20 hours.  Purification by flash column chromatography, eluting 
with 1:9 ethyl acetate:n-hexane, gave ynamide 375 as a yellow oil (1.45 g, 96%).  δH (300 MHz, CDCl3) 
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7.88 (2H, d, J 8.3, ArH), 7.43-7.35 (5H, m, ArH), 7.32 (2H, dd, J 6.5, 2.7, ArH), 3.72-3.60 (2H, m, CH2N), 
2.87-2.76 (2H, m, SCH2CH2), 2.48 (3H, s, CH3S), 2.16 (3H, s, ArCH3). δC (101 MHz, CDCl3) 145.0 (C), 
134.7 (C), 131.5 (CH), 123.0 (CH), 128.4 (CH), 128.1 (CH), 127.8 (CH), 122.7 (C), 82.0 (C), 71.2 (C), 51.2 
(CH2), 32.1 (CH2), 21.8 (CH3), 15.7 (CH3).  IR (neat):  3062 (CH), 2920 (CH), 2235 (C≡C), 1597w, 1493, 
1456, 1363, 1167.  HR-MS (ES-TOF+): m/z calcd for 368.0755 C18H19NO2S2Na: 368.0758 found: 
[M+Na+].  
S-allyl-N-tosylcysteamine (382) Prepared using GP2.  Allylation was performed using cysteamine 
hydrochloride (1.50 g, 13.2 mmol, 1.00 eq.) and allyl bromide (1.26 ml, 14.5 mmol, 
1.10 eq.) in ethanol (45 ml) and LiOH (664 mg, 27.7 mmol, 2.10 eq.) in water (15 
ml) for 3 hours.  N-protection was performed with tosyl chloride (2.54 g, 13.2 mmol, 1.0 eq.) and 
triethylamine (1.70 ml, 23.1 mmol, 1.75 eq.) for 17 hours.   Purification by flash column 
chromatography, eluting with 1:4 ethyl acetate:n-hexane, gave tosylcysteamine 382 as a colourless 
oil (7.23 g, 67% over 2 steps).  δH (300 MHz, CDCl3) 7.75 (2H, d, J 8.2, ArH), 7.30 (2H, d, J 8.2, ArH), 
5.66 (1H, ddt, J 17.0, 9.7, 7.2, CH2CHCH2S), 5.08 (1H, br s, NH), 5.03 (1H, dd, J 9.7, 1.0, CHHCHCH2S), 
5.00 (1H, dd, J 17.0, 1.0, CHHCHCH2S), 3.08 (2H, dd, J 12.8, 6.5, CH2NH), 2.98 (2H, d, J 7.2, CHCH2S), 
2.53 (2H, t, J 6.5, SCH2CH2), 2.42 (3H, s, CH3).  δC (101 MHz, CDCl3) 143.7 (C), 137.0 (C), 133.8 (CH), 
129.9 (CH), 127.2 (CH), 117.8 (CH2), 41.8 (CH2), 34.3 (CH2), 30.4 (CH2), 21.6 (CH3).  IR (neat): νmax = 
3286br (NH), 3087 (CH), 2981 (CH), 2918 (CH), 1733w, 1634w, 1598, 1404, 1323, 1154.  HR-MS (ES-
TOF+): m/z calcd for C12H17NO2S2Na: 294.0598 found: 294.0593 [M+Na
+].  
S-allyl-N-phenylethynyl-N-tosylcysteamine (383) Prepared using GP3.  Alkynylation was performed 
with tosylcysteamine 382 (3.00 g, 11.0 mmol, 1.0 eq.), crude bromophenyl 
acetylene (1.45 ml, ca. 12.1 mmol, 1.1 eq.), 1,10-penanthroline (397 mg, 
2.20 mmol, 0.1 eq.), CHSO4.5H2O (275 mg, 1.10 mmol, 0.2 eq.) and K2CO3 (3.04 g, 22.0 mmol, 2 eq.) in 
toluene (11 ml) for 22 hours.  Purification by flash column chromatography, eluting with 1:9 ethyl 
acetate:n-hexane, gave ynamide 383 as a yellow oil (3.55 g, 87%).  δH (300 MHz, CDCl3) 7.83 (2H, d, J 
8.3, ArH), 7.45–7.31 (4H, m, ArH), 7.3–7.25 (3H, m, ArH), 5.74 (1H, ddt, J 17.1, 9.9, 7.2, CH), 5.18–5.06 
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(2H, m, CH2CHCH2S), 3.64–3.50 (2H, m, CH2N), 3.13 (2H, d, J 7.2, CHCH2S), 2.81–2.66 (2H, m, 
SCH2CH2), 2.45 (3H, s, CH3).  δC (101 MHz, CDCl3) 144.9 (C), 134.8 (C), 133.9 (CH), 131.5 (CH), 123.0 
(CH), 128.4 (CH), 128.1 (CH), 127.8 (CH), 122.8 (C), 117.9 (CH2), 82.1 (C), 71.2 (C), 51.4 (CH2), 34.8 
(CH2), 28.3 (CH2), 21.8 (CH3).  IR (neat):  3066 (CH), 2923 (CH), 2235 (C≡C), 1720w, 1598, 1365, 1168.  
HR-MS (ES-TOF+): m/z calcd for C20H21NO2S2Na: 394.0911 found: 394.0912 [M+Na
+].  
2-(1-phenylbut-3-en-1-ylidene)-3-tosylthiazolidine (384 & 385) Prepared using two methods: with 
and without diphenyl sulfoxide. Ynamide 383 (37.2 mg, 100 µmol, 1.0 eq.) 
was added under argon into a flame-dried Schlenk tube.  Dry CH2Cl2 (1 ml) 
was added under argon, followed by diphenyl sulfoxide (22.2 mg, 110 µmol, 1.1 eq.), AgOTs (1.4 mg, 
5.00 µmol, 0.050 eq.) and then IPrAuCl (3.2 mg, 5.00 µmol, 0.050 eq.).  The reaction mixture was 
stirred for 24 hours then filtered through a small plug of silica (ca. 500 mg) in a Pasteur pipette, 
eluting with CH2Cl2, and then concentrated in vacuo.  The yield and ratio of thiazolidines 384 and 385 
were determined by NMR spectroscopy against a known quantity of 1,2,4,5-tetramethylbenzene 
(52%, 3.8:1.0).  Which structure corresponded to the major isomer could not be determined.   
Alternatively, ynmaide 383 (150 mg, 400 µmol, 4 eq.) was added under argon into a flame-dried 
Schlenk tube.  Dry CH2Cl2 (4 ml) was added under argon, followed by AgOTs (5.6 mg, 20.0 µmol, 0.2 
eq.) and then IPrAuCl (12.8 mg, 20.0 µmol, 0.2 eq.).  The reaction mixture was stirred for 18 hours, 
filtered through a small plug of silica (ca. 500 mg) in a Pasteur pipette, eluting with ethyl acetate, and 
then concentrated in vacuo.  Purification by flash column chromatography, eluting with 2:3 CH2Cl2:n-
hexane, gave a partially separable mixture of thiazolidines isomers 384 and 385 as a colourless oil 
(42.3 mg, 29%, 2:1).  Which structure corresponded to the major isomer could not be determined.  
Major isomer:  δH (300 MHz, CDCl3) 7.36 (2H, d, J 8.2, ArH), 7.33 (2H, dd, J 8.8, 1.5, ArH), 7.33–7.19 
(3H, m, ArH), 7.13 (2H, d, J 8.2, ArH), 5.86 (1H, ddt, J 16.3, 10.1, 6.2, CH2CHCH2C), 5.26 (1H, dd, J 16.3, 
1.7, CHHCHCH2C), 5.11 (1H, dd, J 10.1, 1.7, CHHCHCH2C), 3.81 (2H, t, J 6.3, SCH2CH2N), 3.21 (2H, dt, J 
6.2, 1.7, CHCH2C), 2.86 (2H, t, J 6.3, SCH2CH2N), 2.39 (3H, s, CH3).  δC (101 MHz, CDCl3) 144.1 (C), 141.0 
(C), 135.5 (C), 134.3 (C), 134.2 (CH), 129.7 (C), 129.3 (CH), 128.3 (CH), 128.0 (CH), 127.9 (CH), 126.5 
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(CH), 116.5 (CH2), 51.9 (CH2), 41.7 (CH2), 31.7 (CH2), 21.6 (CH3).  Minor isomer: δH (400 MHz, CDCl3) 
7.87 (2H, d, J 8.3, ArH), 7.43–7.27 (7H, m, ArH), 5.89 (1H, ddt, J 16.8, 10.1, 6.6, CH2CHCH2C), 4.98 (1H, 
dd, J 16.8, 1.2, CHHCHCH2C), 4.94 (1H, dd, J 10.1, 1.2, CHHCHCH2C), 3.88–3.76 (2H, m, SCH2CH2N), 
3.67 (2H, dt, J 6.6, 1.2, CHCH2C), 2.46 (3H, s, ArCH3), 2.43 (2H, t, J 6.8, SCH2CH2N).  δC (101 MHz, 
CDCl3) 144.9 (C), 140.9 (C), 136.0 (CH), 135.5 (C), 133.7 (C), 133.6 (C), 129.8 (CH), 128.52 (CH), 128.4 
(CH), 128.4 (CH), 127.9 (CH), 116.4 (CH2), 51.7 (CH2), 39.9 (CH2), 30.7 (CH2), 21.9 (CH3). IR (neat): νmax 
= 3077 (CH), 2950 (CH), 1638 (C=C), 1597, 1492, 1442, 1356, 1165.  HR-MS (ES-TOF+): m/z calcd for 
C20H21NO2S2Na: 394.0911 found: 394.0899 [M+Na
+]. 
HMBC coupling:  
 
5-allyl-6-phenyl-4-tosyl-3,4-dihydro-2H-1,4-thiazine (386) Ynamide 383 (74.3 mg, 200 µmol, 1.0 eq.) 
was added under argon into a flame-dried Schlenk tube.  Dry CH2Cl2 (2 ml) was added 
under argon, followed by diphenyl sulfoxide (44.4 mg, 220 µmol, 1.1 eq.), and then 
(Ph3PAuNTf2)2.toluene (7.9 mg, 5.00 µmol, 0.025 eq.).  The reaction mixture was stirred for 23 hours 
then filtered through a small plug of silica (ca. 500 mg) in a Pasteur pipette, eluting with CH2Cl2, and 
then concentrated in vacuo.  Yield of thiazine 386 was determined by NMR spectroscopy against a 
known quantity of 1,2,4,5-tetramethylbenzene (20%).  Purification by flash column chromatography, 
eluting with 1:9 ethyl acetate:n-hexane, gave thiazine 386 as a pale yellow oil.  δH (400 MHz, CDCl3) 
7.78 (2H, d, J 8.3, ArH), 7.34-7.29 (5H, m, ArH), 7.25-7.19 (2H, m, ArH), 5.69 (1H, ddt, J 16.6, 10.1, 6.4, 
CH2CHCH2C), 4.92 (1H, dq, J 10.1, 1.4, CHHCHCH2C), 4.86 (1H, dq, J 16.6, 1.4, CHHCHCH2C), 3.78 (2H, 
dd, J 7.2, 4.1), 3.22 (2 H, dt, J 6.4, 1.4, CH2N), 2.96-2.86 (2H, m, CH2S), 2.43 (3H, s, CH3). δC (101 MHz, 
CDCl3) 143.9 (C), 138.0 (C), 137.8 (C), 135.2 (CH), 129.8 (CH), 129.5 (CH), 128.9 (C), 128.5 (CH), 128.4 
(CH), 127.9 (C), 127.4 (CH), 116.2 (CH2), 45.5 (CH2), 37.6 (CH2), 28.2 (CH2), 21.8 (CH3).  IR (neat): νmax = 
2934 (CH), 1638 (C=C), 1598, 1492, 1443, 1343, 1158.  HR-MS (ES-TOF+): m/z calcd for 
C12H17NO2S2Na: 394.0911 found: 394.0910 [M+Na
+]. 
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HBMC Coupling:    NOESY Coupling:   
 
2-allyl-2-phenyl-4-tosylthiomorpholin-3-one (387) Prepared using GP5.  Catalysis was performed 
using ynamide 383 (87.1 mg, 230 µmol, 1.0 eq.), pyridine N-oxide (24.5 mg, 260 µmol, 
1.1 eq.), AgOTs (3.3 mg, 12.0 µmol, 0.050 eq.) and IPrAuCl (7.1 mg, 12.0 µmol, 0.050 
eq.) in acetonitrile (4 ml) for 21 hours.  Purification by flash column chromatography, eluting with 
10:1:89 diethyl ether:triethylamine:n-hexane, gave thiomorpholinone 387 as a colourless oil (131 mg, 
79%).  δH (300 MHz, CDCl3) 7.98 (2H, d, J 8.2, ArH), 7.56–7.36 (7H, m, ArH), 5.57 (1H, ddt, J 14.6, 10.3, 
7.4 CH2CHCH2C), 5.04 (1H, d, J 10.3, CHHCHCH2C), 4.98 (1H, d, J 14.6, CHHCHCH2C), 4.74–4.57 (1H, m, 
CHHN), 3.25–2.99 (2H, m,SCH2CH2), 2.98-2.90 (1H, m, CHHN),  2.84 (1H, dd, J 14.7, 7.4, CHCHHS), 
2.74 (1H, dd, J 14.7, 7.4, CHCHHS), 2.61 (3H, s, CH3).  δC (101 MHz, CDCl3) 169.6 (CO), 145.0 (C), 139.1 
(C), 135.9 (C), 132.2 (CH), 129.5 (CH), 129.0 (CH), 128.6 (CH), 128.0 (CH), 126.1 (CH), 119.0 (CH2), 58.4 
(C), 45.0 (CH2), 43.4 (CH2), 26.8 (CH2), 21.8 (CH3).  IR (neat): νmax = 3073 (CH), 2930 (CH), 1697 (CO), 
1598, 1493, 1446, 1354, 1316, 1263.  HR-MS (ES-TOF+): m/z calcd for C20H21NO3S2Na: 410.0861 
found: 410.0846 [M+Na+].  
HBMC Coupling: 
    
N-(2-(allylthio)ethyl)-2-oxo-2-phenyl-N-tosylacetamide (402) Prepared using GP5.  Catalysis was 
performed using tosylcysteamine 383 (74.3 mg, 200 µmol, 1.0 eq.), pyridine 
N-oxide (57.1 mg, 600 µmol, 3.0 eq.), (Ph3PAuNTf2)2.Toluene (7.9 mg, 5.00 
µmol, 0.025 eq.) in acetonitrile (4 ml) for 27 hours.  Purification by flash column chromatography, 
eluting with 20:1:79 diethyl ether:triethylamine:n-hexane, gave tosylacetamide 402 as a colourless 
oil (30.7 mg, 38%).  δH (300 MHz, CDCl3) 7.96 (2H, dt, J 7.4, 1.5, ArH), 7.91 (2H, d, J 8.2, ArH), 7.72-
7.60 (1H, tt, J 7.4, 1.5, ArH), 7.54 (2H, t, J 7.4, ArH), 7.40 (2H, d, J 8.2, ArH), 5.78 (1H, ddt, J 17.1, 9.9, 
7.2, CH2CHCH2C), 5.20 (1H, d, J 17.1, CHHCHCH2C), 5.13 (1H, d, J 9.9, CHHCHCH2C), 3.87-3.72 (2H, m, 
128 
 
CH2N), 3.17 (2H, d, J 7.2, CHCH2S), 2.84-2.67 (2 H, m, SCH2CH2), 2.48 (3H, s, CH3).  δC (101 MHz, CDCl3) 
187.9 (CO), 167.4 (CO), 146.2 (C), 134.6  (CH), 134.3 (C), 134.0 (CH), 132.9 (C), 130.3 (CH), 129.9 (CH), 
129.0 (CH), 128.6 (CH), 118.0 (CH2), 45.1 (CH2), 34.8 (CH2), 28.5 (CH2), 21.9 (CH3).  IR (neat): νmax = 
3069 (CH), 2922 (CH), 1678 (CO), 1597 (C=C), 1451, 1371, 1207, 1167, 1089, 1053.  HR-MS (ES-TOF+): 
m/z calcd for C20H21NO4S2Na: 426.0810 found: 426.0811 [M+Na
+].  
S-allyl-N-p-nosylcysteamine (406) Prepared using GP2.  Allylation was performed using cysteamine 
hydrochloride (1.00 g, 8.80 mmol, 1.0 eq.), allyl bromide (1.05 ml, 8.80 mmol, 1.0 
eq.) in ethanol (30 ml) and LiOH (443 mg, 18.5 mmol, 2.1 eq.) in water (10 ml) for 
3 days.  N-protection was performed with p-nosyl chloride (2.15 g, 9.70 mmol, 1.1 eq.) and 
triethylamine (1.48 ml, 10.6 mmol, 1.2 eq.) for 23 hours.   Purification by flash column 
chromatography, eluting with 1:3 ethyl acetate:n-hexane, gave nosylcysteamine  406 as colourless 
crystals (1.57 g, 59% over 2 steps), melting point 98-99 °C from CH2Cl2.  δH (300 MHz, CDCl3) 8.38 (2H, 
d, J 9.0, ArH), 8.07 (2H, d, J 9.0, ArH), 5.70 (1H, ddt, J 17.1, 10.0, 7.2, CH2CHCH2S), 5.11-5.07 (1H, br s, 
NH), 5.09 (1H, dd, J 10.0, 1.3, CHHCHCH2S), 5.05 (1H, dd, J 16.8, 1.4, CHHCHCH2S), 3.19 (2H, dd, J 
12.5, 6.3, CH2NH), 3.04 (2H, d, J 7.2, CHCH2S), 2.59 (2H, t, J 6.3, SCH2CH2). δC (101 MHz, CDCl3) 150.1 
(C), 146.2 (C), 133.8 (CH), 128.5 (CH), 124.6 (CH), 118.1 (CH2), 41.9 (CH2), 34.5 (CH2), 30.7 (CH2).  IR 
(Neat): νmax = 3285br (NH), 3121 (CH), 2922 (CH), 1528s (NO2), 1404, 1349s, 1162s. MS (EI+): m/z 
302.0 (28%) [M+•], 215.0 (41%), 186.0 (100%), 122.0 (97%), 116.0 (62%), 87.0 (63%).  HR-MS (EI+): 
m/z calcd for C11H14NO4S2: 302.0400 found: 302.0395 [M
+•]. 
 S-allyl-N-mesylcysteamine (407) Prepared using GP2.  Allylation was performed using cysteamine 
hydrochloride (1.00 g, 8.80 mmol, 1.0 eq.) and allyl bromine (77 µl, 8.80 mmol,1.0 
eq.) in ethanol (30 ml) and LiOH (443 mg, 18.5 mmol, 2.1 eq.) in water (10 ml) for 
3 days.  N-protection was performed with mesyl chloride (1.11 g, 9.70 mmol, 1.1 eq.) and 
triethylamine (1.48 ml, 10.6 mmol, 1.2 eq.) for 23 hours.   Purified by flash column chromatography, 
eluting with 2:3 ethyl acetate:n-hexane, gave mesylcysteamine 407 as a colourless oil (0.983 g, 57% 
over 2 steps).  δH (300 MHz, CDCl3) 5.77 (1H, ddt, J 17.0, 9.7, 7.2, CH), 5.13 (1H, dd, J 17.0, 1.3,  
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CHHCH2CH2S), 5.11 (1H, dd, J 9.7, 1.3, CHHCH2CH2S), 4.79 (1H, br s, NH), 3.29 (2H, dd, J 12.7, 6.3, 
CH2NH), 3.14 (2H, dt, J 7.2, 1.0, CHCH2S), 2.98 (3H, s, CH3), 2.68 (2H, t, J 6.4, SCH2CH2).  δC (101 MHz, 
CDCl3) 134.0 (CH), 118.0 (CH2), 42.1 (CH2), 41.0 (CH3), 34.6 (CH2), 31.2 (CH2).  IR (neat): νmax = 3282br 
(NH), 2925 (CH), 1634 (C=C), 1407, 1315 (SO2NHR), 1145 (SO2NHR).  MS (EI+): m/z 195.0 (85%) [M
+•], 
108.0 (100%), 100.0 (77%), 87.0 (52%).  HR-MS (EI+): m/z calcd for C6H13NO2S2: 195.0392 found: 
195.0388 [M+•]. 
S-allyl-N-phenylethynyl-N-nosylcysteamine (409) Prepared using GP3.  Alkynylation was performed 
with nosylcysteamine 406 (151 mg, 500 µmol, 1.0 eq.), crude 
bromophenylacetylene (66.0 µl, ca. 550 µmol, 1.1 eq.), 1,10-phenanthroline 
(16.2 mg, 90.0 µmol, 0.18 eq.), CuSO4.5H2O (15.0 mg, 60.0 µmol, 0.12 eq.) and K2CO3 (138 mg, 1.00 
mmol, 2.0 eq.) in toluene (1 ml) for 20 hours.  Purification by flash column chromatography, eluting 
with 1:4 ethyl acetate:n-hexane, gave ynamide 409 as colourless crystals (67.5 mg, 33%) melting 
point 71-73 °C, from CH2Cl2.  δH (300 MHz, CDCl3) 8.41 (2H, d, J 9.0, ArH), 8.15 (2H, d, J 9.0, ArH), 
7.50–7.27 (5H, m, ArH), 5.75 (1H, ddt, J 16.7, 10.2, 7.2, CH), 5.19–5.04 (2H, m, CH2CHCH2S), 3.73–3.54 
(2H, m, CH2N), 3.14 (2H, d, J 7.3, CHCH2S), 2.86–2.70 (2H, m, SCH2CH2).  δC (101 MHz, CDCl3) 150.8 (C), 
143.0 (C), 133.9 (CH), 131.7 (CH), 129.1 (CH), 128.6 (CH), 128.6 (CH), 124.5 (CH), 121.9 (C), 118.0 
(CH2), 80.7 (C), 71.9 (C), 51.7 (CH2), 34.8 (CH2), 28.4 (CH2).  IR (neat):  3105 (CH), 2929 (CH), 2238 
(C≡C), 1606w, 1531s (NO2), 1373, 1349, 1172.  HR-MS (ES-TOF+): m/z calcd for C19H20N2O5S2Na: 
443.0711 found: 443.0715 [M+H2O+Na
+]. 
S-allyl-N-phenylethynyl-N-mesylcysteamine (410) Prepared using GP3.  Alkynylation was performed 
with mesylcysteamine 407 (97.7 mg, 500 µmol, 1.0 eq.), crude 
bromophenyl acetylene (66.0 µl, ca. 550 µmol, 1.1 eq.), 1,10-
phenanthroline (16.2 mg, 90.0 µmol, 0.18 eq.), CuSO4.5H2O (15.0 mg, 60.0 µmol, 0.12 eq.) and K2CO3 
(138.2 mg, 1.00 mmol, 0.20 eq.) in toluene (1 ml) for 20 hours.  Purification by flash column 
chromatography, eluting with 1:9 ethyl acetate:n-hexane, gave ynamide 410 as a yellow oil (74.6 mg, 
50%).  δH (300 MHz, CDCl3) 7.5–7.38 (2H, m, ArH), 7.37–7.29 (3H, m, ArH), 5.81 (1H, ddt, J 17.1, 9.9, 
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7.2, CH2CHCH2C), 5.24–5.12 (2H, m, CH2CHCH2S), 3.79–3.69 (2H, m, CH2N), 3.23 (3H, s, CH3), 3.19 (2H, 
d, J 7.2, CHCH2S), 2.95–2.79 (2H, m, SCH2CH2).  δC (101 MHz, CDCl3) 133.8 (CH), 131.6 (CH), 128.4 
(CH), 128.3 (CH), 122.4 (C), 118.0 (CH2), 81.1 (C), 71.7 (C), 50.9 (CH2), 38.9 (CH2), 34.7 (CH2), 28.7 
(CH3).  IR (neat):  3107 (CH), 2928 (CH), 2236 (C≡C), 1634w, 1357, 1161.  HR-MS (ES-TOF+): m/z calcd 
for C14H17NO2S2Na: 318.0598 found: 318.0610 [M+Na
+].  
2-allyl-2-phenyl-4-nosylthiomorpholin-3-one (411) Prepared using GP5.  Catalysis was performed 
using ynamide 409 (105 mg, 260 µmol, 1.0 eq.), pyridine N-oxide (27.3 mg, 287 µmol, 
1.1 eq.), AgOTs (3.6 mg, 13.0 µmol, 0.050 eq.) and IPrAuCl (8.1 mg, 13.0 µmol, 0.050 
eq.) in CH3CN (3 ml) for 15 hours.  Purification by flash column chromatography, eluting with 10:1:89 
diethyl ether:triethylamine:n-hexane, gave thiomorpholinone 411 as a colourless oil (64.2 mg, 59%).  
δH (300 MHz, CDCl3) 8.41 (2H, d, J 9.0, ArH), 8.22–8.13 (2H, m, ArH), 7.38–7.29 (5H, m, ArH), 5.39 (1H, 
ddt, J 17.3, 10.3, 7.3, CH2CHCH2C), 4.92 (1H, d, J 10.3, CHHCHCH2C), 4.86 (1H, dd, J 17.3, 2.0, 
CHHCHCH2C), 4.60–4.45 (1H, m, CHHN), 3.18–2.88 (3H, m, CHHN and SCH2CH2), 2.67 (1H, dd, J 14.3, 
7.3, CHCHHS), 2.57 (1H, dd, J 14.3, 7.3, CHCHHS). δC (101 MHz, CDCl3) 167.0 (CO), 150.8 (C), 144.4 (C), 
138.4 (C), 131.7 (CH), 123.0 (CH), 129.3 (CH), 128.4 (CH), 125.9 (CH), 124.1 (CH), 119.4 (CH2), 58.5 (C), 
44.8 (CH2), 43.7 (CH2), 26.7 (CH2).  IR (neat): νmax = 3107 (CH), 2931 (CH), 1698 (CO), 1608, 1530 (NO2), 
1491, 1446, 1349, 1313, 1171.  HR-MS (ES-TOF+): m/z calcd for C19H18N2O5S2Na: 441.0555 found: 
441.0546 [M+Na+]. 
2-allyl-2-phenyl-4-mesylthiomorpholin-3-one (412) Prepared using GP5.  Catalysis was performed 
using ynamide 410 (80.0 mg, 270 µmol, 1.0 eq.), pyridine N-oxide (28.2 mg, 297 µmol, 
1.1 eq.), AgOTs (3.8 mg, 14.0 µmol, 0.050 eq.) and IPrAuCl (8.4 mg, 14.0 µmol, 0.050 
eq.) in CH3CN (3 ml) for 15 hours.  Purification by flash column chromatography, eluting with 10:1:89 
diethyl ether:triethylamine:n-hexane, gave thiomorpholinone 412 as a colourless oil (24.4 mg, 29%).  
δH (300 MHz, CDCl3) 7.60–7.48 (2H, m, ArH), 7.48–7.28 (3H, m, ArH), 5.56 (1H, ddt, J 17.1, 10.2, 7.4, 
CH2CHCH2C), 5.00 (1H, d, J 10.2, CHHCHCH2C), 4.96 (1H, d, J 17.1, CHHCHCH2C), 4.44-4.21 (1H, m, 
CHHN), 3.44 (3H, s, CH3), 3.01–2.86 (3H, m, CHHN and SCH2CH2), 2.83 (1H, dd, J 15.0, 7.4, CHCHHS), 
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2.78 (1H, dd, J 15.0, 7.4, CHCHHS).  δC (101 MHz, CDCl3) 171.4 (CO), 138.9 (C), 132.2 (CH), 129.3 (CH), 
128.3 (CH), 126.1 (CH), 119.3 (CH2), 58.6 (C), 45.2 (CH2), 42.7 (CH2), 42.4 (CH2), 26.8 (CH3).  IR (neat): 
νmax = 3021 (CH), 2933 (CH), 1692 (CO), 1491, 1446, 1347, 1316, 1163.  HR-MS (ES-TOF+): m/z calcd 
for C14H17NO3S2Na: 334.0548 found: 334.0534 [M+Na
+].  
S-prenyl-N-tosylcysteamine (414) Prepared using GP2.  Allylation was performed using cysteamine 
hydrochloride (1.00 g, 8.80 mmol, 1.00 eq.) and prenyl bromide (1.02 ml, 8.80 
mmol, 1.00 eq.) in ethanol (30 ml) and LiOH (443 mg, 18.5 mmol, 2.10 eq.) in 
water (10 ml) for 47 hours.  N-protection was performed with tosyl chloride (1.70 g, 8.90 mmol, 1.01 
eq.) and triethylamine (2.15 ml, 29.3 mmol, 3.30 eq.) for 16 hours.   Purification by flash column 
chromatography, eluting with 1:4 ethyl acetate:n-hexane, gave tosylcysteamine 414 as a yellow oil 
(2.05 g, 78% over 2 steps).  δH (300 MHz, CDCl3) 7.75 (2H, d, J 8.2, ArH), 7.31 (2H, d, J 8.2, ArH), 5.18–
5.03 (1H, m, CH), 4.90 (1H, t, J 5.9, NH), 3.09 (2H, q, J 6.3, CH2NH), 3.00 (2H, d, J 7.8, CHCH2), 2.54 (2H, 
t, J 6.3, SCH2CH2), 2.43 (3H, s, ArCH3), 1.70 (3H, s, CH3), 1.57 (3H, s, CH3).  δC (101 MHz, CDCl3) 143.7 
(C), 137.1 (C), 136.3 (C), 129.9 (CH), 127.3 (CH), 120.1 (CH), 41.9 (CH2), 31.0 (CH2), 29.1 (CH2), 25.8 
(CH3), 21.7 (CH3), 17.8 (CH3).  IR (neat): νmax = 3279b (NH), 2972 (CH), 2924 (CH), 2859 (CH), 1599 
(C=C), 1440, 1324, 1156.  HR-MS (ES-TOF+): m/z calcd for C14H21NO2S2Na: 322.0911 found: 322.0909 
[M+Na+]. 
S-cinnamyl-N-tosylcysteamine (415) Prepared using GP2.  Allylation was performed using 
cysteamine hydrochloride (1.00 g, 8.80 mmol, 1.0 eq.) and cinnamyl bromide 
(1.73 g, 8.80 mmol, 1.0 eq.) in ethanol (30 ml) and LiOH (443 mg, 18.5 mmol, 
2.1 eq.) in water (10 ml) for 23 hours.  N-protection was performed with tosyl chloride (1.70 g, 8.90 
mmol, 1.01 eq.) and triethylamine (2.15 ml, 29.3 mmol, 3.3 eq.) for 15 hours.   Purified by 
crystallisation, from CH2Cl2 and n-hexane, gave tosylcysteamine 415 as white crystals (1.42 g, 48% 
over 2 steps).  δ H (300 MHz, CDCl3) 7.73 (2H, d, J 8.3, ArH), 7.32 (4H, m, ArH), 7.30-7.23 (3H, m, ArH), 
6.36 (1H, d, J 15.7, PhCHCH), 6.07 (1H, dt, J 15.7, 7.4, CHCHCH2), 4.89 (1H, s, NH), 3.19 (2H, dd, J 7.4, 
1.1, CHCH2S), 3.12 (2H, m, CH2N), 2.58 (2H, t, J 6.5, SCH2CH2), 2.41 (3H, s, CH3). δC (101 MHz, CDCl3) 
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143.7 (C), 137.0 (C), 136.5 (C), 133.0 (CH), 129.9 (CH), 128.8 (CH), 128.0 (CH), 127.2 (CH), 126.5 (CH), 
125.3 (CH), 46.0 (CH2), 34.0 (CH2), 30.6 (CH2), 21.7 (CH3).  IR (neat): νmax = 3308b (NH), 3024 (CH), 
2977 (CH), 1665 (C=C), 1599 (C=C), 1440, 1417, 1351, 1316, 1148, 1086.  HR-MS (ES-TOF+): m/z calcd 
for C18H21NO2S2Na: 370.911 found: 370.0910 [M+Na
+]. 
N-tosyl-2-bromoethanamine (417) Tosyl chloride (9.40 g, 49.3 mmol, 1.01 eq.) and then 
triethylamine (17.0 ml, 122.0 mmol, 2.50 eq.) were added to a stirred solution of 
bromoethanamine (10.0 g, 48.8 mmol, 1.00 eq.) in dry CH2Cl2 (100 ml) under argon at 0 
°C.  After 27 hours the reaction mixture was washed with NH4Cl solution (100 ml) and then water (2 x 
100 ml).  The organic fraction was dried over Na2SO4, filtered and concentrated in vacuo.  The 
resulting oil was purified by flash column chromatography, eluting with 3:7 ethyl acetate:n-hexane, 
to give tosylcysteamine 417 as white crystals (10.1 g, 74%), mp 88-89 °C from CH2Cl2 (Lit.
210 88-90 °C).  
δH (300 MHz, CDCl3) 7.76 (2H, d, J 8.3, ArH), 7.32 (2H, d, J 8.0, ArH), 5.16 (1H, s, J 5.8, NH), 3.40-3.33 
(4H, m, CH2CH2), 2.43 (3H, s, CH3). δC (101 MHz, CDCl3) 144.0 (C), 137.0 (C), 123.0 (CH), 127.2 (CH), 
44.65 (CH2), 31.7 (CH2), 21.7 (CH3). IR (neat): νmax = 3269br (NH), 3030 (CH), 2966 (CH), 2923 (CH), 
1597, 1449, 1423, 1313, 1150, 1087.  Data in agreement with literature values.210 
S-ethyl-N-tosylcysteamine (418) Ethanethiol (0.28 µl, 3.80 mmol, 1.05 eq.) was cautiously added to a 
stirred suspension of 50% NaH (192 mg, 4.00 mmol, 1.10 eq.) in dry THF (50 ml) 
under argon at 0 °C.  After 25 minutes sulfonamide 417 was added (1.00 g, 3.60 
mmol, 1.00 eq.).  The reaction was allowed to warm to room temperature over a period of 10 hours 
and then added to 10% NaOH solution (50 ml).  The organic fraction was collected and the aqueous 
fraction extracted with CH2Cl2 (2 x 50 ml).  The organic fractions were combined, dried over Na2SO4, 
filtered and concentrated in vacuo.  The resulting oil was purified by flash column chromatography, 
eluting with 1:3 ethyl acetate:n-hexane, to give tosylcysteamine 418 as a yellow oil (0.756 g, 81%).  δH 
(300 MHz, CDCl3) 7.75 (2H, d, J 8.3, ArH), 7.31 (2H, d, J 8.0, ArH), 4.69 (1H, br s, NH), 3.11 (2H, t, J 6.4, 
CH2NH), 2.60 (2H, t, J 6.4, SCH2CH2), 2.43 (3H, s, CH3), 2.40 (2H, q, J 7.4, CH3CH2), 1.17 (3H, t, J 7.4, 
CH3CH2). δC (101 MHz, CDCl3) 143.7 (C), 137.1 (C), 129.9 (CH), 127.3 (CH), 41.8 (CH2), 31.5 (CH2), 25.5 
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(CH2), 21.7 (CH3), 14.8 (CH3).  IR (Neat): νmax = 3279br (NH), 2967 (CH), 2924 (CH), 2859 (CH), 1598, 
1450br, 1322, 1156.  HR-MS (ES-TOF+): m/z calcd for C16H19NO2S2Na: 282.0593 found: 282.0598 
[M+Na+].  
S-prenyl-N-phenylethynyl-N-tosylcysteamine (419) Prepared using GP3.  Alkynylation was 
performed with tosylcysteamine 414 (300 mg, 1.00 mmol, 1.0 eq.), crude 
bromophenyl acetylene (181 µl, ca. 1.10 mmol, 1.1 eq.), 1,10-
phenanthroline (32.4 mg, 180 µmol, 0.18 eq.), CuSO4.5H2O (30.0 mg, 120 µmol, 0.12 eq.) and K2CO3 
(276 mg, 2.00 mmol, 2.0 eq.) in toluene (1 ml) for 21 hours.  Purification by flash column 
chromatography, eluting with 1:9 ethyl acetate:n-hexane, gave ynamide 419 as a yellow oil (364 mg, 
91%).  δH (300 MHz, CDCl3) 7.98–7.79 (2H, m, ArH), 7.40–7.32 (4H, m, ArH), 7.32–7.27 (3H, m, ArH), 
5.19 (1H, m, CHCH2), 3.67–3.47 (2H, m, CH2N), 3.16 (2H, d, J 7.8, CHCH2), 2.81–2.69 (2H, m, SCHCH2), 
2.46 (3H, s, ArCH3), 1.70 (3H, s, CH3), 1.66 (3H, s, CH3).  δC (101 MHz, CDCl3) 144.9 (C), 136.2 (C), 134.8 
(C), 131.6 (CH), 130.0 (CH), 128.4 (CH), 128.1 (CH), 127.9 (CH), 122.8 (C), 120.4 (CH), 82.2 (C), 71.2 (C), 
51.8 (CH2), 29.7 (CH2), 29.1 (CH2), 25.8 (CH3), 21.8 (CH3), 17.9 (CH3). IR (neat):  3052 (CH), 2923 (CH), 
2234 (C≡C), 1602w, 1440, 1367, 1165.  HR-MS (ES-TOF+): m/z calcd for C22H25NO2S2Na: 422.1215 
found: 422.1224 [M+Na+]. 
S-cinnamyl-N-phenylethynyl-N-tosylcysteamine (420) Prepared using GP3.  Alkynylation was 
performed with tosylcysteamine 415 (348 mg, 1.00 mmol, 1.0 eq.), 
crude bromophenyl acetylene (181 µl, ca. 1.10 mmol, 1.1 eq.), 1,10-
phenanthroline (32.4 mg, 180 µmol, 1.8 eq.), CuSO4.5H2O (30.0 mg, 120 µmol, 0.12 eq.) and K2CO3 
(276 mg, 2.00 mmol, 2.0 eq.) in toluene (4 ml) for 16 hours.  Purification by flash column 
chromatography, eluting with 1:9 ethyl acetate:n-hexane, gave ynamide 420 as a yellow oil (300 mg, 
75%).  δH (300 MHz, CDCl3) 7.86–7.71 (2H, d, J = 8.4, ArH), 7.40 –7.14 (12H, m, ArH), 6.48 (1H, d, J 
15.7, PhCH), 6.11 (1H, dt, J = 15.7, 7.3, CHCHCH2), 3.70–3.51 (2H, m, CH2CH2N), 3.33 (2H, dd, J 7.3, 
1.1, CHCH2S), 2.87 – 2.68 (2H, m, SCH2CH2), 2.42 (3H, s, CH3). δC (101 MHz, CDCl3) 144.7 (C), 136.5 (C), 
134.7 (C), 132.9 (CH), 131.4 (CH), 129.8 (CH), 128.6 (CH), 128.3 (CH), 127.9 (CH), 127.7 (3 CH), 126.4 
134 
 
(CH), 125.4 (CH), 122.6 (C), 82.0 (C), 71.1 (C), 51.5 (CH2), 34.3 (CH2), 28.3 (CH2), 21.6 (CH3). IR (neat):  
3028 (CH), 2923 (CH), 2234 (C≡C), 1597w, 1493, 1443, 1395, 1168.  HR-MS (ES-TOF+): m/z calcd for 
C26H25NO2S2Na: 470.1224 found: 470.1223 [M+Na
+].  
 S-ethyl-N-phenylethynyl-N-tosylcysteamine (421) Prepared using GP3.  Alkynylation was performed 
with tosylcysteamine 418 (1.08 g, 4.39 mmol, 1.0 eq.), crude bromophenyl 
acetylene (0.58 ml, ca. 4.83 mmol, 1.1 eq.), 1,10-phenanthroline (158 mg, 878 
µmol, 0.2 eq.), CuSO4.5H2O (110 mg, 439 µmol, 0.10 eq) and K2CO3 (1.21 g, 8.78 mmol, 2.0 eq.) in 
toluene (5 ml) for 20 hours.  Purification by flash column chromatography, eluting with 1:9 ethyl 
acetate:n-hexane, gave ynamide 421 as a yellow oil (167 mg, 66%).  δH (300 MHz, CDCl3) 7.85 (2H, d, J 
8.4, ArH), 7.42–7.32 (4H, m, ArH), 7.32–7.26 (3H, m, ArH), 3.65–3.53 (2H, m, CH2N), 2.88–2.74 (2H, m, 
SCH2CH2), 2.56 (2H, q, J 7.4, CH3CH2S), 2.46 (3H, s, PhCH3), 1.26 (3H, t, J 7.4, CH3CH2).  δC (101 MHz, 
CDCl3) 145.0 (C), 134.8 (C), 131.6 (CH), 123.0 (CH), 128.4  (CH), 128.1 (CH), 127.8 (CH), 122.8 (C), 82.1 
(C), 71.2 (C), 51.7 (CH2), 29.5 (CH2), 26.2 (CH2), 21.8 (CH3), 14.9 (CH3).  IR (neat):  3065 (CH), 2976 (CH), 
2926 (CH), 2877 (CH), 2235 (C≡C), 1597w, 1494, 1456, 1365, 1169.  HR-MS (ES-TOF+): m/z calcd for 
382.0911 C19H21NO2S2Na: 382.0908 found: [M+Na
+]. 
2-prenyl-2-phenyl-4-tosylthiomorpholin-3-one (422) Prepared using GP5.  Catalysis was performed 
using ynamide 419 (218 mg, 550 µmol, 1.0 eq.), pyridine N-oxide (57.2 mg, 600 µmol, 
1.1 eq.), AgOTs (7.7 mg, 28.0 µmol, 0.05 eq.) and IPrAuCl (17.1 mg, 28.0 µmol, 0.050 
eq.) in CH3CN (11 ml) for 17 hours.  Purification by flash column chromatography, eluting with 
10:1:89 diethyl ether:triethylamine:n-hexane, gave thiomorpholinone 422 as a yellow oil (154.5 mg, 
68%).  δH (300 MHz, CDCl3) 7.86 (2H, d, J 8.3, ArH), 7.38 (2H, d, J 8.1, ArH), 7.31 (5H, m, ArH), 6.13 
(1H, brs, CH2CHCH2C), 4.91 (1H, d, J 10.0, CHHCHCH2C), 4.92–4.68 (1H, m, CHHCHCH2C), 4.47 (1H, 
ddd, J 14.2, 6.8, 2.5, CHHN), 3.01 (1H, td, J 11.4, 6.8, CHHN), 2.90–2.60 (2H, m, SCH2CH2), 2.51 (3H, s, 
ArCH3), 1.41–0.72 (6H, m, CH3CCH3).  δC (101 MHz, CDCl3) 169.0 (CO), 144.7 (C), 144.1 (CH), 136.0 (C), 
135.9 (C), 129.3 (CH), 128.8 (CH), 128.5 (CH), 128.0 (CH), 113.4 (CH2), 44.9 (C), 43.1 (C), 26.4 (CH2), 
24.5 (CH3), 21.8 (CH3).  IR (Neat): νmax = 3067 (CH), 2973 (CH), 2902 (CH), 1698 (CO), 1596, 1491, 1445, 
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1394, 1311, 1166.  HR-MS (ES-TOF+): m/z calcd for C22H25NO3S2Na: 438.1174 found: 438.1177 
[M+Na+]. 
2-cinnamyl-2-phenyl-4-tosylthiomorpholin-3-one (423) Prepared using GP5.  Catalysis was 
performed using ynamide 420 (38.5 mg, 86.0 µmol, 1.0 eq.), pyridine N-oxide (9.0 
mg, 95.0 µmol, 1.1 eq.), AgOTs (1.2 mg, 4.30 µmol, 0.050 eq.) and IPrAuCl (2.7 mg, 
4.30 µmol, 0.050 eq.) in CH3CN (2 ml) for 15 hours.  Purification by flash column 
chromatography, eluting with 10:1:89 diethyl ether:triethylamine:n-hexane, gave thiomorpholinone 
423 as a colourless oil (28.7 mg, 72%, d.r.: 5.2:1).  δH (300 MHz, CDCl3) 7.88 (2H, d, J 8.3, ArH), 7.38 
(2H, d, J 8.3, ArH), 7.35–7.30 (1H, m, ArH), 7.23–6.91 (7H, m, ArH), 6.85–6.67 (2H, m, ArH), 6.22 (1H, 
ddd, J 17.0, 10.5, 6.5, CH2CHCH2C major), 5.90 (1H, ddd, J 17.0, 10.4, 8.4, CH2CHCH2C minor), 5.04 
(1H, dt, J 10.5, 1.5, CHHCHCH2C major), 4.94 (1H, d, J 10.4, CHHCHCH2C minor), 4.83 (1H, dt, J 17.0, 
1.4, CHHCHCH2C), 4.58 – 4.37 (1H, m, CHHN), 4.25 (1H, d, J 6.5, CHPh major), 4.18 (1H, d, J 8.5, CHPh 
minor), 3.18–2.95 (2H, m, SCH2CH2), 2.95–2.68 (1H, m, CHHN), 2.52 (3H, s, CH3). δ C (101 MHz, CDCl3) 
168.8 (CO), 144.8 (C), 138.1 (C), 137.5 (C), 137.4 (C), 135.7 (C), 130.5 (CH), 129.3 (CH), 128.6 (CH), 
128.4 (CH), 127.7 (CH), 127.3 (CH), 126.7 (CH), 126.6 (CH), 117.7 (CH2), 63.5 (C), 57.6 (C), 43.5 (CH2), 
26.2 (CH2), 21.7 (CH3). IR (neat): νmax = 3029 (CH), 2927 (CH), 1699 (CO), 1596, 1492, 1447, 1356, 
1316, 1169.  HR-MS (ES-TOF+): m/z calcd for C26H25NO3S2Na: 486.1174 found: 486.1176 [M+Na
+].  
2-phenyl-4-tosylthiomorpholin-3-one (424) Prepared using GP5.  Catalysis was performed using 
ynamide 421 (206 mg, 570 µmol, 1.0 eq.), pyridine N-oxide (59.9 mg, 630 µmol, 1.1 
eq.), AgOTs (2.8 mg, 10.0 µmol, 0.050 eq.) and IPrAuCl (6.2 mg, 10.0 µmol, 0.05 eq.) in 
CH3CN (4 ml) for 18 hours.  Purification by flash column chromatography, eluting with 1:4 ethyl 
acetate:n-hexane, gave thiomorpholinone 424 as a yellow oil (111 mg, 56%).  δH (300 MHz, CDCl3) 
7.92 (2H, d, J 8.4, ArH), 7.51–7.16 (7H, m, ArH), 4.69 (1H, s, CHPh), 4.33 (1H, dt, J 14.6, 5.4, CHHN), 
4.20 (1H, ddd, J 14.6, 7.3, 5.4, CHHN), 3.20–3.02 (2H, m, SCH2), 2.47 (3H, s, CH3).  δC (101 MHz, CDCl3) 
167.8 (CO), 145.2 (C), 135.9 (C), 133.9 (C), 129.7 (CH), 128.92 (CH), 128.8 (CH), 128.6 (CH), 128.5 (CH), 
48.3 (CH), 44.9 (CH2), 27.9 (CH2), 21.9 (CH3).  IR (Neat): νmax = 3065 (CH), 2923 (CH), 1677 (CO), 1597, 
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1451, 1367, 1205, 1167.  HR-MS (ES-TOF+): m/z calcd for C17H17NO3S2Na: 370.0548 found: 370.0543 
[M+Na+].  
1-(2,2-dibromovinyl)-4-methylbenzene Prepared using GP6, with para-methylbenzaldehyde (0.59 
ml, 5.00 mmol, 1 eq.), CBr4 (3.3 g, 10.0 mmol, 2 eq.) and PPh3 (5.3 g, 20.0 mmol, 4 
eq.) in dry CH2Cl2 (50 ml).  Purification by flash column chromatography, eluting 
with n-hexane, gave the dibromoalkene as a yellow oil (320 mg, 23%).  δH (300 
MHz, CDCl3) 7.45 (1H, s, CHCBr2), 7.44 (2H, d, J 8.0, ArH), 7.18 (2H, d, J 8.1, ArH), 2.34 (3H, s, CH3).   IR 
(neat): νmax = 3025 (CH), 2920 (CH), 1510 (C=C), 875.  Data in agreement with literature values.
211 
1-(2,2-dibromovinyl)-4-methoxybenzene Prepared using GP6, with para-anisaldehyde (0.61 ml, 5.00 
mmol, 1 eq.), CBr4 (3.3 g, 10.0 mmol, 2 eq.) and PPh3 (5.3 g, 20.0 mmol, 4 eq.) in 
dry CH2Cl2 (50 ml).  Purification by flash column chromatography, eluting with 1:9 
ethyl acetate:n-hexane, gave the dibromoalkene as yellow crystals (1.3 g, 92%), 
m.p. 31-32 °C from CH2Cl2 (Lit.
212  31 - 33 °C).  δH (300 MHz, CDCl3) 7.51 (2H, d, J 8.8, ArH), 7.41 (1H, s, 
CH), 6.89 (2H, d, J 8.8, ArH), 3.82 (3H, s, CH3).  δC (101 MHz, CDCl3) 159.8 (C), 136.5 (CH), 130.0 (CH), 
128.0 (C), 114.0 (CH), 87.4 (CBr2), 55.5 (CH3).  IR (neat): νmax = 3026 (CH), 2931 (CH), 2836 (CH), 1606 
(C=C), 1509(C=C), 1249, 1178, 1032, 804. Data in agreement with literature values.213 
Methyl 4-(2,2-dibromovinyl)benzoate Prepared using GP6, with methyl para-formylbenzoate (0.820 
g, 5.00 mmol, 1 eq.), CBr4 (3.32 g, 10.0 mmol, 2 eq.) and PPh3 (5.25 g, 20.0 
mmol, 4 eq.) in dry CH2Cl2 (50 ml).  Purification by flash column 
chromatography, eluting with 1:9 ethyl acetate:n-hexane, gave the 
dibromoalkene as a yellow oil (399 mg, 25%).  δH (300 MHz, CDCl3) 8.03 (2H, d, J 8.2, ArH), 7.60 (2H, 
d, J 8.2, ArH), 7.52 (1H, s, CHCBr2), 3.92 (3H, s, CH3).  IR (neat): νmax = 3007 (CH), 2957 (CH), 1727 
(C=C), 1286, 1114, 885.  Data in agreement with literature values.214 
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1-(2,2-dibromovinyl)-4-fluorobenzene Prepared using GP6, with para-fluorobenzaldehyde (0.54 ml, 
5.00 mmol, 1 eq.), CBr4 (3.32 g, 10.0 mmol, 2 eq.) and PPh3 (5.25 g, 20.0 mmol, 4 eq.) 
in dry CH2Cl2 (50 ml).  Purification by flash column chromatography, eluting with n-
hexane, gave the dibromoalkene as a yellow oil (1.14 g, 82%).  δH (300 MHz, CDCl3) 
7.52 (2H, dd, J 8.6, 5.4, ArH), 7.44 (1H, s, CHCBr2), 7.06 (2H, t, J 8.6, ArH). δC (101 MHz, CDCl3, CF 
Coupled) 162.60 (d, J 249.5, CF), 135.9 (s, CHCBr2), 131.6 (d, J 3.4, CCHCBr2), 130.4 (d, J 8.3, CH), 
115.6 (d, J 21.7, CH), 89.8 (s, CBr2).  IR (neat): νmax = 3018 (CH), 1603 (C=C), 1506 (C=C), 1230, 1160, 
875, 813.  Data in agreement with literature values.215 
3-(2,2-dibromovinyl)furan Prepared using GP6, with furfural (0.41 ml, 5.00 mmol, 1 eq.), CBr4 (3.32 g, 
10.0 mmol, 2 eq.) and PPh3 (5.25 g, 20.0 mmol, 4 eq.) in dry CH2Cl2 (50 ml).  Purification 
by flash column chromatography, eluting with n-hexane, gave the dibromoalkene as 
brown crystals (763 mg, 60%).  δH (300 MHz, CDCl3) 7.44 (1H, d, J 1.8, ArH), 7.41 (1H, s, CHCBr2), 6.94 
(1H, t, J 3.5, ArH), 6.46 (1H, dd, J 3.5, 1.8, ArH).  δC (101 MHz, CDCl3) 150.2 (C), 142.7 (CH), 126.6 (CH), 
111.7 (CH), 111.6 (CH), 87.3 (CBr2).  IR (neat): νmax = 3152 (CH), 3033 (CH), 1805, 1481, 1230, 1142, 
1020, 947, 836, 741.  Data in agreement with literature values.216, 217 
S-allyl-N-4-methylphenylethynyl-N-tosylcysteamine (430) Prepared using GP4.  Alkynylation was 
performed with tosylcysteamine 382 (280 mg, 1.03 mmol, 1.0 eq.), 
1-(2,2-dibromovinyl)-4-methylbenzene (313 mg, 1.13 mmol, 1.1 
eq.), N,N-dimethylethylenediamine (20.0 µl, 185 µmol, 0.18 eq.), 
CuI  (40.3 mg, 124 µmol, 0.12 eq.) and Cs2CO3 (785 mg, 4.12 mmol, 4.0 eq.) in dioxane (3 ml) for 17 
hours.  Purification by flash column chromatography, eluting with 1:9 ethyl acetate:n-hexane, gave 
ynamide 430 as a colourless oil (173 mg, 44%).  δH (300 MHz, CDCl3) 7.86 (2H, d, J 8.2, ArH), 7.37 (2H, 
d, J 8.1, ArH), 7.27 (2H, d, J 8.0, ArH), 7.12 (2H, d, J 8.0, ArH), 5.77 (1H, ddt, J 17.1, 9.9, 7.2, 
CHCH2CH2C), 5.15 (1H, dd, J 17.1, 1.4, CHHCHCH2C), 5.13 (1H, d, J 9.9, CHHCHCH2C), 3.67–3.52 (2H, 
m, CH2N), 3.16 (2H, d, J 7.2, CHCH2N), 2.84–2.72 (2H, m, CH2CH2S), 2.48 (3H, s, CH3), 2.36 (3H, s, CH3).  
δC (101 MHz, CDCl3) 144.9 (C), 138.3 (C), 134.9 (C), 134.0 (CH), 131.6 (CH), 129.9  (CH), 129.2  (CH), 
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127.9  (CH), 119.6 (C), 117.9 (CH2), 81.4 (C), 71.2 (C), 51.4 (CH2), 34.9 (CH2), 28.4 (CH2), 21.8 (CH3), 
21.6 (CH3).  IR (neat): νmax = 3035 (CH), 2921 (CH), 2236 (C≡C), 1597w, 1365, 1168.  HR-MS (ES-TOF+): 
m/z calcd for C21H23NO2S2Na: 408.1068 found: 408.1056 [M+Na
+]. 
S-allyl-N-4-methoxyphenylethynyl-N-tosylcysteamine (431) Prepared using GP4.  Alkynylation was 
performed with tosylcysteamine 382 (207 mg, 760 µmol, 1.0 eq.), 
1-(2,2-dibromovinyl)-4-methoxybenzene (248 mg, 840 µmol, 1.1 
eq.), N,N-dimethylethylenediamine (15 µl, 137 µmol, 0.18 eq.), CuI  
(29.7 mg, 92.0 µmol, 0.12 eq.) and Cs2CO3 (580 mg, 3.00 mmol, 4.0 eq.) in dioxane (2 ml) for 17 
hours.  Purification by flash column chromatography, eluting with 1:9 ethyl acetate:n-hexane, gave 
ynamide 431 as a colourless oil (81.5 mg, 27%).  δH (300 MHz, CDCl3) 7.83 (2H, d, J 8.3, ArH), 7.36 (2H, 
d, J 8.0, ArH), 7.30 (2H, d, J 8.9, ArH), 6.83 (2H, d, J 8.9, ArH), 5.75 (1H, ddt, J 17.1, 9.9, 7.2, 
CH2CHCH2S), 5.12 (1H, dd, J 17.1, 1.4, CHHCHCH2S), 5.10 (1H, d, J 9.9, CHHCHCH2S), 3.81 (3H, s, 
OCH3), 3.61–3.48 (2H, m, CH2N), 3.14 (2H, d, J 7.2, CHCH2S), 2.83–2.68 (2H, m, SCH2CH2), 2.46 (3H, s, 
CH3). δC (101 MHz, CDCl3) 159.8 (C), 144.8 (C), 134.9 (C), 134.0 (CH), 133.6 (CH), 129.9 (CH), 127.9 
(CH), 117.9 (CH), 114.7 (C), 114.1 (CH2), 80.7 (C), 70.8 (C), 55.5 (CH3), 51.5 (CH2), 34.8 (CH2), 28.4 
(CH2), 21.8(CH3).  IR (neat): νmax = 3075 (CH), 2922 (CH), 2841 (CH), 2237 (C≡C), 1605w, 1512, 1363, 
1167.  HR-MS (ES-TOF+): m/z calcd for C21H23NO3S2Na: 424.1017 found: 424.01021 [M+Na
+]. 
S-allyl-N-(4-methylcarboxy)-phenylethynyl-N-tosylcysteamine (432) Prepared using GP4.  
Alkynylation was performed with tosylcysteamine 382 (271 mg, 
1.00 mmol, 1.0 eq.), methyl 4-(2,2-dibromovinyl)benzoate (351 
mg, 1.10 mmol, 1.1 eq.), N,N-dimethylethylenediamine (20 µl, 
180 µmol, 0.18 eq.), CuI (39.1 mg, 120 µmol, 0.12 eq.) and Cs2CO3 (762 mg, 4.00 mmol, 4.0 eq.) in 
dioxane (3 ml) for 17 hours.  Purification by flash column chromatography, eluting with 1:9 ethyl 
acetate:n-hexane, gave ynamide 432 as a colourless oil (240 mg, 56%).  δH (300 MHz, CDCl3) 7.96 (2H, 
d, J 8.4, ArH), 7.84 (2H, d, J 8.4, ArH), 7.44–7.30 (4H, m, ArH), 5.76 (1H, ddt, J 17.2, 10.0, 7.2, 
CH2CHCH2S), 5.14 (1H, d, J 17.2, CHHCHCH2S), 5.11 (1H, d, J 10.0, CHHCHCH2S), 3.91 (3H, s, CO2CH3), 
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3.65–3.50 (2H, m, CH2N), 3.15 (2H, d, J 7.2, CHCH2S), 2.83–2.67 (2H, m, CH2CH2S), 2.46 (3H, s, CH3).  
δC (101 MHz, CDCl3) 166.7 (C), 145.2 (C), 134.8 (C), 134.0 (CH), 130.8 (CH), 130.1 (CH), 129.7 (CH), 
129.1 (C), 127.9  (CH), 127.8 (CH), 118.0 (CH2), 85.4 (C), 71.3 (C), 52.3 (CH3), 51.3 (CH2), 34.9 (CH2), 
28.5 (CH2), 21.8 (CH3).  IR (neat): νmax = 3081 (CH), 2951 (CH), 2231 (C≡C), 1719s, 1605w, 1405, 1364, 
1274, 1167.  HR-MS (ES-TOF+): m/z calcd for C22H23NO4S2Na: 425.0966 found: 425.0991 [M+Na
+]. 
S-allyl-N-4-fluorophenylethynyl-N-tosylcysteamine (433) Prepared using GP4.  Alkynylation was 
performed with tosylcysteamine 382 (92.8 mg, 342 µmol, 1.0 eq.), 1-
(2,2-dibromovinyl)-4-fluorobenzene (105mg, 380 µmol, 1.1 eq.), N,N-
dimethylethylenediamine (6.6 µl, 62.0 µmol, 0.18 eq.), CuI (13.4 mg, 
41.0 µmol, 0.12 eq.) and Cs2CO3 (261mg, 1.37 mmol, 4.0 eq.) in dioxane (1 ml) for 17 hours.  
Purification by flash column chromatography, eluting with 1:9 ethyl acetate:n-hexane, gave ynamide 
433 as a colourless oil (70.3 mg, 53%).  δH (300 MHz, CDCl3) 7.83 (2H, d, J 8.3, ArH), 7.42-7.29 (4H, m, 
ArH), 6.99 (2H, app. t, J 8.7, ArH), 5.75 (1H, ddt, J 17.2, 9.9, 7.2, CH2CHCH2S), 5.12 (1H, d, J 17.2, 
CHHCHCH2S), 5.11 (1H, d, J 9.9, CHHCHCH2S), 3.65-3.47 (2H, m, CH2N), 3.14 (2H, d, J 7.2, CHCH2S), 
2.82-2.67 (2H, m, SCH2CH2), 2.46 (3H, s, CH3).  δC (101 MHz, CDCl3, CF coupled) 162.5 (d, J 249.3, CF), 
145.0 (C), 134.8 (C), 134.0 (CH), 133.6 (s, J 8.6, CH), 129.0 (CH), 127.8 (CH), 118.8 (C), 117.9 (CH), 
115.8 (CH), 115.6 (CH2), 81.7 (C), 70.1 (C), 51.4 (CH2), 34.8 (CH2), 28.4 (CH2), 21.8 (CH3).  IR (neat): νmax 
= 3082 (CH), 2923 (CH), 2238 (C≡C), 1599w, 1509, 1365, 1168.  HR-MS (ES-TOF+): m/z calcd for 
412.0817 C20H20NO2S2FNa: 412.0815 found: [M+Na
+].  
S-allyl-N-(2-furanyl)-ethynyl-N-tosylcysteamine (434) Prepared using GP4.  Alkynylation was 
performed with cysteamine 382 (250 mg, 920 µmol, 1.0 eq.), 2-(2,2-
dibromovinyl)furan (252 mg, 1.00 mmol, 1.1 eq.), N,N-
dimethylethylenediamine (18 µl, 166 µmol, 0.18 eq.), CuI (35.8 mg, 110 µmol, 0.12 eq.) and 
Cs2CO3(701 mg, 36.8 mmol, 4.0 eq.) in dioxane (5 ml) for 17 hours.  Purification by flash column 
chromatography, eluting with 1:9 ethyl acetate:n-hexane, gave ynamide 434 as colourless crystals 
(163 mg, 49%) melting point 32-33 °C.  δH (300 MHz, CDCl3) 7.81 (2H, d, J 8.3, ArH), 7.38 (1H, dd, J 1.9, 
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0.7, ArH), 7.35 (2H, d, J 8.3, ArH), 6.60 (1H, dd, J 3.4, 0.7, ArH), 6.38 (1 H, dd, J 3.4, 1.9, ArH), 5.72 (1 
H, ddt, J 17.1, 9.9, 7.2, CH2CHCH2S), 5.10 (1H, dd, J 17.1, 1.3, CHHCHCH2S), 5.08 (1H, d, J 9.9, 
CHHCHCH2S), 3.65–3.45 (2H, m, CH2N), 3.10 (2H, d, J 7.2, CHCH2S), 2.81–2.61 (2H, m, CH2CH2S), 2.44 
(3H, s, CH3).  δC (101 MHz, CDCl3) 145.07 (C), 144.18 (CH), 136.60 (C), 134.68 (C), 133.77 (CH), 129.97 
(CH), 127.68 (CH), 117.87 (CH2), 117.40 (CH2), 111.18 (CH), 86.12 (C), 62.00 (C), 51.36 (CH2), 34.69 
(CH2), 28.19 (CH2), 21.71 (CH3).  IR (neat): νmax =  3122 (CH), 3072 (CH), 2922 (CH), 2225 (C≡C), 1597w, 
1491, 1364, 1167.  HR-MS (ES-TOF+): m/z calcd for C18H19NO3S2Na: 384.0704 found: 384.0698 
[M+Na+].  
S-allyl-N-hexynyl-N-tosylcysteamine (435) Prepared using GP3.  Alkynylation was performed with 
tosylcysteamine 382 (1.0 g, 3.70 mmol, 1.0 eq.), crude bromohexyne (0.71 
ml, ca. 5.55 mmol, 1.5 eq.), 1,10-phenanthroline (120 mg, 666 µmol, 0.18 
eq.), CuSO4.5H2O (110 mg, 444 µmol, 0.12 eq.) and K2CO3 (1.0 g, 7.40 mmol, 2.0 eq.) in toluene (10 
ml) for 19 hours.  Purification by flash column chromatography, eluting with 10:1:89 diethyl 
ether:triethylamine:n-hexane, gave ynamide 435 as a colourless oil (324.8 mg, 25%).  δH (300 MHz, 
CDCl3) 7.78 (2H, d, J 8.2, ArH), 7.33 (2H, d, J 8.2, ArH), 5.75 (1H, ddt, J 16.7, 9.4, 7.2, CH2CHCH2S), 5.12 
(1H, d, J 16.7, CHHCHCH2S), 5.11 (1H, d, J 9.4, CHHCHCH2S), 3.52–3.33 (2H, m, CH2N), 3.12 (2H, d, J 
7.3, CHCH2SH), 2.75–2.58 (2H, m, SCH2CH2), 2.45 (3H, s, CH3), 2.25 (2H, t, J 6.9, C≡CCH2), 1.51–1.21 
(4H, m, CH2CH2CH3), 0.89 (3H, t, J 7.2, CH2CH3).  δC (101 MHz, CDCl3) 144.5 (C), 134.9 (C), 134.0 (CH), 
129.8 (CH), 127.8 (CH), 117.8 (CH2), 72.9 (C), 70.8 (C), 51.3 (CH2), 34.8 (CH2), 31.1 (CH2), 28.3 (CH2), 
22.0 (CH2), 21.8 (CH3), 18.3 (CH2), 13.7 (CH3).  IR (Neat): νmax =  2957 (CH), 2930 (CH), 2871 (CH), 2253 
(C≡C), 1597w, 1444, 1362, 1166.  HR-MS (ES-TOF+): m/z calcd for 374.1224 C18H25NO2S2Na: 374.1236 
found: [M+Na+].  
S-allyl-N-trimethylsilylethynyl-N-tosylcysteamine (436) Prepared using GP3.  Alkynylation was 
performed S-allyl-N-tosylcysteamine 382 (98 mg, 500 µmol, 1.0 eq.), crude 
bromotrimethylsilyl acetylene (83 µl, ca. 550 µmol, 1.1 eq.), 1,10-
phenanthroline (16 mg, 90.0 µmol, 0.18 eq.), CuSO4.5H2O (15 mg, 60.0 µmol, 0.12 eq.) and K2CO3 
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(140 mg, 1.00 mmol, 2.0 eq.) in toluene (1 ml) for 20 hours.  Purification by flash column 
chromatography, eluting with 1:9 ethyl acetate:n-hexane, gave ynamide 436 as a yellow oil (75 mg, 
50%). δH (300 MHz, CDCl3) 7.78 (2H, d, J 8.2, ArH), 7.34 (2H, d, J 8.2, ArH), 5.73 (1H, ddt, J = 16.6, 10.2, 
7.2, CH2CHCH2S), 5.14 (1H, d, J 16.6, CHHCHCH2S), 5.11 (1H, d, J 10.2, CHHCHCH2S), 3.57–3.33 (1H, m 
CH2N), 3.11 (1H, d, J 7.2, CHCH2S), 2.76–2.58 (1H, m, CH2CH2S), 2.45 (3H, s, CH3), 0.15 (9H, s, Si(CH3)3).  
δC (101 MHz, CDCl3) 144.9 (C), 134.7 (C), 133.9 (CH), 129.8 (CH), 127.9 (CH), 117.9 (CH2), 94.8 (C), 73.8 
(C), 51.04 (CH2), 34.74 (CH2), 28.14 (CH2), 21.77 (CH3), 0.19 (3 CH3).  IR (Neat): νmax = 2958 (CH), 2166 
(C≡C), 1597w, 1370, 1170.  HR-MS (ES-TOF+): m/z calcd for C17H25NO2S2SiNa: 390.0994 found: 
390.0999 [M+Na+]. 
 S-allyl-N-ethynyl-N-tosylcysteamine (437) A 1 M solution of TBAF (3.93 ml, 3.93 mmol, 2.5 eq.) was 
added under argon to a 0 °C solution of ynamide 436 (577 mg, 1.57 mmol, 
1.0 eq.) in dry THF (12 ml).  After 10 minutes the reaction mixture was 
quenched with NH4Cl solution (20 ml) and extracted with ethyl acetate (3 x 25 ml).  The organic 
fractions were combined, dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash 
column chromatography, eluting with 1:9 ethyl acetate:n-hexane, gave ynamide 437 as a yellow oil 
which proved unstable while drying under high vacuum and was therefore used immediately (350 
mg, >95% purity).  δH (300 MHz, CDCl3) 7.80 (2H, d, J 8.3, ArH), 7.36 (2H, d, J 8.3, ArH), 5.74 (1H, ddt, J 
16.8, 9.6, 7.2, CHCH2CH2S), 5.13 (1H, d, J 16.8, CHHCHCH2S), 5.12 (1H, d, J 9.6, CHHCHCH2S), 3.56–
3.41 (2H, m, CH2N), 3.12 (2H, d, J 7.2, CHCH2S), 2.76 (1H, s, CH), 2.74–2.62 (2H, m, CH2CH2S), 2.45 (3H, 
s, CH3).  δC (101 MHz, CDCl3) 145.1 (C), 134.8 (C), 133.9 (CH), 130.0 (CH), 127.8 (CH), 118.0 (CH2), 75.9 
(C), 59.7 (CH), 51.0 (CH2), 34.8 (CH2), 28.2 (CH2), 21.8 (CH3). IR (neat): νmax = 3298 (CH), 3088 (CH), 
2923 (CH), 2166 (C≡C), 1597w, 1367, 1168.  HR-MS (ES-TOF+): m/z calcd for C14H17NO2S2Na: 318.0596 
found: 318.0593 [M+Na+]. 
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2-allyl-2-(4-tolyl)-4-tosylthiomorpholin-3-one (438) Prepared using GP5.  Catalysis was performed 
using ynamide 430 (77.1 mg, 200 µmol, 1.0 eq.), pyridine N-oxide (20.9 mg, 220 
µmol, 1.1 eq.), AgOTs (2.8 mg, 10.0 µmol, 0.050 eq.) and IPrAuCl (6.2 mg, 10.0 
µmol, 0.050 eq.) in CH3CN (4 ml) for 15 hours.  Purification by flash column 
chromatography, eluting with 10:1:89 diethyl ether:triethylamine:n-hexane, gave thiomorpholinone 
438 as a colourless oil (47.4 mg, 59%).  δH (300 MHz, CDCl3) 7.85 (2H, d, J 8.4, ArH), 7.36 (2H, d, J 8.1, 
ArH), 7.20 (2H, d, J 8.4, ArH), 7.09 (2H, d, J 8.1, ArH), 5.43 (1H, ddt, J 17.1, 10.3, 7.2, CH2CHCH2C), 4.91 
(1H, d, J 10.3, CHHCHCH2C), 4.87 (1 H, d, J 17.1, CHHCHCH2C), 4.63–4.43 (1H, m, CHHN), 3.15–2.98 
(2H, m, SCH2CH2), 2.98–2.84 (1H, m, CHHN), 2.69 (1H, dd, J 14.5, 7.2, CHCHHC), 2.59 (1H, dd, J 14.5, 
7.2, CHCHHC), 2.48 (3H, s, CH3), 2.33 (3, s CH3).  δC (101 MHz, CDCl3) 169.9 (CO), 145.0 (C), 137.9 (C), 
136.2 (C), 136.0 (C), 132.4 (CH), 129.8 (CH), 129.5 (CH), 128.6 (CH), 126.0 (CH), 118.9 (CH2), 58.2 (C), 
45.1 (CH2), 43.5 (CH2), 26.9 (CH2), 21.9 (CH3), 21.1 (CH3).  IR (neat): νmax = 3074 (CH), 2979 (CH), 2924 
(CH), 1698 (CO), 1597, 1509, 1432, 1406, 1353, 1317, 1168.  HR-MS (ES-TOF+): m/z calcd for 
C21H23NO3S2Na: 424.1017 found: 424.1009 [M+Na
+]. 
2-allyl-2-(4-methoxyphenyl)-4-tosylthiomorpholin-3-one (439) and N-(2-(allylthio)ethyl)-2-(4-
methoxyphenyl)-2-oxo-N-tosylacetamide Prepared using GP5.  Catalysis was performed using 
ynamide 431 (81.5 mg, 200 µmol, 1.0 eq.), pyridine N-oxide (20.9 
mg, 220 µmol, 1.1 eq.), AgOTs (2.8 mg, 10.0 µmol, 0.050 eq.) and 
IPrAuCl (6.2 mg, 10.0 µmol, 0.050 eq.) in CH3CN (4 ml) for 15 
hours.  Purification by flash column chromatography, eluting with 
10:1:89 diethyl ether:triethylamine:n-hexane, gave an inseparable 
2:1 mixture of thiomorpholinone 439 and tosylacetamide as a colourless oil (60.1 mg, 72%). 
2-allyl-2-(4-methoxyphenyl)-4-tosylthiomorpholin-3-one δ H (400 MHz, CDCl3) 7.87 (2H, d, J 8.3, ArH), 
7.37 (2H, d, J 8.3, ArH), 7.25 (2H, d, J 8.9, ArH), 6.83 (2H, d, J 8.9, ArH), 5.46 (1H, ddt, J 17.1, 10.2, 7.2, 
CH2CHCH2C), 4.93 (1H, dd, J 10.2, 1.9, CHHCHCH2C), 4.88 (1H, dd, J 17.1, 1.8, CHHCHCH2C), 4.55 (1H, 
ddd, J 13.8, 5.6, 2.9, CHHN), 3.81 (3H, s, OCH3), 3.15-3.07 (1H, m, CHHN), 3.02 (1H, td, J 11.6, 5.6, 
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SCHHCH2N), 2.91 (1H, ddd, J 11.6, 4.3, 2.9, SCHHCH2N), 2.69 (1H, dd, J 14.5, 7.2, CHCHHC), 2.62 (1H, 
dd, J 14.5, 7.2, CHCHHC), 2.49 (3H, s, CH3).  δC (101 MHz, CDCl3) 169.8 (CO), 159.2 (C), 144.8 (C), 135.9 
(C), 132.3 (CH), 130.9 (C), 129.4 (CH), 128.5 (CH), 127.3 (CH), 118.8 (CH2), 114.2 (CH), 57.8 (C), 55.3 
(CH3), 45.1 (CH2), 43.3 (CH2), 26.8 (CH2), 21.2 (CH3). 
N-(2-(allylthio)ethyl)-2-(4-methoxyphenyl)-2-oxo-N-tosylacetamide δ H (400 MHz, CDCl3) 7.94 (2H, d, J 
8.3, ArH), 7.93 (2H, d, J 8.9, ArH), 7.41 (2H, d, J 8.3, ArH), 7.02 (2H, d, J 8.9, ArH), 5.80 (2H, ddt, J 17.1, 
10.0, 7.2, CH2CHCH2S), 5.21 (1H, dd, J 17.1, 1.3, CHHCHCH2S), 5.14 (1H, dd, J 10.0, 1.3, CHHCHCH2S), 
3.91 (3H, s, CH3), 3.87–3.77 (2H, m, SCH2CH2N), 3.18 (2H, d, J 7.2, CHCH2S), 2.82-2.75 (2H, m, 
SCH2CH2N), 2.48 (3H, s, CH3).  δC (101 MHz, CDCl3) 186.5 (CO), 167.4 (CO), 164.7 (C), 145.9 (C), 134.3 
(C), 133.9 (CH), 132.1 (CH), 130.1 (CH), 127.3 (CH), 125.8 (C), 117.9 (CH2), 114.4 (CH), 55.7 (CH3),45.0 
(CH2) 35.6 (CH2), 28.4 (CH2), 21.2 (CH3). 
IR (neat): νmax = 3076 (CH), 2928 (CH), 2840 (CH), 1696 (CO), 1599 (C=C), 1509 (C=C), 1357, 1251, 
1167.  HR-MS (ES-TOF+): m/z calcd for C21H23NO4S2Na: 440.0966 found: 440.0952 [M+Na
+]. 
2-allyl-2-(4-methylcarboxy)-4-tosylthiomorpholin-3-one (440) Prepared using GP5.  Catalysis was 
performed using ynamide 432 (85.9 mg, 200 µmol, 1.0 eq.), pyridine N-oxide 
(20.9 mg, 220 µmol, 1.1 eq.), AgOTs (2.8 mg, 10.0 µmol, 0.050 eq.) and IPrAuCl 
(6.2 mg, 10.0 µmol, 0.050 eq.) in CH3CN (4 ml) for 15 hours.  Purification by flash 
column chromatography, eluting with 10:1:89 diethyl ether:triethylamine:n-hexane, gave 
thiomorpholinone 440 as a colourless oil (48.1 mg, 54%).  δH (300 MHz, CDCl3) 7.95 (2H, d, J 8.5, ArH), 
7.84 (4H, d, J 8.5, ArH), 7.39 (2H, d, J 8.4, ArH), 7.36 (2H, d, J 8.4), 5.41 (1H, ddt, J 17.2, 10.2, 7.2, 
CH2CHCH2C), 4.91 (1H, dd, J 10.2, 1.7 Hz, CHHCHCH2C), 4.82 (1H, dd, J 17.2, 1.7, CHHCHCH2C), 4.62–
4.48 (1H, m, CHHN), 3.91 (3H, s, CH3), 3.09–2.98 (2H, m, SCH2CH2), 2.98–2.83 (1H, m, CHHN), 2.70 
(1H, dd, J 14.4, 7.2, CHCHHS), 2.60 (1H, dd, J 14.4, 7.2, CHCHHS), 2.48 (3H, s, CH3).  δC (101 MHz, 
CDCl3) 169.0 (CO), 166.4 (CO), 145.1 (C), 144.3 (C), 135.6 (C), 131.5 (CH), 130.2 (CH), 129.9 (C), 129.5 
(CH), 128.5 (CH), 126.2 (CH), 119.4 (CH2), 58.3 (C), 52.2 (CH2), 44.8 (CH2), 43.5 (CH2), 26.8 (CH3), 21.7 
(CH3).  IR (neat): νmax = 3081 (CH), 2953 (CH), 1721 (CO), 1698 (CO), 1640, 1607, 1435, 1407, 1355, 
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1315, 1278, 1167.  HR-MS (ES-TOF+): m/z calcd for C24H22NO5S2Na: 468.0939 found: 468.0933 
[M+Na+]. 
2-allyl-2-(4-fluorophenyl)-4-tosylthiomorpholin-3-one (441) Prepared using GP5.  Catalysis was 
performed using ynamide 433 (70.3 mg, 180 µmol, 1.0 eq.), pyridine N-oxide (18.9 
mg, 199 µmol, 1.1 eq.), AgOTs (2.6 mg, 9.40 µmol, 0.050 eq.) and IPrAuCl (5.80 mg, 
9.4 µmol, 0.050 eq.) in CH3CN (4 ml) for 15 hours.  Purification by flash column 
chromatography, eluting with 10:1:89 diethyl ether:triethylamine:n-hexane, gave thiomorpholinone 
441 as a colourless oil (39.3 mg, 54%).  δH (300 MHz, CDCl3) 7.88 (2H, d, J 8.3, ArH), 7.39 (2H, d, J 8.3, 
ArH), 7.36–7.22 (2 H, m, ArH), 7.00 (2H, t, J 8.6, ArH), 5.44 (1H, ddt, J 17.2, 10.1, 7.2, CH2CHCH2C), 
4.95 (1H, dd, J 10.1, 1.7, CHHCHCH2C), 4.87 (1H, dd, J 17.2, 1.6,  CHHCHCH2C), 4.66–4.49 (1H, m, 
CHHN), 3.18–2.99 (2H, m, SCH2CH2), 2.99-2.88 (1H, m, CHHN), 2.71 (1H, dd, J 14.4, 7.2, CHCHHS), 
2.61 (1H, dd, J 14.4, 7.2, CHCHHS), 2.51 (3H, s, CH3).  δC (101 MHz, CDCl3, CF coupled) 169.5 (CO), 
162.4 (d, J 245, CF), 145.1 (C), 135.8 (C), 135.1 (C, d, J 2.5, CF), 131.9 (CH), 129.5 (CH), 128.6 (CH), 
128.1 (d, J 8.1, CH), 119.35 (CH2), 116.0 (d, J 22.0, CH), 57.78 (C), 45.18 (CH2), 43.70 (CH2), 26.84 
(CH2), 21.83 (CH3).  IR (neat): νmax = 3083 (CH), 2927 (CH), 1698 (CO), 1599, 1505, 1355, 1316, 1168.  
HR-MS (ES-TOF+): m/z calcd for C20H20NO3S2FNa: 428.0766 found: 428.0773 [M+Na
+].  
2-allyl-2-(2-furanyl)-4-tosylthiomorpholin-3-one (442) Prepared using GP5.  Catalysis was performed 
using ynamide 434 (40.0 mg, 110 µmol, 1.0 eq.), pyridine N-oxide (11.4 mg, 120 
µmol, 1.1 eq.), AgOTs (1.5 mg, 5.50 µmol, 0.050 eq.) and IPrAuCl (3.4 mg, 5.50 µmol, 
0.050 eq.) in CH3CN (2 ml) for 15 hours.  Purification by flash column 
chromatography, eluting with 10:1:89 diethyl ether:triethylamine:n-hexane, gave thiomorpholinone 
442 as a colourless oil (31.5 mg, 76%). δH (300 MHz, CDCl3) 7.86 (2H, d, J 8.4, ArH), 7.39–7.28 (3H, m, 
ArH), 6.33 (1H, dd, J 3.3, 0.9, ArH), 6.31 (1H, dd, J 3.3, 1.8, ArH), 5.52 (1H, ddt, J 17.3, 10.6, 7.2, 
CH2CHCH2C), 4.96 (2H, d, J 17.3, CHHCHCH2C), 4.92 (2H, d, J 10.6, CHHCHCH2C), 4.54 (1H, dt, J 14.1, 
5.0, CHHN), 3.62 (1H, dt, J 14.1, 6.9 Hz, CHHN), 3.00 (2H, dd, J 6.9, 5.0, CHCH2S), 2.85 (1H, dd, J 14.3, 
7.2, CHCHHS), 2.69 (1H, dd, J 14.3, 7.2, CHCHHS), 2.45 (3H, s, CH3).  δC (101 MHz, CDCl3) 167.5 (CO), 
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152.4 (C), 145.1 (C), 143.0 (CH), 135.9 (C), 132.0 (CH), 129.5 (CH), 128.7 (CH), 119.3 (CH2), 110.7 (CH), 
109.1 (CH), 52.8 (C), 45.2 (CH2), 42.2 (CH2), 26.8 (CH2), 21.8 (CH3).  IR (Neat): νmax = 3074 (CH), 2925 
(CH), 1701 (CO), 1596, 1495, 1463, 1353, 1315, 1168.  HR-MS (ES-TOF+): m/z calcd for 
C18H19NO4S2Na: 400.0653 found: 400.0656 [M+Na
+].  
2-allyl-4-tosylthiomorpholin-3-one (433) Prepared using GP5 from two starting materials.  From 
ynamide 436 (50.1 mg, 140 µmol, 1.0 eq.) catalysis was performed using pyridine N-
oxide (14.3 mg, 15.0 µmol, 1.1 eq.), AgOTs (2.0 mg, 7.00 µmol, 0.050 eq.) and IPrAuCl 
(4.3 mg, 7.00 µmol, 0.050 eq.) in CH3CN (3 ml) for 16 hours.  Purification by flash column 
chromatography, eluting with 20:1:89 ethyl acetate:triethylamine:n-hexane, gave thiomorpholinone 
433 as a colourless oil (15.4 mg, 29%).  From ynamide 437 (88.6 mg, 300 µmol, 1.0 eq.) catalysis was 
performed using pyridine N-oxide (31.4 mg, 33 µmol, 1.1 eq.), AgOTs (4.1 mg, 15 µmol, 0.050 eq.) 
and IPrAuCl (9.3 mg, 15 µmol, 0.050 eq.) in CH3CN (6 ml) for 17 hours.  Purification by flash column 
chromatography, eluting with 10:1:89 diethyl ether:triethylamine:n-hexane, gave thiomorpholinone 
433 as a colourless oil (17.4 mg, 19%).  δH (400 MHz, CDCl3) 7.90 (2H, d, J 8.3, ArH), 7.33 (2H, d, J 8.3, 
ArH), 5.87–5.63 (1H, m, CH2CHCH2CH), 5.09 (1H, d, J 17.4, CHHCHCH2CH), 5.06 (1H, d, J 9.3, 
CHHCHCH2CH), 4.84 (1H, ddd, J 14.8, 4.7, 3.4, CHHN), 3.84–3.68 (1H, ddd, J 14.8, 11.9, 3.4, CHHN), 
3.58 (1H, dd, J 8.0, 5.5, SCHCO), 3.07 (1H, dt, J 11.9, 3.4, SCHHCH2), 2.96 (1H, td, J 11.9, 4.8, 
SCHHCH2), 2.71 (1H, dt, J 15.5, 8.0, CHCHHSCH), 2.44 (3H, s, CH3), 2.24 (1 H, dt, J 15.5, 8.0, 
CHCHHCH).  δC (101 MHz, CDCl3) 169.0 (CO), 145.19(C), 136.0 (C), 133.9 (CH), 129.7 (CH), 128.6 (CH), 
118.2 (CH2), 44.9 (CH2), 42.3 (CH), 33.2 (CH2), 27.7 (CH2), 21.8 (CH3).  IR (Neat): νmax = 3076 (CH), 2924 
(CH), 2853 (CH), 1703 (CO), 1596, 1494, 1464, 1353, 1314, 1166.  HR-MS (ES-TOF+): m/z calcd for 
C14H17NO3S2Na: 334.0548 found: 334.0561 [M+Na].                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
2-allyl-2-(butyl)-4-tosylthiomorpholin-3-one (445) and N-(2-(allylthio)ethyl)-N-tosylhex-2-enamide 
(446)  Prepared using GP5.  Catalysis was performed using ynamide 435 
(106 mg, 300 µmol, 1.0 eq.), pyridine N-oxide (31.5 mg, 330 µmol, 1.1 
eq.), AgOTs (4.20 mg, 15 µmol, 0.050 eq.) and IPrAuCl (9.30 mg, 15 
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µmol, 0.05 eq.) in acetonitrile (6 ml) for 17 hours.  Purification by flash column chromatography, 
eluting with 15:1:84 diethyl ether:triethylamine:n-hexane, gave 2-allyl-2-(butyl)-4-
tosylthiomorpholin-3-one as a colourless oil (11.0 mg, 10%) and an inseparable 20:3 mixture of E and 
Z N-(2-(allylthio)ethyl)-N-tosylhex-2-enamide (40.6 mg, 40%). 
2-allyl-2-(butyl)-4-tosylthiomorpholin-3-one (445): δH (300 MHz, CDCl3) 7.88 (2H, d, J 8.3, ArH), 7.32 
(2H, d, J 8.3, ArH), 5.63 (1H, ddd, J 17.3, 10.5, 7.3, CH2CHCH2C), 5.02 (2H, d, J 17.3, CHHCHCH2C), 4.97 
(1H, d, J 10.5, CHHCHCH2C), 4.41–4.17 (2H, m, CH2N), 3.04–2.82 (2H, m, SCH2CH2N), 2.61 (1H, dd, J 
14.1, 7.2, CHCHHS), 2.43 (3H, s, ArCH3), 2.38 (1H, dd, J 14.1, 7.2, CHCHHS), 1.84 (1H, ddd, J 13.8, 11.9, 
4.4, CCHHCH2CH2), 1.75–1.51 (1H, m, CCHHCH2CH2), 1.36–0.85 (4H, m, (CH2)2CH3), 0.79 (3H, t, J 7.1, 
CH2CH3).  δC (101 MHz, CDCl3) 171.5 (CO), 145.0 (C), 136.0 (C), 132.4 (CH), 129.4 (CH), 128.9  (CH), 
119.5, (CH2), 50.3 (CH2), 44.2 (CH2), 39.7 (CH2), 29.8 (C), 26.5 (CH2), 25.2 (CH2), 22.9 (CH2), 21.8 (CH3), 
14.0 (CH3).  IR (neat): νmax = 2957 (CH), 2928 (CH), 2860 (CH), 1679 (CO), 1639, 1597, 1465, 1406, 
1356, 1167.  HR-MS (ES-TOF+): m/z calcd for C18H25NO3S2Na: 390.1174 found: 390.1177 [M+Na
+].  (E)-
N-(2-(allylthio)ethyl)-N-tosylhex-2-enamide (446): δH (300 MHz, CDCl3) 7.75 (2H, d, J 8.2, ArH), 7.32 
(2H, d, J 8.2, ArH), 6.95 (1H, dt, J 15.1, 6.9, CHCHCH2), 6.65 (1H, dt, J 15.1, 1.5, COCHCH), 5.80 (1H, 
ddt, J 17.0, 9.9, 7.2, CH2CHCH2S), 5.21 (1H, dd, J 17.0, 1.4, CHHCHCH2S), 5.13 (1H, dd, J 9.9, 1.4, 
CHHCHCH2S), 4.02–3.86 (2H, m, CH2N), 3.19 (2H, d, J 7.2, CHCH2S), 2.82–2.70 (2H, m, SCH2CH2), 2.43 
(3H, s, ArCH3), 2.16 (2H, dtd, J 7.3, 6.9, 1.4, CHCH2CH2), 1.44 (4H, m, CH2), 0.88 (3H, t, J 7.4, CH2CH3).  
δC (101 MHz, CDCl3) 165.7 (CO), 151.2 (CH), 144.8 (C), 136.9 (C), 134.0 (CH), 129.9 (CH), 127.4 (CH), 
121.4  (CH), 117.7 (CH2), 46.1 (CH2), 34.6 (CH2), 29.6 (CH2), 21.6 (CH3), 21.2 (CH2), 13.6 (CH3). (Z)-N-(2-
(allylthio)ethyl)-N-tosylhex-2-enamide (446): δH (300 MHz, CDCl3) 7.70 (2H, d, J 8.4, ArH), 7.26 (2H, d, 
J 8.0, ArH), 6.42 (1H, dt, J 11.6, 1.7, COCHCH), 6.10 (1H, dt, J 11.6, 7.4, CHCHCH2), 5.80 (1H, ddt, J 
17.0, 9.9, 7.2, CH2CHCH2S), 5.21 (1H, dd, J 17.0, 1.4, CHHCHCH2S), 5.13 (1H, dd, J 9.9, 1.4, 
CHHCHCH2S), 3.61 (2H, t, J 7.3, CH2N), 3.32 (2H, d, J 7.0, CHCH2S), 2.79 (2H, t, J 7.3, SCH2CH2), 2.43 
(3H, s, ArCH3), 2.30 (2H, dtd, J 7.4, 7.3, 1.7), 1.37–1.23 (4H, m, CH2), 0.84 (1H, t, J 7.4 CH2CH2). δC (101 
MHz, CDCl3) 165.7 (CO), 149.2 (CH), 144.8 (C), 136.9 (C), 134.0 (CH), 129.6 (CH), 127.4 (CH), 121.0 
(CH), 115.8 (CH2), 45.9 (CH2), 34.6 (CH2), 29.6 (CH2), 21.6  (CH3), 21.2 (CH2), 13.6 (CH3).  IR (neat): νmax 
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= 2960 (CH), 2925 (CH), 2872 (CH), 1681 (CO), 1634 (C=C), 1597, 1507, 1404, 1352, 1158.  HR-MS (ES-
TOF+): m/z calcd for C18H25NO3S2Na: 390.1174 found: 390.1177 [M+Na
+]. 
 S-hexyl-N-tosylcysteamine (447) Hexanethiol (0.56 µl, 3.95 mmol, 1.1 eq.) was cautiously added to a 
stirred suspension of 50% NaH (207 mg, 4.30 mmol, 1.1 eq.) in dry THF (25 ml) 
under argon at 0 °C.  After 35 minutes bromoethanamine 417 was added (1.00 g, 
3.60 mmol, 1.0 eq.).  The reaction was allowed to warm to room temperature over a period of 10 
hours and then added to 10% NaOH solution (50 ml).  The organic fraction was collected and the 
aqueous fraction extracted with CH2Cl2 (2 x 50 ml).  All the organic fractions were combined, dried 
over Na2SO4, filtered and concentrated in vacuo.  The resulting oil was purified by flash column 
chromatography, eluting with 1:3 ethyl acetate:n-hexane, to tosylcysteamine 447 as a colourless oil 
(0.348 g, 30%).  δH (300 MHz, CDCl3) 7.78 (2H, d, J 8.1, ArH), 7.33 (2H, d, J 8.1, ArH), 4.93 (1H, t, J 6.3, 
NH), 3.13 (2H, q, 6.3, CH2N), 2.60 (2H, t, J 6.3, SCH2CH2N), 2.45 (3H, s, ArCH3), 2.36 (2H, t, J 7.4, 
SCH2CH2CH2), 1.55-1.39 (2H, qn, J 7.4, SCH2CH2CH2), 1.39-1.15 (6H, m, (CH2)3CH3), 0.90 (3H, t, J 6.9, 
CH3).  δC (101 MHz, CDCl3) 143.7 (C), 137.1 (C), 129.9 (CH), 127.3 (CH), 41.8 (CH2), 31.9 (CH2), 31.7 
(CH2), 31.5 (CH2), 29.7 (CH2), 28.6 (CH2), 22.7 (CH2), 21.7 (CH3), 14.14 (CH3).  IR (neat): νmax = 3285 
(NH), 2958 (CH), 2924 (CH), 2855 (CH), 1599, 1495, 1408, 1326, 1157.  HR-MS (ES-TOF+): m/z calcd 
for C15H25NO2S2Na: 338.1224 found: 390.1212 [M+Na
+]. 
2,2-dibromovinylbenzene Prepared using GP6, with benzaldehyde (0.54 ml, 5.00 mmol, 1 eq.), CBr4 
(3.316 g, 10.0 mmol, 2 eq.) and PPh3 (5.246 g, 20.0 mmol, 4 eq.) in dry CH2Cl2 (50 ml).  
Purification by flash column chromatography, eluting with n-hexane, gave the 
bromoalkene as a yellow oil (1.144 g, 82%).  δH (300 MHz, CDCl3) 7.57–7.50 (2H, m, ArH), 7.49 (1H, s, 
CHCBr2), 7.42-7.32 (2H, m, ArH).  MS (EI+): m/z 259.9 (100) [M
+•], 181 (18), 102.0 (47).  Data in 
agreement with literature values.218 
 S-hexyl-N-phenylethynyl-N-tosylcysteamine (448) Prepared using GP4.  Alkynylation was performed 
with tosylcysteamine 447 (348 mg, 1.10 mmol, 1.0 eq.), 2,2-
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dibromovinylbenzene (0.32 ml, 2.20 mmol, 2.0 eq.), N,N-dimethylethylenediamine (43 µl, 400 µmol, 
0.36 eq.), CuI (84.7 mg, 260 µmol, 0.24 eq.) and Cs2CO3 (838 mg, 4.40 mmol, 4.0 eq.) in DMF (8 ml) 
for 17 hours.  The DMF was removed by diluting the reaction mixture with diethyl ether (20 ml) and 
washing with water (5 x 15 ml).  Purification by flash column chromatography, eluting with 1:19 ethyl 
acetate:n-hexane, gave ynamide 448 as a colourless oil (0.202 mg, 44%).  δH (300 MHz, CDCl3) 7.85 
(2H, d, J 8.3, ArH), 7.41-7.32 (4H, m, ArH), 7.32- 7.27 (3H, m, ArH), 3.64-3.52 (2H, m, CH2N), 2.85-2.75 
(2H, m, SCH2CH2N), 2.58-2.49 (2H, t, J 7.3, SCH2CH2CH2), 2.46 (3H, s, PhCH3), 1.64-1.49 (2H, qn, J 7.3, 
SCH2CH2CH2), 1.42-1.17 (6H, m, CH2CH2CH2), 0.88 (3H, t, J 6.8, CH2CH3).  δC (101 MHz, CDCl3) 144.9 
(C), 134.8 (C), 131.6 (CH), 123.0 (CH), 128.4 (CH), 128.1 (CH), 127.9 (CH), 122.8 (C), 82.1 (C), 71.2 (C), 
51.8 (CH2), 32.4 (CH2), 31.6 (CH2), 30.0 (CH2), 29.8 (CH2), 28.6 (CH2), 22.7 (CH2), 21.8 (CH3), 14.2 (CH3).  
IR (Neat): νmax = 3062 (CH), 2958 (CH), 2928 (CH), 2862 (CH), 2236 (C≡C), 1686 (CO), 1598 (C=C), 1443, 
1367, 1169.  HR-MS (ES-TOF+): m/z calcd for C23H29NO2S2Na: 438.1537 found: 438.1545 [M+Na
+]. 
S-benzyl-N-tosylcysteamine (456) Prepared using GP2.  Benzylation was performed using cysteamine 
hydrochloride (1.00 g, 8.80 mmol, 1.00 eq.) and benzyl bromide (1.05 ml, 8.90 
mmol, 1.05 eq.) in ethanol (30 ml) and LiOH (443 mg, 18.5 mmol, 2.10) in water (10 
ml) for 23 hours.  N-protection was performed with tosyl chloride (1.70 g, 8.90 mmol, 1.05 eq.) and 
triethylamine (2.15 ml, 29.3 mmol, 3.30 eq.) for 16 hours.   Purification by flash column 
chromatography, eluting with 1:4 ethyl acetate:n-hexane, gave tosylcysteamine 456 as a colourless 
oil (2.16 g, 77% over 2 steps).  δH (300 MHz, CDCl3) 7.74 (2H, d, J 8.5, ArH), 7.33 (2H, d, J 8.5, ArH), 
7.30–7.18 (5H, m, ArH), 4.80 (1H, t, J 6.2, NH), 3.59 (2H, s, CCH2S), 3.06 (2H, q, J 6.2, CH2NH), 2.51 
(2H, t, J 6.2, SCH2CH2), 2.45 (3H, s, CH3). δC (101 MHz, CDCl3) 143.7 (C), 137.8 (C), 137.1 (C), 129.9 
(CH), 128.9 (CH), 128.8 (CH), 127.5 (CH), 127.3 (CH), 41.7 (CH2), 35.8 (CH2), 31.2 (CH2), 21.7 (CH3).  IR 
(neat): νmax = 3280br (NH), 3067 (CH), 3030 (CH), 2924 (CH), 1599 (C=C), 1495, 1453, 1324, 1157. HR-
MS (ES-TOF+): m/z calcd for C16H19NO2S2Na: 344.0757 found: 344.0755 [M+Na
+].  
 S-p-methoxybenzyl-N-tosylcysteamine (457) Prepared using GP2.  Benzylation was performed using 
cysteamine hydrochloride (0.500 g, 4.40 mmol, 1.00 eq.), para-
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methoxybenzyl bromide (0.61 ml, 4.40 mmol, 1.00 eq.), LiOH (221 mg, 9.40 mmol, 2.10 eq.) in 
ethanol (15 ml) and water (9 ml) for 2 hours.  N-protection was performed with tosyl chloride (847 
mg, 4.40 mmol, 1.00 eq.) and triethylamine (1.07 ml, 7.70 mmol, 1.75 eq.) for 21 hours.   Purification 
by flash column chromatography, eluting with 1:4 ethyl acetate:n-hexane, gave tosylcysteamine 457 
as a yellow oil (0.160 g, 10% over 2 steps).  δH (300 MHz, CDCl3) 7.72 (2H, d, J 8.2, ArH), 7.31 (2H, d, J 
8.2, ArH), 7.13 (2H, d, J 8.7, ArH), 6.81 (2H, d, J 8.7, ArH), 4.79 (2H, t, J 6.3, NH), 3.79 (3H, s, CH3O), 
3.53 (3H, s, PhCH2S), 3.03 (2H, q, J 6.3, CH2N), 2.48 (2H, t, J 6.3, SCH2CH2), 2.43 (3H, s, CH3).  δC (101 
MHz, CDCl3) 159.0 (C), 143.7 (C), 137.1 (C), 123.0 (CH), 129.9 (CH), 129.6 (C), 127.2 (CH), 114.2 (CH), 
55.4 (CH2), 41.7 (CH2), 35.2 (CH2), 31.1 (CH3), 21.7 (CH3).  IR (neat): νmax = 3288br (NH), 2922 (CH), 
2951 (CH), 1610 (C=C), 1584 (C=C), 1511, 1441, 1324, 1157, 1093. HR-MS (ES-TOF+): m/z calcd for 
C17H21NO3S2Na: 374.0861 found: 374.0865 [M+Na
+]. 
 S-p-trifluoromethylbenzyl-N-tosylcysteamine (458) Prepared using GP2.  Benzylation was 
performed using cysteamine hydrochloride (0.500 g, 4.40 mmol, 1.00 eq.), 
para-trifluoromethylbenzyl bromide (1.052 g, 4.40 mmol, 1.00 eq.) and LiOH 
(221 mg, 9.40 mmol, 2.10 eq.), in ethanol (15 ml) and water (9 ml) for 2 hours.  N-protection was 
performed with tosyl chloride (847 mg, 4.4 mmol, 1.00 eq.) and triethylamine (1.07 ml, 7.7 mmol, 
1.75 eq.) for 21 hours.   Purification by flash column chromatography, eluting with 1:4 ethyl 
acetate:n-hexane, gave tosylcysteamine 458 as colourless crystals (1.162 g, 68% over 2 steps), m.p 
87-88 °C from CH2Cl2.  δH (300 MHz, CDCl3) 7.72 (2H, d, J 8.3, ArH), 7.55 (2H, d, J 8.3, ArH), 7.35 (2H, d, 
J 8.1, ArH), 7.31 (2H, d, J 8.1, ArH), 4.80 (1H, t, J 6.5, NH), 3.64 (2H, s, PhCH2S), 3.06 (2H, q, J 6.5, 
CH2N), 2.50 (2H, t, J 6.5, SCH2CH2), 2.43 (3H, s, CH3).  δC (101 MHz, CDCl3, CF coupled) 143.8 (C), 142.0 
(C), 137.1 (C), 129.9 (CH), 192.3 (C), 129.2 (CH), 127.2 (CH), 125.8 (CH), 125.7 (CH), 124.0 (1C, q, J 242, 
CF3) 41.8 (CH2), 35.5 (CH2), 31.4 (CH2), 21.7 (CH3). IR (Neat): νmax = 3280br (NH), 3067 (CH), 3030 (CH), 
2924 (CH), 1599 (C=C), 1495, 1453, 1324 (SO2NHR), 1157 (SO2NHR). HR-MS (ES-TOF+): m/z calcd for 
C16H19NO2S2Na: 344.0757 found: 344.0755 [M+Na
+]. 
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S-benzyl-N-phenylethynyl-N-tosylcysteamine (459) Prepared using GP3.  Alkynylation was 
performed with tosylcysteamine 456 (500.0 mg, 1.56 mmol, 1.0 eq.), crude 
bromophenyl acetylene (0.20 ml, ca. 1.70 mmol, 1.1 eq.), 1,10-
phenanthroline (50.4 mg, 280 µmol, 0.18 eq.), CuSO4.5H2O (46.7 mg, 187 µmol, 0.12 eq.) and K2CO3 
(431.2 mg, 3.12 mmol, 2.0 eq.) in toluene (3 ml) for 20 hours.  Purification by flash column 
chromatography, eluting with 1:9 ethyl acetate:n-hexane, gave ynamide 459 as a yellow oil (492.9 
mg, 75%).  δH (300 MHz, CDCl3) 7.80 (2H, d, J 8.3 Hz, ArH), 7.41–7.29 (12H, m, ArH), 3.74 (2H, s, 
PhCH2S), 3.64–3.44 (2H, m, CH2N), 2.82–2.63 (2H, m, SCH2CH2), 2.47 (3H, s, CH3).  δC (101 MHz, CDCl3) 
144.9 (C), 138.2 (C), 134.8 (C), 131.6 (CH), 129.9 (CH), 129.1 (CH), 128.8 (CH), 128.4 (CH), 128.1 (CH), 
127.8 (CH), 127.3 (CH), 122.8 (C), 82.1 (C), 71.2 (C), 51.4 (CH2), 36.3 (CH2), 29.0 (CH2), 21.8 (CH3).  IR 
(Neat):  3062 (CH), 2923 (CH), 2237 (C≡C), 1598w, 1496, 1456, 1366, 1171.  HR-MS (ES-TOF+): m/z 
calcd for 441.1068 C24H23NO2S2Na: 441.1078 found: [M+Na
+]. 
 S-p-methoxybenzyl-N-phenylethynyl-N-tosylcysteamine (460) Prepared using GP3.  Alkynylation 
was performed with tosylcysteamine 457 (102 mg, 290 µmol, 1.0 
eq.), crude bromophenyl acetylene (38.4 µl, ca. 320 µmol, 1.1 eq.), 
1,10-phenanthroline (9.4 mg, 52.0 µmol, 0.18 eq.), CuSO4.5H2O (8.7 mg, 35.0 µmol, 0.12 eq.) and 
K2CO3 (80.2 mg, 580 µmol, 2.0 eq.) in toluene (2 ml) for 16 hours.  Purification by flash column 
chromatography, eluting with 1:9 ethyl acetate to n-hexane, gave ynamide 460 as a colourless oil 
(57.4 mg, 77%). δH (300 MHz, CDCl3) 7.82 (2H, d, J 8.3, ArH), 7.44-7.31 (7H, m, ArH), 7.26 (2H, d, J 8.6, 
ArH), 6.84 (2H, d, J 8.6, ArH), 3.79 (3H, s, CH3O), 3.71 (2H, s, PhCH2S), 3.61-3.46 (2H, m, CH2N), 2.77-
2.64 (2H, m, SCH2CH2), 2.48 (3H, s, CH3).  δC (101 MHz, CDCl3) 158.9 (C), 144.9 (C), 134.7 (C), 131.6 
(CH), 130.1 (CH), 129.9 (CH), 129.9 (C), 128.4 (CH), 128.1 (CH), 127.8 (CH), 122.7 (C), 114.1 (CH), 82.1 
(C), 71.1 (C), 55.3 (CH2), 51.4 (CH2), 35.6 (CH2), 28.8 (CH3), 21.8 (CH3).  IR (neat):  3059 (CH), 2925 (CH), 
2235 (C≡C), 1617w (C=C), 1598w (C=C), 1494, 1443, 1366, 1324, 1168, 1121.  HR-MS (ES-TOF+): m/z 
calcd for 474.1174 C25H25NO3S2Na: 474.1181 found: 474.1174 [M+Na
+]. 
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S-p-trifluoromethylbenzyl-N-phenylethynyl-N-tosylcysteamine (461) Prepared using GP3.  
Alkynylation was performed with tosylcysteamine 458 (200 mg, 510 
µmol, 1.0 eq.), crude bromophenyl acetylene (68.4 µl, ca. 570 µmol, 
1.1 eq.), 1,10-penanthroline (16.6 mg, 92.0 µmol, 0.18 eq.), CuSO4.5H2O (15.2 mg, 61.0 µmol, 0.12 
eq.) and K2CO3 (141 mg, 1.0 mmol, 2.0 eq.) in toluene (2 ml) for 16 hours.  Purification by flash 
column chromatography, eluting with 1:9 ethyl acetate:n-hexane, gave ynamide 461 as a colourless 
oil (20. mg, 81%). δH (300 MHz, CDCl3) 7.80 (2H, d, J 8.3, ArH), 7.55 (2H, d, J 8.3, ArH), 7.46 (2H, d, J 
8.1, ArH), 7.40-7.31 (7H, m, ArH), 3.79 (2H, s, PhCH2S), 3.63-3.46 (2H, m, CH2N), 2.80-2.61 (2H, m, 
SCH2CH2), 2.47 (3H, s, CH3).  δC (101 MHz, CDCl3, CF coupled) 145.0 (C), 142.3 (C), 134.7 (C), 131.6 
(CH), 123.0 (CH), 129.7 (C), 129.4 (CH), 128.5 (CH), 128.2 (CH), 127.8  (CH), 125.7 (CH), 125.7 (CH), 
124.0 (q, J 275, CF3), 122.6 (C), 82.0 (C), 71.3 (C), 51.4 (CH2), 35.8 (CH2), 29.2 (CH2), 21.8 (CH3).  IR 
(Neat):  3069 (CH), 2925 (CH), 2235 (C≡C), 1617w (C=C), 1598w (C=C), 1494, 1443, 1366, 1324, 1167, 
1119.  HR-MS (ES-TOF+): m/z calcd for C25H22NO2S2F3Na: 512.0942 found: 512.0943[M+Na
+]. 
 S-benzyl-N-phenylethynyl-N-tosylcysteamine S-oxide (462) MoO2Cl2 (1.8 mg, 8.90 µg, 0.0150 eq.) 
was added to a solution of tosylcysteamine 459 (250 mg, 590 µmol, 1.00 
eq.) in a water (7.5 ml) and acetone (11.5 ml) mixture.  This was 
immediately followed by 33% H2O2 solution (58 µl, 620 µmol, 1.05 eq.) and the reaction was stirred 
for 0.5 hours.  The reaction was quenched with NaHCO3 carbonate solution (10 ml) and extracted 
with CH2Cl2 (4 x 20 ml).  The organic fractions were combined, dried over Na2SO4, filtered and 
concentrated in vacuo.  Purification by flash column chromatography, eluting with 3:1 ethyl 
acetate:n-hexane, gave ynamide 462 as a colourless oil (92.2 mg, 36%).  δH (300 MHz, CDCl3) 7.83 
(2H, d, J 8.3, ArH), 7.61 (2H, d, J 8.3, ArH), 7.43 (2H, d, J 8.1, ArH), 7.37 (2H, d, J 8.1, ArH), 7.30 (6H, d, 
J 7.3, ArH), 4.14 (1H, d, J 13.0, PhCHHS), 4.04 (1H, d, J 13.0, PhCHHS), 3.97-3.71 (2H, m, CH2N), 3.08 
(1H, dt, J 13.4, 7.5, SCHHCH2), 2.99-2.83 (1H, m, SCHHCH2), 2.46 (3H, s, CH3).  IR (neat):  3059 (CH), 
2926 (CH), 2236 (C≡C), 1619w (C=C), 1598w (C=C), 1494, 1444, 1365, 1324, 1168, 1122, 1067.  HR-MS 
(ES-TOF+): m/z calcd for C25H22NO2S2F3Na: 460.1017 found: 460.1008 [M+Na
+]. 
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2-benzyl-2-phenyl-4-tosylthiomorpholin-3-one (463) Prepared using GP5.  Catalysis was performed 
using ynamide 459 (200.0 mg, 474 µmol, 1.0 eq.), pyridine N-oxide (496 mg, 522 
µmol, 1.1 eq.), AgOTs (6.6 mg, 24.0 µmol, 0.050 eq.) and IPrAuCl (14.7 mg, 24.0 
µmol, 0.050 eq.) in CH2Cl2 (8 ml) for 21 hours.  Purification by flash column chromatography, eluting 
with 10:1:89 diethyl ether:triethylamine:n-hexane, gave thiomorpholinone 463 as a colourless oil 
(112.4 mg, 54%).  δH (300 MHz, CDCl3) 7.89 (2H, d, J 8.4, ArH), 7.40 (2H, d, J 8.0, ArH), 7.350–7.19 (4H, 
m, ArH), 7.14 (2H, dd, J 8.0, 1.5, ArH), 7.05 (2H, t, J 7.3, ArH), 6.58 (2H, d, J 7.0, ArH), 4.66–4.45 (1H, 
m, CHHN), 3.32 (1H, d, J 14.0, PhCHH), 3.25 (1H, d, J 14.0, PhCHH), 3.09 – 2.92 (2H, m, SCH2CH2N), 
2.93–2.78 (1 H, m, CHHN), 2.53 (3H, s, CH3).  δC (101 MHz, CDCl3) 167.0 (CO), 145.0 (C), 138.4 (C), 
136.0 (C), 135.0 (C), 131.1 (CH), 129.6 (CH), 128.9 (CH), 128.7 (CH), 128.2 (CH), 127.5 (CH), 126.9 (CH), 
126.7 (CH), 59.6 (C), 46.2 (CH2), 43.4 (CH2), 26.9 (CH2), 21.9 (CH3).  IR (neat): νmax = 3031 (CH), 2930 
(CH), 1698 (CO), 1596, 1495, 1454, 1356, 1317, 1168.  HR-MS (ES-TOF+): m/z calcd for 
C24H23NO3S2Na: 460.1017 found: 460.1032 [M+Na
+]. 
(S)-S-(3-methyl-2-(4-methylphenylsulfonamido)butyl) ethanethioate (469) Prepared via a modified 
literature procedure.219  A solution of NaH (2M, 57.5 ml, 115 mmol, 2.70 eq.) was 
added over 3 hours via dropping funnel to a stirred solution of tosyl chloride (10.58 
g, 55.5 mmol, 1.30 eq.) and L-valine (5.00 g, 42.6 mmol, 1.00 eq.) in an ethyl acetate (92 ml) and 
water (16 ml) mix.  After another hour the aqueous phase was separated and 1M HCl solution was 
added to it.  The resulting white precipitate was collected by suction filtration and dried in vacuo to 
give the crude N-tosyl valine 467.  The crude tosylate (7.015 g, ca. 25.9 mmol, 0.600 eq.) was 
dissolved in dry THF (150 ml), the resulting solution was cooled to 0 °C and LiAlH4 (2.944 g, 77.6 
mmol, 1.80 eq.) was cautiously added.  The reaction was allowed to reach room temperature over 
0.5 hours and then heated to reflux for 15 hours.  The reaction mixture was then quenched with 
ethyl acetate (150 ml) and sodium potassium tartrate solution (250 ml) was added.  The resulting 
mixture was extracted with ethyl acetate (3 x 100 ml); the organic fractions were combined, dried 
over Na2SO4, filtered and concentrated in vacuo to give the crude amino alcohol 468.  Diisopropyl 
azodicarboxylate (9.280 g, 45.9 mmol, 1.06 eq.) was added to a 0 °C solution of PPh3 (12.039 g, 45.9 
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mmol, 1.06 eq.) in dry THF (100 ml) and stirred for 0.5 hours.  The crude amino alcohol (5.905, ca. 
22.9 mmol, 0.530 eq.) was then added, followed immediately by thioacetic acid (3.23 ml, 45.9 mmol, 
1.06 eq.) and allowed to reach room temperature over 16 hours.  The reaction mixture was 
concentrated in vacuo, n-hexane was added and the precipitated phosphine and phosphate removed 
by suction filtration.  Purification by flash column chromatography, eluting with 1:4 ethyl acetate:n-
hexane, gave ethanethioate 469 as a colourless solid (0.777 g, 6% over 3 steps. Melting point 94-95 
°C from CH2Cl2 (Lit.
220 99-101 °C).  [α]D
21 –10.45 (c 0.011 in CHCl3).  δH (300 MHz, CDCl3) 7.73 (2H, d, J 
8.2, ArH), 7.29 (2H, d, J 8.2, ArH), 4.60 (1H, d, J 8.2, NH), 3.27 (1 H, tt, J 8.2, 5.0, NCHCH2), 2.93 (1H, 
dd, J 14.2, 8.2, CHCHH), 2.82 (1H, dd, J 14.2, 5.0, CHCHH), 2.43 (3H, s, CH3), 2.20 (3H, s, CH3), 1.87 (1H, 
qnd, J 6.8, 5.0, CH3CHCH3), 0.88 (3H, d, J 6.8, CHCH3), 0.86 (3H, d, J 6.8, CHCH3).  IR (neat): νmax = 3307 
(CH), 2973 (CH), 2933 (CH), 2878 (CH), 1665 (CO), 1500 (C=C), 1430, 1399, 1161, 1051.  Data in 
agreement with literature values.220  
 (S)-S-(2-(4-methylphenylsulfonamido)propyl) ethanethioate (475)  Prepared via a modified 
literature procedure.221  L-alaninol (1.000 g, 13.3 mmol, 1.0 eq.) was added to a 
stirred 0 °C solution of tosyl chloride (5.586 g, 29.3 mmol, 2.2 eq.) and pyridine (7.5 
ml, 93.0 mmol, 7 eq.) in dry CH2Cl2 (10 ml) under argon.  The reaction mixture was allowed to reach 
room temperature over 18 hours, added to 1 M HCl solution (20 ml) and extracted with CH2Cl2 (3 x 20 
ml).  The organic fractions were combined, washed with CuSO4 solution (20 ml) and then brine (20 
ml).  The organic fraction was dried over Na2SO4, filtered and concentrated in vacuo.  The resulting oil 
was dissolved in acetone (150 ml) and potassium thioacetate (6.076 g, 53.2 mmol, 4.0 eq.) was added 
with stirring.  After 20 hours ethyl acetate was added (100 ml), followed by silica gel, then the 
mixture was concentrated in vacuo to give a dry, free-flowing powder.  Purification by flash column 
chromatography, eluting with 1:3 ethyl acetate:n-hexane, gave ethanethioate 475 as blood red 
crystals (2.913 g, 76% over two steps). Melting point 58-60 °C from CH2Cl2.  [α]D
21 -19.33 (c 0.015 in 
CHCl3).   δH (300 MHz, CDCl3) 7.77 (2H, d, J 8.2, ArH), 7.32 (2H, d, J 8.0, ArH), 4.63 (1H, brd, J 7.2, NH), 
3.55 (1H, m, CH), 2.93 (2H, qd, J 14.1, 5.9), 2.45 (3H, s, ArCH3), 2.29 (3H, s, COCH3), 1.16 (3H, d, J 6.6, 
CHCH3).  δC (101 MHz, CDCl3) 195.9 (C), 143.5 (C), 138.1 (C), 129.8 (CH), 127.3 (CH), 50.1 (CH), 35.5 
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(CH2), 30.6  (CH3), 21.7 (CH3), 21.4 (CH3).  IR (neat):  3273 (NH), 2975 (CH), 2931 (CH), 2874 (CH), 1682 
(CO), 1599, 1439, 1420, 1325, 1152, 1140.  HR-MS (ES-TOF+): m/z calcd for C12H17NO3S2Na: 310.0548 
found: 310.0534 [M+Na+]. 
(S)-S-(2-(4-methylphenylsulfonamido)-3-phenylpropyl) ethanethioate (476) 
Prepared via a modified literature procedure.221  L-phenylalaninol (2.000 g, 13.2 
mmol, 1.0 eq.) was added to a stirred 0 °C solution of tosyl chloride (5.537 g, 29.0 
mmol, 2.2 eq.) and pyridine (7.5 ml, 92.0 mmol, 7.0 eq.) in dry CH2Cl2 (15 ml) under argon.  The 
reaction mixture was allowed to reach room temperature over 18 hours, added to 1 M HCl solution 
(20 ml) and extracted with CH2Cl2 (3 x 20 ml).  The organic fractions were combined, washed with 
CuSO4 solution (20 ml) and then brine (20 ml).  The organic fraction was dried over Na2SO4, filtered 
and concentrated in vacuo.  The resulting oil was dissolved in acetone (150 ml) and potassium 
thioacetate (6.030 g, 52.8 mmol, 4.0 eq.) was added with stirring.  After 20 hours ethyl acetate was 
added (100 ml), followed by silica gel, then the mixture was concentrated in vacuo to give a dry, free-
flowing powder.  Purification by flash column chromatography, eluting with 1:3 ethyl acetate:n-
hexane, gave ethanethioate  476 as blood red crystals (1.043 g, 22% over two steps).  Melting point 
84-87 °C from CH2Cl2.  [α]D
21 –9.19 (c 0.011 in CHCl3).   δH (300 MHz, CDCl3) 7.61 (2H, d, J 8.3, ArH), 
7.22 (5H, m, ArH), 7.04 (2H, dd, J 7.0, 2.4, ArH), 4.69 (1H, d, J 7.1, NH), 3.59 (1H, m, CH), 2.95 (1H, dd, 
J 14.2, 6.6, CHCHH), 2.89 (1H, dd, J 14.3, 5.5, CHCHH), 2.86 (1H, dd, J 14.1, 6.4, CHCHH), 2.79 (1H, dd, 
J 14.1, 7.4, CHCHH), 2.31 (3H, s, CH3), 2.26 (3H, s, CH3). δC (101 MHz, CDCl3) 196.1 (CO), 143.4 (C), 
137.5 (C), 136.5 (C), 129.7 (CH), 129.5 (CH), 128.9 (CH), 127.2 (CH), 127.1 (CH), 55.3 (CH), 41.2 (CH2), 
33.2 (CH2), 30.6 (CH3), 21.7 (CH3). IR (neat):  3307 (NH), 3030 (CH), 2926 (CH), 1660 (CO), 1598 (C=C), 
1496, 1434, 1399, 1152, 1320, 1157.  HR-MS (ES-TOF+): m/z calcd for C18H21NO3S2Na: 386.0861 
found: 386.0846 [M+Na+]. 
(S)-N-(1-(allylthio)propan-2-yl)-4-methyl-N-(phenylethynyl)benzenesulfonamide (477) 
K2CO3 (480.9 mg, 3.48 mmol, 2.0 eq.) was added to a stirred solution of 
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ethanethioate 475 (500.0 mg, 1.74 mmol, 1.0 eq.) in CH3OH (10 ml), followed by allyl bromide (150 
µl, 1.74 mmol, 1.0 eq.).  After 17 hours the reaction mixture was added to NH4Cl solution (20 ml) and 
then extracted with CH2Cl2 (3 x 30 ml).  The organic fractions were combined, dried over Na2SO4, 
filtered and concentrated in vacuo.  A portion of the resulting white crystals (407.1 mg, 1.06 mmol, 
0.60 eq) was dissolved in dry toluene (1 ml) and alkynylated with crude bromophenyl acetylene (0.25 
ml, ca. 2.11 mmol, 1.2 eq.), 1,10-penanthroline (34.2 mg, 190 µmol, 0.11 eq.), CuSO4.5H2O (32.5 mg, 
130 µmol, 0.075 eq.) and K2CO3 (291.6 mg, 2.11 mmol, 1.2 eq.) for 20 hours.  Purification by flash 
column chromatography, eluting with 1:9 ethyl acetate:n-hexane, gave ynamide 477 as a yellow oil 
(58.0 mg, 14%).  [α]D
21
 +85.31 (c 0.011 in CHCl3).  δH (300 MHz, CDCl3) 7.86 (2H, d, J 8.3, ArH), 7.51–
7.16 (7H, m, ArH), 5.74 (1H, ddt, J 17.1, 10.0, 7.2, CH2CHCH2S), 5.12 (2H, d, J 17.1, CHHCHCH2S), 5.11 
(1H, d, J 10.0, CHHCHCH2S), 4.29–4.07 (1H, m, CHCH3), 3.11 (2H, d, J 7.2, CHCH2S), 2.69 (1H, dd, J 
13.9, 7.0, SCHHCH), 2.55 (1H, dd, J 13.9, 7.4, SCHHCH), 2.45 (3H, s, ArCH3), 1.24 (3H, d, J 6.6, CHCH3).  
δC (101 MHz, CDCl3) 144.7 (C), 135.9 (C), 134.1 (CH), 131.4 (CH), 129.8 (CH), 128.4 (CH), 127.9 (CH), 
127.8 (CH), 123.1 (C), 117.7 (CH2), 79.2 (C), 73.5 (C), 56.2 (CH), 35.4 (CH2), 35.1 (CH2), 21.8  (CH3), 18.3 
(CH3).  IR (neat):  3065 (CH), 2979 (CH), 2923 (CH), 2237 (C≡C), 1598w, 1363, 1171.  HR-MS (ES-TOF+): 
m/z calcd for 408.1068 C21H23NO2S2Na: 408.1072 found: [M+Na
+]. 
(S)-N-(1-(allylthio)-3-phenylpropan-2-yl)-4-methyl-N-(phenylethynyl)benzenesulfonamide (478) 
K2CO3 (380 mg, 2.75 mmol, 2.0 eq.) was added to a stirred solution of 
ethanethioate 476 (500.0 mg, 1.38 mmol, 1.0 eq.) in methanol (10 ml), 
followed by allyl bromide (120 µl, 1.74 mmol, 1.0 eq.).  After 17 hours the reaction mixture was 
added to NH4Cl solution (20 ml) and then extracted with CH2Cl2 (3 x 30 ml).  The organic fractions 
were combined, dried over Na2SO4, filtered and concentrated in vacuo.  A portion of the resulting 
white crystals (392.2 mg, 850 µmol, 0.61 eq.) was dissolved in dry toluene (1 ml) and alkynylated 
with crude bromophenyl acetylene (0.20 ml, ca. 1.70 mmol, 1.2 eq.), 1,10-phenanthroline (27.0 mg, 
150 µmol, 0.10 eq.), CuSO4.5H2O (25.5 mg, 102 µmol, 0.074 eq.) and K2CO3 (235.0 mg, 1.70 mmol, 1.2 
eq.) for 20 hours.  Purification by flash column chromatography, eluting with 1:9 ethyl acetate:n-
hexane, gave ynamide 478 as a yellow oil (58.0 mg, 14%).  [α]D
20
 -9.10 (c 0.022 in CHCl3).   δH (300 
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MHz, CDCl3) 7.53 (2H, d, J 8.3, ArH), 7.45-7.42 (1H, m, ArH), 7.40 (1H, dd, J 5.1, 2.3, ArH), 7.35-7.33 
(2H, m, ArH), 7.33-7.30 (1H, m, ArH), 7.24-7.11 (7H, m, ArH), 5.75 (1 H, ddt, J 17.2, 9.0, 6.8, 
CH2CHCH2S), 5.07 (1 H, d, J 9.0, CHHCHCH2S), 5.06 (2 H, d, J 17.2, CHHCHCH2S), 4.43-4.29 (1H, m, 
NCHCH2), 3.16 (2H, d, J 6.8, SCH2CHCH2), 3.09 (1H, dd, J 13.9, 5.5, CHCHH), 2.91 (1H, dd, J 13.9, 8.8, 
CHCHH), 2.82 (1H, dd, J 14.1, 7.4, CHCHH), 2.74 (1H, dd, J 14.2, 6.6, CHCHH), 2.41 (3H, s, CH3).  δC 
(101 MHz, CDCl3) 144.2 (C), 137.5 (C), 135.3 (C), 134.0 (C), 131.4 (CH), 129.5 (CH), 129.4 (CH), 128.6 
(CH), 128.4 (CH), 127.9 (CH), 127.7 (CH), 126.7 (CH), 123.0 (CH), 117.7 (CH2), 79.4 (C), 74.3 (C), 62.5 
(CH), 38.7 (CH2), 35.1 (CH2), 33.9 (CH2), 21.7 (CH3).  IR (neat):  3035 (CH), 2919 (CH), 2230 (C≡C), 
1598w, 1496, 1363, 1168.  HR-MS (ES-TOF+): m/z calcd for 484.1381 C27H27NO2S2Na: 484.1386 found: 
[M+Na+]. 
(S)-N-(1-(allylthio)propan-2-yl)-2-oxo-2-phenyl-N-tosylacetamide (481) Prepared using GP5.  
Catalysis was performed using ynamide 477 (42.4 mg, 110 µmol, 1.0 eq.), 
pyridine N-oxide (11.4 mg, 120 µmol, 1.1 eq.), AgOTs (1.4 mg, 5 µmol, 0.050 
eq.) and IPrAuCl (3.1 mg, 5. µmol, 0.050 eq.) in CH3CN (2 ml) for 16 hours.  Purification by flash 
column chromatography, eluting with 20:1:79 diethyl ether:triethylamine:n-hexane, gave 
tosylacetamide  481 as a colourless oil (20.3 mg, 81%).  [α]D
21 +5.50 (c 0.011 in CHCl3).δH (300 MHz, 
CDCl3) 8.00 (2H, d, J 7.4, ArH), 7.95 (2H, d, J 8.3, ArH), 7.64 (1H, t, J 7.4, ArH), 7.53 (2H, t, J 7.4, ArH), 
7.41 (2H, d, J 8.3, ArH), 5.73 (1H, ddd, J 17.0, 10.1, 7.2 CH2CHCH2), 5.09 (1H, d, J 17.0, CHHCHCH2S), 
5.06 (1H, d, J 10.1, CHHCHCH2S), 4.18–3.99 (1H, m, CH2CHCH3), 3.03 (2H, t, J 6.8, CHCH2S), 2.48 (3H, s, 
J 7.2, ArCH3), 1.42 (3H, d, J 6.3, CHCH3).  δC (101 MHz, CDCl3) 187.2 (CO), 168.5 (CO), 146.3 (C), 134.9 
(C), 134.7 (CH), 134.4 (CH), 133.3 (C), 130.6 (CH), 130.4 (CH), 129.3 (CH), 129.1 (CH), 118.0 (CH2), 35.3 
(CH2), 34.5 (CH2), 30.2 (CH), 22.2 (CH3), 17.3 (CH3).  IR (neat): νmax = 3065 (CH), 2923 (CH), 1677 (CO), 
1597 (C=C), 1451, 1367, 1205, 1167.  HR-MS (ES-TOF+): m/z calcd for C21H23NO4S2Na: 440.966 found: 
440.0970 [M+Na+]. 
 S-benzyl tosylthiocarbamate (488) Benzyl thiol (0.60 ml, 5.12 mmol, 1.01 eq.) was added to a 
solution of N-tosyl isocyanate (0.77 ml, 5.07 mmol, 1.00 eq.) in dry CH2Cl2 (20 ml) and 
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stirred for 26 hours.  The reaction mixture was concentrated in vacuo and purified by flash column 
chromatography, eluting with 3:2 ethyl acetate:petroleum ether (boiling range 40-60 °C), to give an 
opaque, viscous oil, which crystallised upon standing to give thiocarbamate 488 as white crystals 
(0.130 g, 33%), melting point 91-95 °C from CH2Cl2.  δH (300 MHz, CDCl3) 7.96 (2H, d, J 8.4, ArH), 7.38 
(2H, d, J 8.4, ArH), 7.33-7.14 (5H, m, ArH), 4.13 (2H, s, SCH2), 2.48 (3H, s, ArCH3).  δC (101 MHz, CDCl3) 
165.4 (CO), 145.4 (C), 136.0 (C), 135.5 (C), 129.7 (CH), 128.9 (CH), 128.7 (CH), 128.4 (CH), 127.7 (CH), 
34.6 (CH2), 21.71 (CH3).  IR (neat): νmax = 3218 (NH), 3069 (CH), 2925 (CH), 1700 (CO), 1597, 1432, 
1345, 1172, 1079.  HR-MS (ES-TOF+): m/z calcd for C15H15NO3S2Na: 344.0391 found: 344.0398 
[M+Na].  
Benzyl(phenylethynyl)sulfide (489) Prepared using GP3.  Alkynylation was performed with 
tosylthiocarbamate 488 (500 mg, 1.56 mmol, 1.0 eq.), crude bromophenyl 
acetylene (220 µl, ca. 1.87 mmol, 1.2 eq.), 1,10-phenanthroline (11.3 mg, 624 µmol, 
0.40 eq.), CuSO4.5H2O (77.9 mg, 31.2 µmol, 0.20 eq.) and K3PO4 (79.5 mg, 3.74 mmol, 2.4 eq.) in 
toluene (5 ml) for 22 hours.  Purification by flash column chromatography, eluting with 3:97 ethyl 
acetate:n-hexane, gave sulfide  489 as a yellow oil (250 mg, 71%).  δH (300 MHz, CDCl3) 7.49- 7.18 
(10H, m, ArH), 4.04 (2H, s, CH2).  δC (101 MHz, CDCl3) 136.6 (C), 131.3 (CH), 129.1 (CH), 128.6 (CH), 
128.2 (CH), 128.0 (CH), 127.8 (CH), 123.4 (C), 94.6 (C), 79.2 (C), 40.5 (CH2).  IR (neat): νmax = 3061 (CH), 
3029 (CH), 2927 (CH), 2165 (C≡C), 1595 (C=C), 1486, 752.  In agreement with literature data.186 
 Phenyl(phenylethynyl)sulfide (494) Prepared as per literature procedure.185  A solution of n-butyl 
lithium (2.5 M, 4.3 ml, 10.8 mmol, 1.1 eq.) in dry THF was added to a -78 °C solution of 
phenyl acetylene (1.08 ml, 9.80 mmol, 1.0 eq.) in dry THF (100 ml).  After 1 hour a 
solution of S-phenyl benzenesulfonothioate (2.929 g, 1.11 mmol, 1.2 eq.) in dry THF (50 ml) was 
added.  After a further 5 hours the reaction mixture was added to NH4Cl solution (100 ml) and 
extracted with ethyl acetate (3 x 100 ml).  The organic fractions were combined, dried over Na2SO4, 
filtered and concentrated in vacuo.  Purification by flash column chromatography, eluting with n-
hexanes, gave sulfide 494 as a colourless oil (1.87 g, 91%).  δH (300 MHz, CDCl3) 7.58-7.47 (5H, m, 
158 
 
ArH), 7.41-7.32 (5H, m, ArH).  δC (101 MHz, CDCl3) 133.0 (C), 131.7 (CH), 129.3 (CH), 128.6 (CH), 128.4 
(CH), 126.5 (CH), 126.2 (CH), 122.9 (C), 97.9 (C), 75.5 (C).  IR (neat): νmax = 3059 (CH), 2168 (C≡C), 1583 
(C=C), 1477, 1440, 1023, 752.  Data in agreement with literature values.185 
 Phenyl(butylethynyl)sulfide (495) Prepared as per literature procedure.185  A solution of n-butyl 
lithium (2.5 M, 2.4 ml, 6.10 mmol, 1.0 eq.) in dry THF was added to a -78 °C solution 
of 1-hexyne (700 µl, 6.10 mmol, 1.0 eq.) in dry THF (50 ml).  After 1 hour S-phenyl 
benzenesulfonothioate (1.680 g, 6.71 mmol, 1.1 eq.) was added.  After a further 2 hours the reaction 
mixture was added to NH4Cl solution (50 ml) and extracted with ethyl acetate (3 x 40 ml).  The 
organic fractions were combined, dried over Na2SO4, filtered and concentrated in vacuo.  Purification 
by flash column chromatography, eluting with n-hexane, gave sulfide 495 as a colourless oil (0.85 g, 
73%).  δH (300 MHz, CDCl3) 7.42 (2H, dd, J 8.0, 1.2, ArH), 7.33 (2H, t, J 8.0, ArH), 7.20 (1H, tt, J 7.2, 1.2, 
ArH), 2.47 (2H, t, J 7.0, CCH2), 1.66-1.54 (2H, m, CH2CH2CH2), 1.47 (2H, h, J 7.1, CH2CH3), 0.95 (3H, t, J 
7.1, CH3).  δC (101 MHz, CDCl3) 134.0 (C), 129.2 (CH), 126.2 (CH), 125.9 (CH), 100.2 (C), 64.7 (C), 30.9 
(CH2), 22.1 (CH2), 20.1 (CH2), 13.7 (CH3).  IR (neat): νmax = 3062 (CH), 2958 (CH), 2930 (CH), 2872 (CH), 
2167 (C≡C), 1584 (C=C), 1479, 1441, 1024, 736.  Data in agreement with literature values.185 
Benzyl(butylethynyl)sulfide (496) Prepared as per literature procedure.186  A solution of n-butyl 
lithium (4.3 ml, 10.8 mmol, 1.1 eq.) in dry THF was added to a stirred, -78 °C 
solution of 1-hexyne (1.12 ml, 9.79 ml, 1.0 eq.) in dry THF.  Sulfur (313 mg, 9.79 
mmol, 1.0 eq.) was added after 15 minutes and the reaction mixture was allowed to reach 0 °C over a 
period of an hour.  Benzyl bromide (1.16 ml, 9.79 mmol, 1.0 eq.) was added and the reaction mixture 
stirred for a further hour.  The reaction was added to NH4Cl solution (50 ml) and extracted with 
diethyl ether (3 x 40 ml).  The organic fractions were combined, dried over Na2SO4, filtered and 
concentrated in vacuo.  Purification by flash column chromatography, eluting with n-hexane, gave 
sulfide 496 as a colourless oil (0.863, 43%).  δH (300 MHz, CDCl3) 7.40-7.27 (5H, m, ArH), 3.89 (3H, s, 
CH3), 2.27 (1H, t, J 6.9, SCH2), 1.60-1.22 (4H, m, CH2CH2), 0.88 (3H, t, J 7.2, CH3).  δC (101 MHz, CDCl3) 
137.2 (C), 129.2 (CH), 128.6 (CH), 127.7 (CH), 96.2 (C), 68.1 (C), 40.3 (CH2), 30.9 (CH2), 22.0 (CH2), 19.9 
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(CH2), 13.7 (CH3).  IR (neat): νmax = 3030 (CH), 2958 (CH), 2927 (CH), 2855 (CH), 2167 (C≡C), 1495, 
1455, 1070, 697.  Data in agreement with literature values.186 
Methyl(phenylethynyl)sulfide (497) Prepared as per literature procedure.186  A solution of n-butyl 
lithium (4.3 ml, 10.8 mmol, 1.1 eq.) in dry THF was added to a stirred, -78 °C solution of 
phenyl acetylene (1.08 ml, 9.79 ml, 1.0 eq.) in dry THF.  Sulfur (313 mg, 9.79 mmol, 1.0 
eq.) was added after 15 minutes and the reaction mixture was allowed to reach 0 °C over a period of 
an hour.  CH3I (610 µl, 9.79 mmol, 1.0 eq.) was added and the reaction mixture stirred for a further 
hour.  The reaction was added to NH4Cl solution (50 ml) and extracted with diethyl ether (3 x 40 ml).  
The organic fractions were combined, dried over Na2SO4, filtered and concentrated in vacuo.  
Purification by flash column chromatography, eluting with n-hexane, gave sulfide 497 as a colourless 
oil (1.1, 73%).  δH (300 MHz, CDCl3) 7.49-7.35 (2H, m, ArH), 7.35-7.09 (3H, m, ArH), 2.50 (3H, s, CH3).  
δC (101 MHz, CDCl3) 131.6 (CH), 128.4 (CH), 128.2 (CH), 123.6 (C), 92.0 (C), 81.0 (C), 19.6 (CH3).  IR 
(Neat): νmax = 3061 (CH), 2926 (CH), 2852 (CH), 2168 (C≡C), 1596, 1487, 1442, 1070, 754.  In 
agreement with literature data.186 
 Methyl(butylethynyl)sulfide (498) Prepared as per literature procedure.186  A solution of n-butyl 
lithium (4.3 ml, 10.8 mmol, 1.1 eq.) in dry THF was added to a stirred, -78 °C solution 
of 1-hexyne (1.12 ml, 9.79 ml, 1.0 eq.) in dry THF.  Sulfur (313 mg, 9.79 mmol, 1.0 eq.) 
was added after 15 minutes and the reaction mixture was allowed to reach 0 °C over a period of an 
hour.  CH3I (610 µl, 9.79 mmol, 1.0 eq.) was added and the reaction mixture stirred for a further 
hour.  The reaction was added to NH4Cl solution (50 ml) and extracted with diethyl ether (3 x 40 ml).  
The organic fractions were combined, dried over Na2SO4, filtered and concentrated in vacuo.  
Purification by flash column chromatography, eluting with n-hexane, gave sulfide 498 as a colourless 
oil (730 mg, 53%).  δH (300 MHz, CDCl3) 2.35 (3H, s, SCH3), 2.29 (2H, t, J 6.9, CCH2), 1.59-1.30 (4H, m, 
CH2(CH2)2CH3), 0.90 (3H, t, J 7.2, CH2CH3). δC (101 MHz, CDCl3) 93.4 (C), 69.9  (C), 31.0 (CH2), 22.1 
(CH2), 19.9 (CH2), 19.5 (CH3), 13.7 (CH3).  IR (Neat): νmax = 2658 (CH), 2927 (CH), 2857 (CH), 1465, 
1378, 1314, 1106, 744.  Data in agreement with literature values.186 
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Benzoyl(pyridinium)amide (521) Prepared as per literature procedure.69  Benzoyl chloride (0.52 ml, 
9.0 mmol, 2 eq.) was added to a 0 °C stirred solution of aminopyridinium iodide 
(1.000 g, 4.5 mmol, 1 eq.) in 10% NaOH solution (50 ml).  The reaction mixture was 
allowed to reach room temperature and stirred for 16 hours, then extracted with CH2Cl2 (3 x 50 ml).  
The organic fractions were combined, dried over Na2SO4, filtered and concentrated in vacuo.  
Recrystallisation from CH2Cl2 and diethyl ether gave pyridinium 521 as light brown needles (0.71 g, 
79%), melting point 180-181 °C (Lit.222 179-180 °C).  δH (300 MHz, CDCl3) 8.93-8.79 (2H, dd, J 7.0, 1.3, 
ArH), 8.25-8.16 (2H, m, ArH), 7.96 (2H, t, J 7.7, ArH), 7.79-7.65 (2H, m, ArH), 7.51-7.38 (2H, m, ArH).  
IR (neat): νmax = 3099 (CH), 3065 (CH), 2946 (CH), 2827 (CH), 1591, 1548, 1465, 1331, 1296, 1181.  
Data in agreement with literature values.69  
2,5-diphenyl-4-(phenylthio)oxazole (522)  AuCl was added to a solution of 
methyl(phenylethynyl)sulfide and pyridinium 521 in dry toluene in a flame-dried 
Schlenk flask and then the reaction mixture was immediately heated to 90 °C, using a 
preheated block.  After 18 hours the reaction mixture was cooled to room 
temperature and filtered through a plug of silica, eluting with ethyl acetate.  The filtrate was 
concentrated in vacuo and analysed by NMR spectroscopy. The yield was calculated against a known 
quantity of 1,2,4,5-tetramethylbenzene (9% by NMR).  To acquire sufficient material for 
characterisation the individual screening reactions were combined and purified by flash column 
chromatography, eluting with 3:7 toluene:n-hexane, to give oxazole 522  as a colourless oil.  δH (300 
MHz, CDCl3) 8.36-7.91 (4H, m, ArH), 7.55-7.42 (5H, m, ArH), 7.41-7.32 (1H, m, ArH), 2.52 (3H, s, SCH3).  
δC (101 MHz, CDCl3) 162.5 (C), 142.6 (C), 140.3 (C), 131.3 (CH), 130.8 (C), 128.9 (CH), 128.6 (CH), 
128.3  (CH), 127.3 (C), 127.3 (CH), 126.7 (CH), 18.8 (CH3). IR (neat): νmax = 3061 (CH), 2926 (CH), 1554, 
1489, 1447, 1341, 1072, 979.  MS (EI+): m/z (%): 267.1 (40) [M+•], 239 (31), 219 (100), 131 (46), 121 
(72); HR-MS (EI+): m/z calcd for C16H13NOS: 267.0718, found 267.0711 [M
+•]. 
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